Developing a framework to assess healthcare facilities’ essential medicine management practices by Muatunga, Ndahambelela Ndapewa Ndeshiahfela
Developing a framework to assess healthcare facilities’
essential medicine management practices
Ndahambelela Ndapewa Ndeshihafela Muatunga
Supervisor: Mr. WG Bam
Thesis presented in fulfilment of the requirements for the degree of Master of
Engineering (Engineering Management) in the Faculty of Engineering at
Stellenbosch University
December 2019
Declaration
By submitting this thesis electronically, I declare that the entirety of the
work contained therein is my own, original work, that I am the sole author
thereof (save to the extent explicitly otherwise stated), that reproduction
and publication thereof by Stellenbosch University will not infringe any
third party rights and that I have not previously in its entirety or in part
submitted it for obtaining any qualification.
Date: December 2019
Copyright © 2019 Stellenbosch University
All rights reserved
i
Stellenbosch University https://scholar.sun.ac.za
Abstract
Access to essential medicines is a fundamental human right; yet, millions
of people die each year from diseases that could be treated with modern
medicines. A lack of access to essential medicines remains the most serious
public healthcare problem globally, with approximately 30% of the world’s
population not having access to essential medicines. This figure rises to
over 50% in the poorest parts of Africa and Asia. Frequent stock-outs and
shortages of medicines continue to deny quality healthcare treatment to low-
income populations.
Medicine management seeks to find an optimal way to ensure access to
essential medicines given various constraints. The absence of adequate
assessment tools and frameworks that measure medicine management
performance at a facility level, makes it difficult for decision-makers to
make informed decisions to improve access to essential medicines.
To address this need, a maturity model was developed to assess essential
medicine management performance in public healthcare facilities. A maturity
model is a framework that is used to describe the evolution of a system over
time through the assessment of its processes. Maturity models provide a well-
structured approach to achieving tangible transformation and continuous
improvement. The developed model intends to identify opportunities for
improvement that extend access to essential medicines.
The maturity model in this study was developed using a three-phase
approach that integrated essential medicine management dimensions into
maturity model architecture. The model is based on extensive literature
reviews on essential medicines, medicine management, and maturity
models. The review of literature on essential medicine at facility level
helped to define the dimensions of the maturity model. Medicine
management literature was also reviewed to identify the key practices that
ii
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ensure access to essential medicine in healthcare facilities. Finally, maturity
model literature was reviewed to identify the appropriate maturity model
architecture which formed the basis of the maturity model developed.
The maturity model was refined and validated by subject matter experts to
ensure that the theoretical basis of the model was sound. The validation
process found that the developed maturity model adequately measures the
performance of essential medicine management at a facility level.
The maturity model developed in this research study provides an
alternative assessment method to traditional quantitative performance
measurement methods in the healthcare sector and helps healthcare
facilities focus on the various practices that drive essential medicine
management performance to increase access to essential medicine.
iii
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Opsomming
Toegang tot essensie¨le medisyne word beskou as ’n fundamentele mensereg;
tog sterf miljoene mense elke jaar aan siektes wat deur moderne medisyne
kon behandel word. ’n Gebrek aan toegang tot essensie¨le medisyne bly
weˆreldwyd die ernstigste gesondheidsorgprobleem, met ongeveer 30% van
die weˆreldbevolking wat nie toegang tot essensie¨le medisyne het nie.
Hierdie syfer styg tot meer as 50% in die armste dele van Afrika en Asie¨.
Die gereelde tekorte en onbeskikbaarheid van medisyne verhoed steeds
toegang tot gesondheidsorgbehandeling vir bevolkings met ’n lae inkomste.
Medisynebestuur poog om ’n optimale manier te vind om toegang tot
medisyne te verseker, gegewe verskillende beperkings. Daar bestann geen
voldoende assesseringsinstrumente of raamwerke wat
medisynebestuursprestasie op ’n fasiliteitvlak kan meet nie. Dit is dus
moeilik vir besluitnemers om besluite te neem wat toegang tot essensie¨le
medisyne verbeter.
Om hierdie behoefte aan te spreek, is ’n volwassenheidsmodel ontwikkel om
essensie¨le medisynebestuurprestasie in gesondheidsorgfasiliteite te assesseer.
’n Volwassenheidsmodel is ’n raamwerk wat gebruik word om die evolusie
van ’n stelsel te beskryf oor ’n tydperke deur die beoordeling van die stelsel
se prosesse. Volwassenheidsmodelle is ’n gestruktureerde metode om
prosesverbetering te bewerkstellig. Die doel van die volwassenheidsmodel
wat in hierdie studie ontwikkel is, is om geleenthede te identifiseer om
toegang tot medisyne te verbeter.
‘n Omvattende literatuur studie van essensie¨le medisyne, medisyne-bestuur
en volwassenheidsmodelle vorm die basis van die volwassenheidsmodel wat
ontwikkel is. Eerstens is essensie¨le medisyneliteratuur bestudeer om die
dimensies van die volwassenheidsmodel te identifiseer. Daarna is ’n
literatuurstudie oor medisyne-bestuur uitgevoer om belangrike elemente te
iv
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identifiseer wat toegang tot medisyne verbeter. Laastens is literatuur oor
volwassenheidsmodelle bestudeer om toepaslike
volwassenheidsmodelle-argitektuur te identifiseer wat gebruik is om die
raamwerk in hierdie studie te ontwikkel. Die volwassenheidsmodel wat in
hierdie studie ontwikkel is, is ontwikkel met behulp van ’n driefase
prosedure wat essensie¨le medisyne-bestuursdimensies in die
volwassenheidsmodelle-argitektuur ge¨ıntegreer het.
Die volwassenheidsmodel is deur drie kundiges verfyn en bekragtig om te
verseker dat die model sy doel bereik het. Die valideringsproses het bevind
dat die ontwikkelde volwassenheidsmodel die prestasie van essensie¨le
medisynebestuur op ’n fasiliteitvlak voldoende meet. Die
volwassenheidsmodel wat in hierdie studie ontwikkel is, bied ’n nuttige
assesseringsmetode wat gesondheidsorgfasiliteite help om op die belangrike
praktyke te konsentreer wat toegang tot essensie¨le medisyne kan verbeter.
v
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Chapter 1
Introduction
The purpose of this research is to develop an assessment framework that can be used
to assess essential medicine management performance in public healthcare facilities in
sub-Saharan Africa. The intent is to identify opportunities for improvement that extend
access to essential medicines. This introductory chapter presents the rationale for the
research, the problem under study and the research aim and objectives. The chapter
then concludes with a brief discussion on the ethical implications of the study and the
outline of this thesis.
Section objectives: §1.1: To explain the rationale behind the research study;
§1.2: To state the problem under study;
§1.3: To present the research aim and objectives;
§1.4: To present the structure of the document; and
§1.5: To discuss the ethical implications of the research.
1.1 Rationale of the Research
Sub-Saharan Africa has the most impoverished healthcare in the world (Conway et al.,
2017). This status has been measured by the World Health Organization (WHO) which
assesses the state of a nation’s health by using three main indicators, namely:
 life expectancy;
 healthy life expectancy; and
1
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1.1 Rationale of the Research
 the number of deaths before the age of 70.
The region of sub-Saharan Africa lags far behind other regions globally on all three
indicators (Conway et al., 2017). Further, while it accounts for 11% of the world’s
population it is responsible for 24% of the global disease burden (World Bank Group,
2008). The region has the highest burden of infectious diseases globally. Additionally,
in terms of life expectancy, one in four premature deaths from communicable diseases
are reported in sub-Saharan Africa (Meyer et al., 2017).
In 2015 at the United Nations (UN) Conference in Rio Janeiro, Brazil, the 2030
Agenda for Sustainable Development was adopted whereby 17 Sustainable Development
Goals (SDGs) were established. The focus of this present research is aligned with Goal 3
of the SDGs which resolved to promote healthcare to “[e]nsure healthy lives and promote
well-being for all at all ages” (United Nations, 2017). According to the SDGs Report at
the time, Goal 3 aims to address major health challenges to (United Nations, 2017):
 improve reproductive, maternal and child health;
 eradicate communicable diseases;
 reduce non-communicable diseases and other health hazards; and
 ensure universal access to safe, effective, quality and affordable medicines and
vaccines.
This 2015 resolution, therefore brought essential medicines centre stage as they are
known to prevent, treat or alleviate the leading causes of premature death (Embrey,
2012). In 1975, the WHO had already defined essential medicines as “indispensable
and necessary for the health needs of the population. They should be available at all
times, in proper dosage forms, to all segments of society” (Namaya, 2007).
Furthermore, access to quality healthcare, including essential medicines had been
declared a fundamental human right (WHO, 2002); yet millions of people have
continued to die each year due to common conditions which can be prevented or
treated with modern medicine. This, according to Embrey (2012), signals a
fundamental failure of a healthcare system. Medicine management, therefore, is an
important component of an effective and affordable healthcare delivery system (WHO,
2017) as it seeks to find an optimal way to ensure access to medicine given the various
2
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1.1 Rationale of the Research
constraints (Iqbal et al., 2017b). Consequently, by improving access to essential
medicines and other medical supplies, it is estimated that ten million lives can be saved
per year (Kagaruki et al., 2013).
Since medicine is the primary vehicle for healthcare delivery and has a significant
impact on the health and well-being of patients around the world (Shrestha et al., 2018)
the lack of access to essential medicines remains the most serious public healthcare
problem globally. Approximately 30% of the world’s population does not have access to
essential medicines. This figure rises to over 50% in the poorest parts of Africa and Asia
(Kagaruki et al., 2013). Frequent stock-outs and shortages 1 of medical supplies and
the reliance on out-of-pocket purchases continue to deny low-income populations quality
healthcare treatment (Mackintosh et al., 2018).
In 1977, the WHO introduced the first Model List of Essential Medicines in response
to requests for assistance from the member states for the selection and procurement of
medicine for priority healthcare needs (WHO, 2017). The first Model List contained 224
medical products which could safely and effectively treat the majority of diseases (Dukes
& Walkowiak, 2012). Medicines for the list were selected according to disease prevalence,
health relevance, evidence of clinical efficacy, safety and cost (WHO, 2010). According
to the WHO (2010), the list helps to define the minimum requirements of medicines
needed in a basic healthcare system. However, the Model List is not exhaustive but
serves rather as a guide for the member states to develop national essential medicines
lists (EMLs) which can cater best for the needs of their distinct populations.
In 1978, the International Conference of Primary Health Care, held in Alma-Ata,
Kazakhstan, identified the provision of essential medicines as one of the eight building
blocks of primary healthcare (Quick et al., 2002). Essential medicines are viewed as an
input in a system that needs to be available to allow service delivery (Bigdeli et al., 2013).
The availability of medicine is cited in several studies as a key determinant of access and
the use of healthcare services which is often a measure of the quality of a healthcare
system (Bigdeli et al., 2013). Interruptions in the supply of medicine, therefore, can lead
to disease progression, drug resistance due to disease mutation, and death (Wagenaar
1The definition of shortage and stock-out used in this thesis is in line with the definition established
by the WHO which states that (WHO, 2016): a shortage is an event when the supply of medicines,
health products, and vaccines identified as essential by the health system is considered to be insufficient
to meet public health and patient needs and a stock-out is the complete absence of the medicine, health
product or vaccine at the point of service delivery to the patient.
3
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et al., 2014). Conway et al. (2017) have also stated that the absence of essential medicinal
products is particularly problematic when trying to combat the spread of diseases.
The earlier study by Wagenaar et al. (2014) had already found that the lack of
progress in improving access to essential health products is especially evident in
developing counties. Not only are they already burdened with medicine shortages but
in recent years there is the new phenomenon of an increasing rate of shortages that has
prompted international concern about the long-term supply of essential medicines
(Hedman, 2016). Over the past decade in particular, poor performing supply systems
have been internationally recognised as a bottleneck that delays the strengthening of
healthcare systems (Yadav, 2015). However, as more low- and middle-income countries
(LMICs) face significant demographic, epidemiological and economic transitions, they
are realising the value of investing in improving their healthcare supply systems
(Yadav, 2015). There is now a recognised need to standardise medicine supply system
performance assessment by, for example, the use of benchmarking tools and approaches
to generate tangible recommendations for the improvement of supply system
performance (Yadav, 2015). Therefore, challenges affecting the efficiency of medicine
supply systems need to be identified, assessed and prioritised to improve the
availability of essential medicines in public healthcare (Musonda et al., 2018).
1.2 Problem Statement
Healthcare facilities procure and consume a wide range of medical products. Over the
past few years, however, public healthcare facilities in various developing countries have
been experiencing frequent shortages and stock-outs of essential medicines. Previous
research has shown that insufficient access to essential medicines has a direct effect
on the quality of healthcare delivered. The absence of adequate assessment tools to
measure essential medicine management performance at facility level makes it difficult
for decision-makers to make informed decisions to remedy the problem.
1.3 Research Aim and Objectives
This research aims to develop an assessment framework to benchmark essential
medicines management performance in public healthcare facilities to identify areas for
improvement. The framework developed in this study aims to serve as a
4
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complementary assessment method to traditional quantitative methods in the
healthcare sector (which focus on collecting data on performance outcomes e.g.
number of stock-outs). In particular, it aims to focus on the various practices that
drive performance. This has the potential to enable policymakers to better understand
the root causes of poor performance. To accomplish the aim of this research, the
following objectives have been identified:
1. To identify factors which hinder effective medicine management;
2. To investigate an appropriate approach for structuring/developing the proposed
framework;
3. To describe best practices for medicine management;
4. To develop a benchmarking assessment framework to evaluate essential medicine
management practices at facility level; and
5. To validate the developed assessment framework.
1.4 Chapter Structure
Table 1.1 below presents the structure of this study with a brief overview of each chapter’s
content.
Table 1.1: Structure of chapters
Chapter Chapter description
Chapter 1:
Introduction
This chapter highlights the need for this research study.
It introduces the research problem under study and
presents the research aims and objectives which will be
used to guide the development of the essential medicine
management assessment framework.
Chapter 2:
Literature Review:
Background
Overview and
Research Gap
This chapter presents an overview of essential medicine
supply system challenges and identifies the need for
an alternative method of assessing essential medicine
management performance at facility level. The chapter
also discusses the advantages of benchmarking for
process improvement and presents evidence of using
maturity models as effective assessment frameworks in the
healthcare domain.
Continued on next page
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Table 1.1 – Continued from previous page
Chapter Chapter description
Chapter 3: Research
Methodology
This chapter presents the research methodology used to
develop the essential medicine management assessment
framework.
Chapter 4: Literature
Review: Maturity
Models
This chapter presents background on maturity models and
their application. The chapter also reviews maturity model
architecture literature that could potentially be used for
the development of the essential medicine management
assessment framework.
Chapter 5: Literature
Review: Medicine
Management
This chapter presents the key focus areas for improving
access to essential medicines at facility level.
Chapter 6:
Framework
This chapter presents the essential medicine management
assessment framework developed in this study and outlines
the framework validation process.
Chapter 7:
Conclusion and
Future Work
The final chapter provides a concise summary of the
research conducted and presents research’s limitations and
recommendations for future work.
1.5 Ethical Implications of Research
There are no significant ethical implications for this study. However, since as human
participants were involved during the validation data collection phase, ethical clearance
was obtained from the Research Ethics Committee of Stellenbosch University. All
participants of the study, therefore, explicitly consented to take part in the study and
were assured that their contribution was voluntary and that anonymity would be
preserved in these final published research findings.
1.6 Conclusion: Chapter 1
Chapter 1 introduces the research study by establishing the background for the research,
presenting the problem statement and presenting the research aim and objectives. The
chapter concludes with a brief discussion regarding the ethical implications of the study.
Chapter 2 presents a literature review which provides an overview of the challenges for
essential medicines supply systems as well as evidence to support the development of an
alternative assessment method to evaluate essential medicines management performance
at facility level.
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Literature Review: Background
Overview and Research Gap
Chapter 1 presented a background on the research problem under study and
highlighted the need for improved access to essential medicines in the developing
countries of sub-Saharan Africa. Chapter 2 presents an overview of the challenges
facing medicine supply systems and introduces the concept medicine management as
an approach to improve access to essential medicines. This chapter also presents a
review of existing methods of assessing access to medicine and highlights the benefit of
using maturity models as a benchmarking assessment tool for evaluating essential
medicine management performance.
Section objectives: §2.1: To highlight challenges facing medicine supply systems;
§2.2: To introduce the key functional areas for effective
medicine supply;
§2.3: To present existing methods of assessing medicine
supply management;
§2.4: To present the research gap identified;
§2.5: To provide evidence of benchmarking as an effective
assessment method and decide which benchmarking
assessment framework will be developed in this study;
and
§2.6: To present the outcome of a systematic literature
review on maturity models as a useful benchmarking
assessment frameworks in the healthcare domain.
7
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2.1 Medicine Supply Systems
In developing countries, medicine is responsible for approximately 40% to 60% of total
health expenditure (Shrestha et al., 2018). Medicine supply management, therefore,
has been brought to the forefront of many of these countries’ healthcare agendas to
improve efficiency. The WHO has established that an efficient medicines supply system
forms an integral part of a strong healthcare system (WHO, 2017). Recent research has
revealed that, depending on the country, supply system inefficiencies occur globally with
different causes and challenges (Musonda et al., 2018). It appears, therefore, that under-
performing supply systems contribute to high prices and limit the availability of quality
healthcare products for effective disease control (Bam et al., 2017). The effectiveness of
a medicines supply system, therefore, is considered a reflection of a country’s ability to
address public healthcare challenges (Uthayakumar & Priyan, 2013).
Medicines supply systems are large and often extend outside the borders of the
country and this factor makes them particularly challenging to analyse. In addition,
supply management of essential medicines differs from that of other medical supplies due
to the nature of the products (Musonda et al., 2018). Supply systems are further made
complex by uncertainty in supply and demand and in order to increase the availability
and access to medicines, supply systems already in place need to become more robust,
agile and flexible (Iqbal et al., 2017b). According to Bam et al. (2017), supply systems
need to have the ability to withstand unplanned changes in demand caused by external
variables without shortages or stock-outs.
According to Yadav (2015), medicine supply systems in developing countries are
fraught with problems. Improving medicine supply management requires the vertical
and horizontal interconnectivity of human resources, information systems, financing
and evidence-informed regulations and policies (Oteba et al., 2018). Figure 2.1 below
illustrates the different focus areas of improvement at different levels of a healthcare
system.
8
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Figure 2.1: Priority action areas to strengthen medicine supply (Oteba et al., 2018)
Sections 2.1.1 to 2.1.4 provide an overview of medicine supply system challenges in
a healthcare system focussing primarily on challenges regarding regulations and polices,
financing, information systems and human resources, respectively.
2.1.1 Regulations and Policies
A good policy at a national and facility level is known to have far reaching
repercussions and is considered a necessity for optimal system functionality (Conway
et al., 2017) and it is governments that have the responsibility of developing laws,
policies and standards which regulate medicine in a healthcare system. According to
the WHO (1999), however, existing government policies and regulations as well as
institutional structures for medicines supply management are frequently inadequate
and can hinder the overall efficiency of a healthcare system. Healthcare policies and
regulations dictate the state and success of a system and according to Conway et al.
(2017), poor access to medical products is a result of outdated strategies and policies.
It has been established that at facility level, lack of policy or poor policy often results
9
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in functional problems and poor service delivery due to resource mismanagement
(Conway et al., 2017).
For any intervention to be successful, the changes implemented often need to be
integrated into existing policies, regulations, procedures and practices and rigorously
evaluated to avoid replication of unsuccessful approaches (Oteba et al., 2018). In
addition, policies and regulations need to be regularly updated to ensure that they
address the current health situation in a country and are in line with international
standards (Tema, 2014).
2.1.2 Financing
Governments have the responsibility to establish appropriate and reliable funding
strategies for public healthcare delivery and to ensure adequate funding is available at
all times (Kai Hong, 2016). Sources of financing for medicine include government
financing, user fees, health insurance, community co-financing and donor financing.
According to Kai Hong (2016), each of these funding sources vary in terms of the
efficiency, equity and sustainability. In particular, it has been found that unsustainable
sources of funds often lead to medicine shortages and result in the overall inefficiency
of a healthcare system (WHO, 1999).
Adequate healthcare financing ensures timely procurement and guarantees the
uninterrupted availability of medicines at different levels of a healthcare system
(Yadav, 2015). According to the WHO (1999), a system’s ability to order medicine
when needed and to pay for them on delivery has a positive effect on reducing
stock-out rates. Furthermore, the prompt and reliable payments increase suppliers’
confidence in a system which allows for better price negotiations (WHO, 1999). The
Tema (2014) found that irregular funding leads to delayed payments, which in turn
forces suppliers to deny credit and insist on advance payments. Another factor is that
limited health budgets also put pressure on manufactures to lower prices which then
threatens the quality of the products being produced (Hedman, 2016). Efficient and
effective financial management systems are important especially when funding is
limited (Barraclough & Clark, 2012).
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2.1.3 Information Systems
Timely and accurate information is critical for improved productivity, effectiveness and
efficiency of medicine supply management practices to help control costs and also
minimise the possibility of a stock-out (Ombaka, 2009). Information systems can be
used to identify problems, assess the impact of inventions and monitor and evaluate a
system’s performance (Oteba et al., 2018). Information included in an information
system needs to be of high quality and accurate as it forms the basis for decision
making; however, if the quality of information is poor at facility level it makes data
related to consumption and stock-outs difficult to analyse. For this particular
challenge, a health information system (HIS) is applicable. This system integrates data
collection, processing, reporting and use of the information needed to improve health
service effectiveness and efficiency through better management (Kagaruki et al., 2013).
A strong HIS enables evidence-based decision making for planning, budgeting and
allocation of scarce resources and helps practitioners gain insight in to the performance
of a healthcare system (Kagaruki et al., 2013).
2.1.4 Human Resources
Human resources need to ensure that medicine supply management practices are
carried out effectively, efficiently and in accordance with national policies, laws and
regulations (WHO, 1999). Given the impact of medicine supply management activities
on the operation and effectiveness of a healthcare system, it is particularly essential
that these activities are performed by qualified staff with high professional and ethical
standards, using sound procedures based on appropriate policies and regulations
(Muhia et al., 2017). According to the WHO (1999), the lack of properly trained staff
in key positions contributes to poor access to medicines even when well established
policies and regulations are in place. Unfortunately, the lack of career development and
generally unattractive public sector salaries restricts the healthcare sector’s capacity to
attract and retain qualified and competent personnel (Henderson & Tulloch, 2008).
2.2 WHO Medicine Management Cycle
Figure 2.2 below illustrates the WHO Medicine Management Cycle, whereby the cycle
represents the main functional areas of effective medicine supply management, namely
11
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selection, quantification, procurement, storage and distribution (WHO, 2017). These
functions are organised in a cycle to emphasise their interdependence (Tema, 2014).
Figure 2.2: The WHO Medicine Management Cycle (WHO, 2017).
According to Embrey (2012), to improve access to essential medicines, the medicine
management cycle needs to be reinforced by strong management support systems such
as:
 organization;
 sustainable financing;
 information management; and
 human resources management.
The entire medicine management cycle and its support systems, rely on well developed
and established policies, laws and regulations which, when supported by good
governance, enable sufficient access to essential medicines. The WHO Medicine
Management Cycle is discussed in more detail in Chapter 5.
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2.3 Assessment Tools
One of the most basic yet significant advances in medicine management has been the
introduction of objective standard indicators for assessing, comparing and monitoring
the effectiveness medicine management practices (Embrey, 2012). Effective monitoring
and evaluating focus on a small set of well-formulated and specific indicators1 that
are directly related to the performance of the system (Miralles et al., 2012). Standard
indicators allow a system to compare itself to a target performance level, identify areas of
strength and weakness, and to make comparisons with similar systems (Embrey, 2012).
Given the complexity of monitoring access to medicines, a range of indicators are used
to provide data on medicine availability and price in conjunction with policy indicators
(WHO, 2010). The WHO recommends the use of the following core indicators to measure
access to essential medicines every three to five years (WHO, 2010):
 Average availability of 14 selected essential medicines in public and
private health facilities. This indicator is a measure of the average percentage
of medicine outlets, where the selection of essential medicines were found on the
day of the survey.
 Median consumer price ratio of 14 selected essential medicines in
public and private health facilities. This indicator measures consumer price
ratios, which is calculated as the ratio between median unit prices and
Management Science for Health median international reference prices.
Sources of information on access to essential medicines take the form of facility
surveys and key informant surveys. Facility surveys on the data related to the
availability and use of essential medicines (WHO, 2010). The WHO and Health Action
International (HAI) developed a standardised methodology for facility-based surveys
on access to essential medicines. The survey collects data on the availability and prices
of approximately 50 medicines (14 medicines in use worldwide, 16 regionally specific
medicines and 20 medicines of national importance). These data are collected through
visits to medicine outlets.
1An indicator is a variable that measures change and is generally linked to a system’s plans, objectives
and targets (Miralles et al., 2012).
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Key informant surveys provide information about medicine supply system practices.
According to the WHO (2010), surveys with experts who have extensive knowledge about
the medicine context in a country can be used to acquire information about medicine
selection, procurement, use and policy. This method is low cost and relatively easy to
implement: however, one drawback of the method is its subjectivity which introduces
measurement errors and affects the comparability of results (WHO, 2010).
The WHO survey package developed in 2002 to monitor and assess the
pharmaceutical situation in countries provides a cost-effective means of determining
availability of essential drugs, their safety, efficacy and quality (Namaya, 2007). The
survey’s indicators measure the degree to which a country is meeting the National
Drug Policy’s objectives of availability, affordability, quality and rational use of
essential medicines (Namaya, 2007).
According to Miralles et al. (2012), it is important that outcome indicators for
medicine management focus on aspects of availability and affordability of essential
medicines, as well as quality issues and the appropriate use of medicines. Miralles et al.
(2012) state that these indicators are typically the most visible and commonly cited for
evaluating the success of a supply system’s functionality. In sum, systematic and
ongoing monitoring is essential:
 to ensure that the performance is on track;
 to improve performance; and
 to achieve long-term goals and results.
2.4 The Research Gap
Given that medicine management practices have a positive or negative effect on access
to appropriate healthcare treatment, research into mechanisms that affect healthcare
outcomes needs further study to improve the state of healthcare in sub-Saharan Africa
(Conway et al., 2017). More recently Mackintosh et al. (2018) have concurred that
medicine management in LMICs remains understudied and unanalysed.
When analysis of medicine management in the healthcare sector takes place little
attention is often paid to medicine supply management practices (Mackintosh et al.,
2018). Literature reviews by Kjos et al. (2016) and Iqbal et al. (2017a) have agreed that
14
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there is a paucity of published literature on medicine supply management activities for
public health facilities in developing countries. These activities include the following:
 selection;
 quantification;
 procurement;
 storage; and
 distribution.
The studies mentioned above have also found that there are no adequate performance
measures or tools available which assess and evaluate medicine management activities
in public healthcare facilities. Many countries do not routinely monitor or report on
the performance of their supply systems, which in itself is a significant indicator of sub-
optimal performance (Iqbal et al., 2017b). When the existing monitoring does occur it
usually takes the form of a periodic survey for only a limited set of indicators with a
focus primarily on the availability of essential medicines.
Healthcare processes and the management thereof have a direct impact on the
quality of healthcare services delivered (Tarhan et al., 2015). Healthcare organizations
are now under constant pressure to achieve better outcomes with fewer resources
(Schriek et al., 2016), while simultaneously facing various challenges ranging from
operational inefficiencies to high costs and poor quality (Fitterer & Rohner, 2010). The
importance of continuously improving healthcare processes to improve the quality of
care delivered has been documented in many studies (Schriek et al., 2016). The failure
to use a systematic diagnostic method or tools to determine why a healthcare system is
under-performing has tended to lead to ad-hoc projects that address only the
symptoms of the underlying structural causes (Yadav, 2015).
Since the healthcare domain offers high-risk services to patients daily in a complex,
dynamic and multidisciplinary environment it requires the right tools to assess and
sustain process improvement interventions. Process improvement is significantly
enabled by measurement tools that facilitate benchmarking against best practices
(Caralli et al., 2012). Benchmarking the performance of medicine supply management
practices provides important information on whether the processes and practices in
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place are satisfactorily ensuring access to medicine. Being able to benchmark a system
against a recognised standard helps to evaluate the effectiveness of improvement efforts
and encourages policy-makers to provide funds for new initiatives to expand and
improve the system when the results demonstrate inadequacies within the current
system (Kjos et al., 2016).
2.5 Benchmarking
Benchmarking is the process of identifying the highest standards of excellence for
products, services or processes and then making the improvements necessary to reach
those standards (Elmuti & Kathawala, 1997). According to Ahmed & Rafiq (2002),
benchmarking provides a clear signal of success or failure in a system. The process of
benchmarking entails analysing one’s own performance by highlighting the strengths
and weaknesses, and assessing what needs to be done to improve the performance
(Salem et al., 2012). The central essence of benchmarking is about learning how to
improve organizational activities, processes, and management (Hashim et al., 2012).
Benchmarking helps organizations to determine what they could be doing better by
setting achievable goals that have already been proven successful (Elmuti &
Kathawala, 1997). Benchmarking is also used in a variety of industries as a method of
identifying new ideas for process development and is increasingly becoming popular as
a tool for continuous improvement (Hashim et al., 2012).
Benchmarking assessment frameworks seek to evaluate the determinants of high
performing processes and activities in order to identify “gaps”; gaps are indicative of
the potential for improvement in an organization (Ahmed & Rafiq, 2002). This
research aims to develop a benchmarking assessment framework to assess the
performance of essential medicine management practices at facility level. The
framework aims to identify opportunities for improvement while simultaneously
providing guidance of which practices need to be improved to extend access to essential
medicines. The researcher reviewed three types of benchmarking frameworks in
Appendix A for assessing processes; namely: gap analysis, balanced scorecards and
maturity models. The aim of the review was to identify a suitable benchmarking
framework to develop in this study to achieve this research’s aim and objectives.
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All three frameworks reviewed have the potential to benchmark medicine
management practices at a facility level and have been widely used to assess processes
in the healthcare domain; however, for this research, a maturity model will be
developed. According to Marra et al. (2018), benchmarking frameworks can be
valuable when they can be used to identify the sequence of steps needed for process
improvement. After the review of the gap analysis and balanced scorecard approaches,
the researcher found that those frameworks focus primarily on the “to-be” state of a
process or system and do not provide guidance on how to improve the current state.
As Hofmann et al. (2012) noted, some frameworks focus too much on the fulfilment of
requirements but do not help determine how to improve the performance of a system.
The researcher found this to be case for the gap analysis and balanced scorecard
approaches.
A maturity model will be developed in this study because it measures and thereby
support process improvement and facilitates extensive benchmarking and continuous
improvement (Gastaldi et al., 2018). Maturity models are an established approach for
assessing processes which emphasises the notion of continuous improvement through
levels of process formality (Srai et al., 2013) and help organizations to plan and execute
process-based transformation (Schriek et al., 2016).
2.6 Maturity Models
An analysis by Wendler (2012) of 237 articles between 1999 and 2010 found that the
majority of the literature on maturity models focused primarily on software engineering,
information systems, and information communication and technology. It also found that
only six of the 237 articles were related to healthcare. The analysis by Wendler (2012)
led So¨ylemez & Tarhan (2016) to identify a lack of maturity models specifically focused
on process assessment or process improvement in the healthcare domain.
The following subsections present the methodology used and the outcome of a
systematic literature review on maturity models in the healthcare domain.
2.6.1 Methodology Used
The aim of this systematic literature review is to identify literature that proves the
usefulness of maturity models in accessing process and practices in the healthcare
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domain. According to Carvalho et al. (2016) it is important to define a strategy to
systematically identify and analyse the literature. The methodology used for this
systematic literature review was adapted from the approach by Carvalho et al. (2016)
as illustrated below in Figure 2.3.
Figure 2.3: Systematic literature review methodology
A description of this fourfold approach is outlined as follows:
Keywords and search criteria. The inclusion and exclusion criteria ensures the
quality and similarity of literature required to address the aim of the systematic literature
review (Carvalho et al., 2016). The keywords defined as the literature search criteria
were:
“health care” or “healthcare”
and
“maturity model” or “capability maturity model”
and
“process” or “process improvement” or “process maturity” or “process assessment” or
“process capability”
An initial review of maturity model literature identified a trend in the focus on
information systems and technology (IST) maturity models. A similar trend was also
noticed during a general search for maturity models literature in the healthcare domain.
Owing to the extensive literature on IST maturity models reviewed (both generally and
specific to healthcare) in Chapter 4, this systematic literature review excluded the review
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IST maturity model literature. The literature included in this review focused specifically
on the use of maturity models as process assessment framework in the healthcare domain.
Relevant literature. It is important to identify relevant literature using extensive
and reputable databases which efficiently produce objective search results. Two
databases were used to identify the relevant literature, namely: Scopus and Web of
Science. Scopus and Web of Science are well know and widely used scientific literature
databases. Web of Science includes literature from more than 10 000 peer-reviewed
journals (Aghaei Chadegani et al., 2013). According to Aghaei Chadegani et al. (2013),
Scopus is the largest multidisciplinary scientific literature database with more than 49
million publications and over 20 500 peer-reviewed journals.
The keywords were used to search the title, abstract and keywords of publications
on Scopus and Web of Science, which identified 72 documents on 2 May 2019.
Assessment and selection of literature. After a review of the document results
from the initial search, nine documents were selected based on their adherence to the
inclusion and exclusion criteria. Figure 2.4 below illustrates the process of elimination.
Figure 2.4: Search results 2 May 2019
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Literature synthesis A literature synthesis is the process of systematically extracting
relevant information from each selected document. The type of data extract should be
relevant to the review’s aim and objectives (Okoli & Schabram, 2010). The selected
literature listed in Table 2.1 below was used to achieve the aim of a systematic literature
review by answering the following questions:
1. Are maturity models an appropriate tool/method for assessing process in the
healthcare domain?
2. How are maturity models developed in the healthcare domain?
3. How are maturity models validated in the healthcare domain?
Table 2.1: List of selected literature
Author(s) Title
So¨ylemez & Tarhan (2016) The Use of Maturity/Capability Frameworks for Healthcare
Process Assessment and Improvement
Tarhan et al. (2015) Assessing healthcare Process Maturity: Challenges of using
a Business Process Maturity Model
Fitterer & Rohner (2010) Towards assessing the networkability of health care
providers: A maturity model approach
Schriek et al. (2016) A maturity model for care pathways
Cleven et al. (2014) Process management in hospitals: an empirically grounded
maturity model
Gastaldi et al. (2018) Measuring the maturity of business intelligence in
healthcare: Supporting the development of a roadmap
toward precision medicine within ISMETT hospital
Voigt et al. (2014) ‘Act on oncology’ as a new comprehensive approach to
assess prostate cancer centres - Method description and
results of a pilot study
Mettler & Blondiau (2012) HCMM - A maturity model for measuring and assessing
the quality of cooperation between and within hospitals
Hofmann et al. (2012) Act on stroke - optimization of clinical processes and
workflow for stroke diagnosis and treatment
The findings of the systematic literature review are presented in the following
subsections.
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2.6.2 Maturity Model as an Assessment Framework
Given that the improvement of key processes in the healthcare domain leads to better
healthcare outcomes (Hofmann et al., 2012), the first step to enhance the effectiveness
and efficiency of a process is to assess the current state of such a process. Assessment
frameworks form part of the foundation of process improvement initiatives; they enable
process quality to be rated by a consideration of the degree of conformity to a specified
standard (So¨ylemez & Tarhan, 2016).
Many maturity models have been developed to guide process improvement initiatives
in the healthcare domain (Schriek et al., 2016). According to Tarhan et al. (2015), the
quality of healthcare services is influenced by the maturity of the processes that comprise
the system. The findings from maturity models are often translated into action plans
which result in process improvement (So¨ylemez & Tarhan, 2016). According to Fitterer
& Rohner (2010), process maturity is the basis for improving an organisations capacity
to carry out its objectives efficiently and effectively.
Introducing maturity models as an assessment tool brings a total quality perspective
to the healthcare domain (Tarhan et al., 2015) and provides a holistic assessment method
to improve process maturity (Fitterer & Rohner, 2010). The literature supports the
use of maturity models as an effective assessment framework in the healthcare domain,
however, Hofmann et al. (2012) state that there is a drawback in the fact that each
individual organization has to establish its own definition of a quality process. This
makes it difficult for the model to be widely used and accepted.
2.6.3 Maturity model architecture
An effective way of designing a new maturity model is by reviewing existing maturity
models (Fitterer & Rohner, 2010). According to So¨ylemez & Tarhan (2016), there is
no set guideline for developing maturity models specifically for the healthcare domain
as there is a lack of consensus regarding which dimensions and maturity levels are most
applicable to the healthcare sector. However, including relevant model elements from
existing maturity models allows for the integration of accepted concepts for assessing
process maturity (Fitterer & Rohner, 2010). So¨ylemez & Tarhan (2016) also recommend
developing new maturity models based on well validated existing models.
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The Capability Maturity Model (CMM) is widely used as the basis for developing
new maturity models by adapting its structure and content (So¨ylemez & Tarhan,
2016). Organizations in the healthcare domain often operate as loosely coupled sets of
highly specialised silos which make them different from organizations in other
industries, therefore, generic maturity models such a CMM need to be adapted to serve
its purpose in a new domain (Schriek et al., 2016). Adaptations to the CMM require
changes in dimensions, adopting domain specific terminology, and changing the level of
abstraction for each maturity level to incorporate critical core competencies of the new
domain (Schriek et al., 2016).
Extensive literature reviews are required to ensure that all the necessary components
of a maturity model are included (Gastaldi et al., 2018). Fitterer & Rohner (2010)
further suggest that dimensions included in the maturity model should be based on
aligning the dimensions to best practices to improve the model’s ability to assess process
maturity effectively. While the descriptions of maturity levels vary, depending on the
domain for which the maturity model is developed, it is important that a consistent
scale of maturity is established to ensure the model is adequately able to determine
process maturity (Fitterer & Rohner, 2010). According to Fitterer & Rohner (2010),
this can be accomplished by developing maturity levels that are comparable to those of
the CMM. The CMM architecture is useful in providing guidance on defining dimensions
and maturity levels a meaningful sequence (Cleven et al., 2014).
2.6.4 Maturity model validation
It is important to validate a maturity model to ensure that it captures the real-context of
the domain appropriately (Fitterer & Rohner, 2010). Validation determines a maturity
model’s rigour and relevance (Fitterer & Rohner, 2010). Relevance is closely linked to
utility which describes the ability of the maturity model to solve the outlined problem
(Cleven et al., 2014). Most studies advocate for the validation of maturity models using
case studies and implementation. According to Tarhan et al. (2015), these methods are
preferred because they allow the model to be tested in a real-world setting and, therefore,
help to validate the general applicability of a maturity model (Voigt et al., 2014).
Consulting experts in a field is also known to increase the relevance and validity of
the maturity model (Gastaldi et al., 2018). Qualitative research methods can be used
to gain insight into a practitioner’s understanding of a framework and has been proved
22
Stellenbosch University https://scholar.sun.ac.za
2.7 Conclusion: Chapter 2
to be useful to investigate new ideas and determine the applicability of the model in the
“real world” (Cleven et al., 2014). It is, however, important that these experts are key
actors in the domain to ensure that their input is meaningful (Fitterer & Rohner, 2010).
2.7 Conclusion: Chapter 2
Chapter 2 provides a brief overview of medicine supply system challenges and
introduces the concept of medicine management. The chapter reviews the literature for
methods of assessing medicine management performance that improve access to
essential medicine. It also identifies the need for the development of a maturity model
to benchmark medicine management practices and pinpoint opportunities for
improvement. Chapter 3 presents the research methodology used in this study to
develop an essential medicine management benchmarking framework.
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Research Methodology
Chapter 2 presented an overview on medicine supply system challenges and identified
the need for a benchmarking tool to assess essential medicine management practices at
facility level. Chapter 3 presents the research methodology used in this study. The
chapter starts by defining the type of research that will be conducted and identifies the
research methods that will be used for data collection. The chapter also presents the
research approach to develop an essential medicine management maturity model in this
study.
Section objectives: §3.1: To define the type of research that will be conducted in
this study;
§3.2: To describe the research method used for data
collection.
§3.3: To provide an overview of the research approach
developed by Srai et al. (2013) and explain why it
was chosen as a guideline for the development of the
essential medicine management maturity model; and
§3.4: To describe the process of developing an essential
medicine management benchmarking framework.
3.1 Research Design
The function of research design is to ensure that the evidence obtained in the research
answers the initial research question unambiguously (de Vaus, 2001). Research is often
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classified in terms of its purpose (Kothari, 2004). Research designs are typically grouped
as exploratory, descriptive or explanatory (Kothari, 2004). Table 3.1 below summarises
the research design types.
Table 3.1: Types of research design.
Research design Description
Exploratory This research design seeks to achieve new insights into
a phenomenon and is often undertaken when few or no
previous studies on a subject exist (van Wyk, 2011). The
aim of this approach is look for patterns, hypothesis or
ideas that can be tested and will form the basis for further
research (Neville, 2012).
Descriptive This research design seeks to provide an accurate and valid
representation of the factors or variables that are relevant
to the research question (van Wyk, 2011). Quantitative
techniques are often used to collect, analyse and summarise
data for descriptive research (Neville, 2012).
Explanatory This research design seeks to identify cause and
effect relationships between variables (van Wyk, 2011).
Explanatory research can be viewed as an extension of
descriptive research as it aims to explain why something is
happening (de Vaus, 2001).
The research for this study comprises strong elements of exploratory research that
focuses on developing an essential medicine management maturity model. Although
essential medicine shortages and stock-outs are not a new phenomenon (see section 1.1)
and extensive research continues to be conducted on the subject the tool for this study
enables healthcare facilities to benchmark and analyse the performance of their medicine
management practices. This capability is to ensure adequate access to essential medicines
- the current challenge identified as a gap in the literature in section 2.4.
3.2 Research Method
Research methods refer to a range of techniques and procedures used for the collection
of research data that can facilitate inference and interpretation for explanation and
prediction (Naicker, 2014). Research methods refer to the tools used to conduct
research and can be classified as either qualitative, quantitative or mixed. Quantitative
research methods examine numerical data and often make use of statistical tools to
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analyse the data collected (Neville, 2012). Quantitative methods allow for the
measurement of variables to establish the relations between them. Qualitative research
methods, on the other hand, are non-numerical research methods focused on
establishing an understanding of a phenomena in their ‘natural setting’ (Neville, 2012).
According to Neville (2012), qualitative research methods are more subjective in
nature and focus on reflecting on the less tangible aspects of a search subject. Mixed
methods, however, are composed of a combination of qualitative and quantitative
research methods.
This research made use of qualitative interviews as a research method for data
collection. Qualitative interviews are used when seeking the views and opinions on a
topic from an interviewees’ perspective (MacDonald & Headlam, 1999). According to
Kothari (2004), exploratory investigations which involve original field interviews secure
greater insight into the practical aspects of the problem under study. In addition,
interviews can be grouped into three main styles, namely: structured, semi-structured
and unstructured interviews. These are described as follows:
 Structured interviews. Structured interviews involve the use of a questionnaire
based on a predetermined and identical set of questions (Neville, 2012). This type
of interview is used when the researcher sets out to acquire information where
responses are directly comparable (MacDonald & Headlam, 1999).
 Semi-structured interviews. Semi-structured interviews list the themes and
areas to be covered and there may be some standardised questions; however, the
interviewer may omit or add questions depending on the situation and flow of
the conversation (Neville, 2012). According to MacDonald & Headlam (1999),
semi-structured interviews provide flexibility for the researcher to develop themes
and issues by responding to answers provided by an interviewee. Semi-structured
interviews are well suited for exploratory research.
 Unstructured interviews. Unstructured interviews are considered informal
discussions where the interviewer explores a topic in-depth with another person
in a spontaneous way (Neville, 2012). This method of interviewing does not
follow any predetermined pattern of questions or themes, unstructured interviews
are useful when a researcher wishes to explore the full breadth of a topic
(MacDonald & Headlam, 1999).
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Semi-structured interviews were identified as the most appropriate data collection
method as they provided the interviewer with the flexibility to explore the area of study in
great detail and allowed the interviewees to fully express themselves without restriction.
3.3 Research Approach Selection
Research approaches are plans and procedures for research that detail the steps from
broad assumption to detailed methods of data collection, analysis, and interpretation
(Creswell, 2014). According to Creswell (2014), the selection of a research approach
should be based on the nature of the research problem, the researcher’s experience, and
the audience of the study. The research approach used in this study is an adapted
research approach proposed by Srai et al. (2013).
The study by Srai et al. (2013) is based on supply network maturity models, supply
networks and sustainability. They describe a three-phase approach for the development
of a maturity model. The maturity model developed integrated sustainability
dimensions into an established supply network maturity model architecture based on
extensive literature reviews on supply network maturity models, supply network and
sustainability. The maturity model developed helped organization to benchmark their
sustainable supply network practices and identify areas where they could be more
efficient with the use of energy and resources while minimising waste (Srai et al., 2013).
The study developed an effective tool to measure the sustainability activities of
organizations.
Consequently, this study followed the research approach by Srai et al. (2013)
because it successfully led to the development of an alternative measurement tool to
existing quantitative measurement approaches which were complex, resource-intensive
and presented significant validation challenges. This challenge, therefore, is similar to
that faced in this research. Srai et al. (2013) identified that effective sustainable supply
networks management led to improved organizational performance. The same principle
is also supported by the WHO (2004); namely, that more effective medicine
management practices would result in improved access to essential medicines. The
maturity model approach for the assessment of an organization’s processes, therefore,
moves the focus of assessment from process outcomes to evaluating practices within a
27
Stellenbosch University https://scholar.sun.ac.za
3.4 Research Approach of this Study
process that contribute to the outcomes. Having an appropriate method of evaluating
a process has a significant effect on the ability to improve process outcome.
3.4 Research Approach of this Study
This research aims to develop an assessment framework to benchmark essential medicine
management performance in public healthcare facilities. The objective of the framework
is to identify areas for improvement that ultimately improve access to essential medicines.
To address the aim and objectives of this research, an adapted assessment framework
development approach proposed by Srai et al. (2013) was followed as a guideline. The
adapted research approach can be seen in Figure 3.1 below.
Figure 3.1: Research approach of this study
An overview of the three phases of the research approach used in this study is
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provided by the following subsections: framework development, framework validation,
and analysis and results.
3.4.1 Framework development
The framework developed in this study assesses the maturity of essential medicine
management practices at facility level. While the extensive literature review provided
the theoretical foundation (Okoli & Schabram, 2010) to bring the research problem
into context, it also formed a firm foundation for advancing knowledge and helped to
identify areas where research is needed (Levy & Ellis, 2006).
Essential medicine literature was reviewed to help gain a deeper understanding of
this key element in the provision of quality healthcare service delivery. The review of
literature on essential medicine at facility level helped to define the dimensions of the
assessment framework. Literature on medicine management was reviewed to identify
the key practices that ensure access to essential medicine in healthcare facilities. The
literature review on medicine management also set out to identify the recognised best
practices of medicine management. Maturity model literature was reviewed to identify
appropriate maturity model architecture which formed the basis of the assessment
framework developed.
Srai et al. (2013) has found that incorporating dimensions into maturity model
architecture provided a basis for an effective assessment framework. Essential medicine
management dimensions found in the literature were integrated into maturity model
architecture to develop a preliminary essential medicine management assessment
framework.
3.4.2 Framework validation
Validity represents the trustworthiness of the research findings (Naicker, 2014). Ways
of ensuring validity include the use of various sources of data and relating the findings
of the research to broader theory (Naicker, 2014). Implementation or case studies (as
discussed in section 2.6.4) are the best methods for validating maturity models. However,
these methods of validation were not feasible for this study due to the time constraints,
resources available, and extensive ethical clearance required to conduct comprehensive
validation studies in healthcare facilities.
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The preliminary essential medicine management assessment framework developed in
this study was subject to construct validity (both face and content validity) to ensure
that the theoretical basis of the framework was sound. Face validity assesses whether
good translations of the constructs have been achieved (De Bruin et al., 2005) and
one suggestion is that experts in the field are consulted to judge whether the particular
research outcomes address the research’s objectives (Kothari, 2004). Content validation,
on the other hand, determines how well a domain has been represented (De Bruin et al.,
2005). The extent of the literature review and the breadth of the domain covered provides
a good measure of content validity.
Triangulation was then applied to strengthen the validity of this study.
Triangulation is defined as the use of two or more methods of data collection to
examine a particular phenomenon (MacDonald & Headlam, 1999). According to
MacDonald & Headlam (1999) triangulation provides additional sources of valuable
insight that cannot be obtained from a literature review in that it aims to find
consistency in the forms of the data collected. Subject matter experts were consulted
to ensure that the appropriate dimensions, maturity level, and best practices were
identified to achieve the aim of the maturity model. The following subsections provide
an overview of the subject matter expert selection process as well the subject matter
expert consultation process.
3.4.2.1 Subject matter expert selection
This research made use of non-probabilistic sampling. In particular, the sampling
method used was purposive sampling; a method of sampling that enables the
researcher to use their judgement to choose participants best suited to provide the data
required for the research study’s objectives (Neville, 2012). It involves selecting
participants that are especially informed on a specific subject in order to gain a better
understanding of a phenomenon (Neville, 2012).
For this study it involved selecting pharmacists with a qualification equivalent to a
B.Pharm1 with a minimum of five years experience in medicine management practices
in the public or private healthcare sector.
1Bachelor of Pharmacy (B.Pharm) is an undergraduate degree course in the field of pharmacy
education.
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3.4.2.2 Subject matter expert consultations
The researcher conducted three semi-structured interviews between 20 June 2019 and
31 July 2019 with subject matter experts who provided opinions on the following:
 the research problem;
 the ability of the assessment framework to benchmark essential medicine
management practices;
 whether the framework represents medicine management practices in the real-world
adequately; and
 whether the solutions proposed by the model are realistic.
The interview questions were predetermined and standardised, each participant was
asked identical questions and in the same sequence and the interviews were conducted
on a face-on-face basis. The interview questions can be found in Appendix B.
3.4.3 Analysis and Results
The final phase of the research approach dealt with the integration of feedback from the
subject matter expert consultations into the preliminary framework where applicable;
and presented the final version of the assessment framework.
3.5 Conclusion: Chapter 3
Chapter 3 presents the research design and research methods used in this study. The
chapter also presents the research approach used in this study to develop an essential
medicine management maturity model. Chapter 4 reviews maturity model literature to
gain an understanding of the architectural elements of a maturity model.
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Literature Review: Maturity
Models
Chapter 3 presented the research methodology used in this study to develop an essential
medicine management maturity model. Chapter 4 introduces the concept of ‘maturity’
and provides a brief history of maturity models. The chapter also describes the types of
maturity models that can be developed and the type of entities that can be measured
using maturity models. Finally, the chapter concludes with an overview of maturity
model architecture which could potentially be used to develop an essential medicine
management maturity model for this study.
Section objectives: §4.1: To define ‘maturity’ in the context of maturity models
and provide a historical overview of maturity models;
§4.2: To describe how maturity models are categorised
according to their intent;
§4.3: To present the types of entities that can be measured
with maturity models; and
§4.4: To present the maturity model architecture that will
be used in this study and explain how the structure
of a maturity model contributes to effective process
assessment.
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4.1 Background
Maturity is defined as “the state of being complete, perfect or ready” (Tarhan et al.,
2016). According to Paulk (1993), setting goals for process improvement requires an
understanding of the concept of maturity. Maturity in the context of maturity models
is defined as a “measure to evaluate the capabilities 1 of an organization” (Cleven et al.,
2014).
A maturity model refers to a conceptual model that describes the evolution of
organizational capabilities (Gastaldi et al., 2018). Tarhan et al. (2015) describes a
maturity model as: “a conceptual model that consists of a sequence of discrete
maturity levels for a class of processes in a domain and represents the anticipated,
desired or typical evolutionary path of these processes”. A maturity model is an
instrument used to assess and continually improve organizational performance (Tarhan
et al., 2015) by determining the gap between the current and desired states of
capability maturity (Blondiau et al., 2016). According to Gastaldi et al. (2018),
maturity models incorporate formality into possible improvement initiatives therefore
illustrating a favourable development path towards ‘maturity’.
Maturity as an assessment approach originated in the field of quality management
(Fitterer & Rohner, 2010). One of the earliest approaches was Crosby’s Quality
Management Maturity Grid in 1979 which described the typical behaviour exhibited by
organization at five levels of maturity for each of the six aspects of quality management
(Lahti et al., 2009). The stage-wise framework was used to benchmark organizations
on how mature their quality control processes were (Srai et al., 2013). This work
formed the foundation for the development of a Capability Maturity Model (CMM) for
Software.
Maturity models have been widely applied in different domains since the concept
of maturity was popularised by CMMs for Software (Srai et al., 2013). The Software
Engineering Institute (SEI) at Carnegie Mellon University developed the five-level CMM
for Software in 1987 (Paulk, 1993). The model described how software organization could
enhance their software development capabilities by focusing on process improvement
1 Capabilities refer to an organization’s capacity to deploy resources using an organizational process
to derive a particular outcome (Srai et al., 2013). Capabilities can be both tangible and intangible
processes specific to an organization or industry as a result of complex interaction between resources
(Srai et al., 2013).
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(Paulk, 1993). The model was initially developed as a reference model for assessing and
evaluating software process maturity and as a normative model to guide an organization
to move from informal processes to well-organized and controlled software processes (Srai
et al., 2013).
The premise behind the development of the CMM was that the quality of a
software product is largely determined by the quality of the development and
maintenance processes used to build it (Paulk, 1993). The CMM provided a guide on
how to gain control of processes and how to work towards a culture of process
excellence (Paulk et al., 1993). The CMMs are designed and developed to aid the
selection of process improvement strategies by determining the current maturity of a
process and identifying the most critical problems to improve the quality of the process
(Paulk et al., 1993). According to Paulk et al. (1993), focusing on a limited set of
activities allows for steady process improvement which enables continuous and lasting
gains in process capability.
4.2 Maturity Model Types
Maturity models can be categorised according to their function. De Bruin et al. (2005)
have identified three categories for maturity models; namely, descriptive, prescriptive
and comparative. Table 4.1 summarises the maturity model categories.
Table 4.1: Types of maturity models (De Bruin et al., 2005)
Maturity model Description
Descriptive maturity
model
This model is ideal for assessing the ‘as-is’ state of
the maturity of an organization (De Bruin et al.,
2005). Descriptive maturity models can be considered
diagnostic tools and are suitable for internal, external and
longitudinal benchmarking (Van Dyk & Schutte, 2012). It
requires a single encounter and makes no provision for
improving the maturity of the organization (De Bruin
et al., 2005).
Prescriptive maturity
model
This maturity model is focused on the performance of an
organization and intends to map out strategies to improve
the maturity of an organization (De Bruin et al., 2005).
Comparative maturity
model
This maturity model enables benchmarking and comparing
similar practices across industries or geographical regions
(De Bruin et al., 2005).
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De Bruin et al. (2005) argue that although the above-mentioned maturity models
are often seen as distinctly different, they form part of the evolutionary phases of the
maturity model life cycle. A maturity model starts in the descriptive phase to gain a
deeper understanding of the ‘as-is’ state of a system. The model then evolves into a
prescriptive phase where substantial and repeatable improvements can be made based
on the sound understanding of a system as found in the descriptive phase. Finally, for
a model to be used comparatively, it has to be applied in a wide range of organizations
to attain sufficient data to enable valid comparison.
4.3 Maturity Model Applications
Maturity models have been adopted in various domains as a way to appraise and
improve the competence and capacity of an organization or system (Tarhan et al.,
2015). According to Lahti et al. (2009), the principle idea behind the development of
maturity models is to describe the typical behaviour exhibited by an organization at a
number of levels of maturity and pinpoint their current maturity level with a view to
the next step towards advanced practices. The maturity of an organization’s process
helps to predict its ability to accomplish its goals; as maturity increases the difference
between targeted results and actual results decreases (Paulk et al., 1993). According to
Gastaldi et al. (2018), maturity models can serve as a common ground for shared
learning and improvement interventions. Blondiau et al. (2016) have identified three
groups of entities in an organization which can be measured using maturity models:
process-focused, technology/object focused, and people- focused. These are described
as follows:
 Process-focused: The concept of process maturity suggests that processes have
life cycles which can be assessed by the extent to which a specific process is defined,
managed, measured, controlled and effective (Lockamy & McCormack, 2004). It
is a measure of how the efficiency or effectiveness of the current process relates to
a possible ideal process (Blondiau et al., 2016). The maturity of a process implies
that it is well understood, supported by documentation and training, is consistently
applied in the organization and is continually being monitored for improvement
(Lahti et al., 2009).
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 Technology/ object-focused: This concept aims to assess to which extent a
product, machine or anything similar reaches a defined level of satisfaction
(Blondiau et al., 2016). According to Blondiau et al. (2016), this is an evaluation
of the extent to which technology improves a process.
 People-focused: This concept aims to measure the extent to which individual
skills are suitable to achieve or support an organizational goal (Blondiau et al.,
2016).
The concept of process maturity is becoming increasingly important as
organizations start adopting a process view of the organization (Lockamy &
McCormack, 2004). As an organization increases its process maturity,
institutionalisation takes place via policies, standards and organizational structures
(Lockamy & McCormack, 2004). Maturity models provide organizations with the
ability to measure and assess their process capability maturity at any given time (De
Bruin et al., 2005). This provides organizations with a better understanding of existing
capabilities, enables benchmarking, greater efficiency in the utilisation of recourse for
improving process capabilities, and presents an opportunity for improved success in a
domain (De Bruin et al., 2005).
4.4 Maturity Model Architecture
Maturity models allow organizations to have their practices, processes and methods
evaluated against a clear set of artefacts that establish a benchmark (Caralli et al.,
2012). These artefacts typically represent best practices and incorporate standards of
practice that are important in a particular domain (Caralli et al., 2012). Despite the
differences in application, most maturity models conform to the same basic structural
design (Lahrmann et al., 2011). All maturity models share the common property of
defining a number of dimensions at several levels of maturity with a description of the
characteristics of performance at various level of granularity (Gastaldi et al., 2018).
The following subsections discuss the components of a maturity model in more detail:
namely, dimensions and levels, and also describe how maturity can be measured in
practice.
36
Stellenbosch University https://scholar.sun.ac.za
4.4 Maturity Model Architecture
4.4.1 Dimensions
Dimensions are commonly referred to as capability areas or key process areas
depending on the field of study (Lahrmann et al., 2011). Dimensions are a cluster of
related activities that, when performed collectively, achieve a set of goals that are
considered important to enhance process maturity (Paulk et al., 1993). According to
Cleven et al. (2014), items considered relevant and somehow related or that can
attribute a particular world-view are grouped together into dimensions. A dimension is
a means of grouping similar attributes into areas of importance for a domain and for
the purpose of the maturity model (Caralli et al., 2012). Attributes represent the core
content of a dimension, based on observed practices, standards or expert knowledge
and can be expressed as characteristics, indicators or practices (Caralli et al., 2012).
Attributes also represent the qualities that are important for supporting process
improvement (Caralli et al., 2012).
Dimensions can be broken up into sub-dimensions which enable a richer analysis of
an organization to gain a deeper understanding of its relative strengths and weaknesses
and to target specific improvement strategies that could enable more efficient resource
allocation (De Bruin et al., 2005). A limited set of dimensions are typically selected for a
more focused process improvement approach and to ensure long-lasting and continuous
improvement (Paulk et al., 1993). Although there are other challenges that affect the
process performance, dimensions are selected based on their effectiveness in improving
process maturity (Paulk et al., 1993).
4.4.2 Levels
Continuous improvement is based on evolutionary rather than revolutionary steps
(Lockamy & McCormack, 2004). Architecturally, maturity models typically have ‘level’
to represent the transitional states along an evolutionary scale (Caralli et al., 2012).
The concept of an evolutionary path implies that progress towards higher maturity
level is incremental and is achieved through a set of intermediate states (Gastaldi
et al., 2018). According to Lockamy & McCormack (2004), achieving a higher level of
maturity establishes a higher level of process capability. Maturity levels, therefore,
represent different states through which an organization is transformed as its process
improve (Tarhan et al., 2015).
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Levels are also defined as archetypal states of maturity for specific dimensions
(Lahrmann et al., 2011). Each level has a distinguishing descriptor, clearly providing
the intent of the level and a detailed description of its characteristics (Lahrmann et al.,
2011). Maturity levels describe fundamental policies, procedures, infrastructure and
activities that contribute most to effective implementation and institutionalisation of a
dimension (Paulk et al., 1993). Furthermore, they represent the ability to consistently
implement processes with a defined scope that contribute to the achievement of the
organization’s strategic objective (Caralli et al., 2012). According to Wendler (2012), a
maturity level describe the development of the examined object in a simplified way.
Furthermore, maturity levels should be sequential in nature and represent a
hierarchical progression (Wendler, 2012). A higher level represents better control of
output results, improved forecasting of goals, costs and performance, and greater
effectiveness in achieving defined goals (Lahti et al., 2009). To be effective, a maturity
model must also have an impact on process improvement, and the transition between
maturity levels needs to be measurable. Maturity levels should, therefore, be based on
empirical data that has been validated in practise to ensure that each level is more
mature than the preceding level (Caralli et al., 2012). This can be accomplished
through extensive literature reviews into a specific domain’s critical success factors and
best practices (De Bruin et al., 2005).
In addition, most maturity models follow the potential performance perspective
instead of the life cycle approach (Wendler, 2012). Models based on the life cycle
perspective have a well-defined ‘final’ stage of maturity which can be reached by
transitioning through maturity levels. However, the potential performance, is primarily
focused on the potential improvement which occurs while transitioning through
maturity levels, as each level holds an inherent effectiveness and value (Wendler, 2012).
A common design principle in maturity model development is to represent maturity
in a number of cumulative stages (De Bruin et al., 2005). Maturity models commonly
have between three and six maturity levels with generic descriptions or a summary of
the characteristics of each level (Gastaldi et al., 2018). The number of levels differs
depending on the maturity model being developed; however, it is important that the
levels are distinct and well defined (De Bruin et al., 2005). There are also different
possibilities for defining and naming maturity levels (Cleven et al., 2014). It is common
practice to label levels with names which are indicative of the intent of the stage and
38
Stellenbosch University https://scholar.sun.ac.za
4.4 Maturity Model Architecture
that provide a summary of the major requirements and measures of the level, especially
with aspects that are new and not included in the preceding levels (De Bruin et al.,
2005). According to Cleven et al. (2014), defining maturity levels is an interpretive task.
Maturity models can be either continuous or staged depending on the maturity levels.
Continuous models allow scoring dimensions at different levels (Cleven et al., 2014). This
means that the level can be either the (weighted) sum of the individual scores or the
individual levels in different dimensions (Lahrmann et al., 2011). Staged models require
compliance with all elements of one level before progression to the next level (Lahrmann
et al., 2011). They specify a number of goals and key practices to reach a predefined level
(Lahrmann et al., 2011). Once goals are achieved they stabilize an important component
in a process which improves the process capability (Paulk et al., 1993). According to
Gastaldi et al. (2018), most maturity models in literature are fixed level models in that
they have a fixed number of maturity levels for every dimension.
Many maturity models adopt the generic five maturity levels defined by the CMM
with or without adaptation (Cleven et al., 2014). The CMM provide a framework for
organizing evolutionary steps in five maturity levels that provide a successive foundation
for continuous process improvement (Paulk et al., 1993). Skipping maturity levels is
counter-productive as each maturity level builds a foundation from which to achieve the
subsequent level; therefore, organizations need to evolve through each level to ensure
process excellence is ingrained the company’s culture (Lockamy & McCormack, 2004).
According to Paulk et al. (1993), improvement initiatives may prove ineffective without
maturity levels because the necessary foundation for supporting successive improvement
is not established. The aim of the levels of the CMM is to provide sufficient levels
of abstraction and to describe what the essential attributes normally expected of the
process are, rather than overly constrain how a process is implemented (Paulk et al.,
1993). Table 4.2 below summarises the five maturity levels of the CMM.
Table 4.2: CMM five maturity levels (adapted from Paulk et al. (1993))
Level Description
Level 1: Initial Processes are characterised as ad hoc and occasionally even
chaotic. Few processes are defined and success depends on
individual effort.
Continued on next page
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Table 4.2 – Continued from previous page
Level Description
Level 2: Repeatable Basic processes are established. The necessary process
discipline is in place to repeat earlier success with similar
application.
Level 3: Defined The processes are documented, standardised and
integrated into standard process for the organization. All
processes follow the approach with a tailored version of
the standard processes.
Level 4: Managed Detailed measures of the process outcome quality are
collected. The process is quantitatively understood and
controlled.
Level 5: Optimising Continuous process improvement is enabled by
quantitative feedback from the process and from piloting
innovating ideas and technologies.
Maturity levels describe ‘what’ is to be done and should not be interpreted as
mandating ‘how’ goals should be achieved (Paulk et al., 1993). Various practices can
be used to accomplish the requirements of the maturity level. The structure of a
maturity level can be used to derive recommendations and strategies for process
improvement (Paulk et al., 1993).
4.4.3 Maturity assessment
According to Lahti et al. (2009), there are two methods to determine the maturity of
an organization. The first is for an organization to self-assess their current maturity
level based on the detailed description of the maturity levels of the maturity model;
and the second is through the use of an assessment instrument which contains questions
based on the key areas of the maturity model. The latter is, however, preferred (Lahti
et al., 2009). The focus of the assessment instrument is to determine the state of an
organization’s current processes and guide the prioritization of process improvement
(Paulk et al., 1993).
The instruments used to determine the maturity level of an organization need to
be appropriate to the purpose of the model. According to De Bruin et al. (2005),
it is important to consider the model and the resources available for conducting an
assessment. The assessment instrument can be qualitative or quantitative (Lahrmann
et al., 2011) but generally takes the form of a questionnaire or survey (Lahti et al., 2009).
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The questions included in the instrument should be guided by the dimensions and sub-
dimension of the maturity model produced from an extensive review of literature (De
Bruin et al., 2005).
The assessment should be performed in an open, collaborative environment by
individuals or teams which are knowledgeable about the domain as well the
fundamental concepts of the maturity models (Paulk et al., 1993). The assessment
process takes the form of interviews and reviews of relevant documents to gain a better
understanding of the organization’s processes. The assessment instrument should guide
the questioning, listening, reviewing and synthesising of the information from the
interviews and documents (Paulk et al., 1993). Professional judgement is then used to
decide whether an organization’s processes satisfy the relevant goals and practices of a
defined maturity level (Paulk et al., 1993).
When determining a maturity level, the maturity model acts as a reference
framework against which the current status quo of a process is appraised with the
assessment instrument (Tarhan et al., 2016). Assessment instruments then investigate
strong, weak or missing points in the definition and application of a process with
respect to a reference framework (Tarhan et al., 2016). According to Tarhan et al.
(2016) the findings from the process assessment are usually used to derive the gap with
respect to the reference framework, which, in turn, is an input into developing a
roadmap for process improvement.
The assessment instruments used for a maturity assessment can take varying forms
of scope, detail and precision (Tarhan et al., 2015). It is, therefore, important that
the outcome or results of the assessment are easy to interpret (Lahti et al., 2009). A
visual representation of maturity allows for fast and easy interpretations and comparison
of outcomes. According to Marra et al. (2018), presenting information visually, helps
personnel in an organisations to share the same visual vocabulary and priorities which
improves collaboration to achieve a specific goal.
4.5 Conclusion: Chapter 4
Chapter 4 provides a brief background of maturity models and reviews maturity model
architecture that could potentially be used to develop an essential medicine management
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maturity model. Chapter 5 will present a review of literature on medicine management
practices to identify key focus areas to improve access to essential medicines.
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Chapter 5
Literature Review: Medicine
Management
Chapter 4 provided an overview of maturity models and presented maturity model
architecture which could possibly be used to develop the maturity model in this study.
Chapter 5 provides a background of the WHO Medicine Management Cycle and its
functional areas. The literature review in this chapter identifies the key practices which
need to be analysed and improved in order to improve access to essential medicines at
facility level.
Section
objectives:
§5.1: To provide a background of the WHO Medicine
Management Cycle;
§5.2: To present the key focus areas and recommended practices
for effective medicine selection at facility level;
§5.3: To present the key focus areas and recommended practices
for effective medicine quantification at facility level;
§5.4: To provide a brief overview of the role of procurement in
the medicine supply management;
§5.5: To present the key focus areas and recommended practices
for effective medicine storage at facility level; and
§5.6: To study the different types of medicine distribution
systems used at facility level and present the recommended
practices for effective and efficient medicine distribution for
inpatients.
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5.1 Background
A well-functioning healthcare system necessitates supply systems that can ensure
consistent availability of affordable high-quality medicines at all healthcare service
delivery points (Yadav, 2015). The WHO supports its member states in the
maintenance of a constant supply of quality essential medicines and also collaborates
with various stakeholders to develop solutions for essential medicine shortages and
stock-outs (WHO, 2017). In addition, the WHO provides guidance and advocates for
secure and efficient medicine supply systems to improve the availability and access to
essential medicines (WHO, 2017). Improved medicine supply systems put organisations
in a better position to adapt to changes in the external supply chain environment
(Lahti et al., 2009).
According to Yadav (2015), there are countless ways to organise a medicine supply
system. Figure 2.2 in section 2.2 illustrates the WHO Medicine Management Cycle,
which organises medicine management functions into a cycle; that represents an effective
medicine supply management system.
According to Iqbal et al. (2017b), the medicine management cycle provides healthcare
systems with a road map for continuous improvement. Each functional area builds on
the success of preceding functions: therefore, failure in one function could result in lack
of access to essential medicines and the inefficiency of the entire system (Tema, 2014).
Medicine management is becoming an increasingly important area of study to find ways
for the optimal use of a national health budget that offers the best quality healthcare
services possible (Devnani et al., 2010).
Medicine supply systems are complex, context specific, diverse, and dynamic (Yadav,
2015). According to Kanyoma & Khomba (2013), the importance of healthcare services
have reduced the extent to which industrial supply chain improvement methods and
strategies can be applied. Therefore, in order to improve medicine management practices,
best practices and critical success factors need to be identified within the healthcare
sector. Sections 5.2 to 5.6 below present the key focus areas for improving access to
essential medicines at facility level by reviewing literature on selection, quantification,
procurement, storage and distribution.
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5.2 Selection
Medicine selection is defined as the process of identifying medicines which can effectively
prevent and treat common or prioritised health problems in a region (Tema, 2014).
According to Pharasi & Miot (2012), the medicine selection process is integral to the
successful implementation of access to equitable healthcare plans. Not only does the
selection process have a significant impact on the quality and cost of healthcare services
delivered; it also ensures that all medicines within a healthcare system are selected based
on well-defined selection criteria and according to a well-defined selection process that
ensures quality medicines are widely available at affordable prices (Olson, 2012a).
The selection of the most appropriate medicines is dependent on accurate information
regarding public health relevance, comparative cost-effectiveness, and pharmaceutical
advances (Aitken, 2016). Further, selection of a limited range of essential medicines
results in a higher quality of care, better medicine supply management, and more cost-
effective use of health resources (Namaya, 2007). The selection of essential medicines
should be linked to standard treatment guidelines (STGs) and essential medicine lists
(EMLs); as they promote access to quality healthcare delivery and rational use of the
medicine by both patients and healthcare professionals (WHO, 2002). Medicine selection
based on well developed STGs and EMLs improves prescribing quality which leads to
better healthcare outcomes (Hogerzeil, 2004) as well as significant cost savings, especially
for high-unit-cost and high-volume medicines that make up a large portion of a medicine
budget (Embrey, 2012).
Sub-sections 5.2.1 and 5.2.2 below present the key focus areas for effective essential
medicine selection at facility level in terms of selection process and selection criteria,
respectively.
5.2.1 Selection process
The WHO advocates for the principle that some medicines are more essential than others
(Laing et al., 2003). The WHO found that many medicines in developing countries were
not useful, whereas those that were, often did not reach the populations in need (Laing
et al., 2003). This led to the development of the first WHO Model List of Essential
Medicines in 1977 (Quick et al., 2002) that represents the basic medicine needs of a
healthcare system (Namaya, 2007). The Model List promotes availability, accessibility,
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affordability, quality and rational use of medicines (Hogerzeil, 2004). The initial Model
List contained 186 medicines (Laing et al., 2003) and is revised every two to three years
(Dukes & Walkowiak, 2012). To date more than 156 countries around the world have
developed national EMLs (Embrey, 2012). According to the WHO (2002), factors that
influence the selection of essential medicines include:
 patterns of prevalent diseases;
 treatment facilities;
 training and experience of available personnel;
 financial resources;
 demographics; and
 environmental factors.
An EML, therefore, represents medicines considered to be the optimal treatment
choice of a population’s healthcare needs (Olson, 2012a). They allow a healthcare
system to concentrate on medicines that are the most cost-effective and affordable for
treating prevailing health conditions (Hogerzeil, 2004). By contrast, a wide variety of
pharmaceuticals available in a healthcare system contribute to inconsistent prescribing
(Olson, 2012a). According to the WHO (1999), EMLs allow practitioners to
concentrate on a limited1 number of products which simplifies the supply management
activities and reduces inventory carrying costs. Procurement in the public sector
should be limited to medicines of EMLs, as no public healthcare system can afford to
buy all medicines available on the pharmaceutical market (Barraclough & Clark, 2012)
and short and specific lists are easier to manage and procure (Iqbal et al., 2017b).
Hogerzeil (2004) adds that limiting the number of medicines used in a healthcare
system allows for larger quantities of specific medicines to be purchased which creates
an opportunity to achieve economies of scale. In sum, the advantages of an EML are
both medical and economic (Hogerzeil, 2004).
Most WHO member states have national EMLs while others also have provincial or
institutional lists (WHO, 2002). Development of an EML at facility level is especially
1A national EML should only have approximately 300-400 medicines, while district hospitals should
each have 150 -200 medicines, and health centres should each have 40-50 drugs (Iqbal et al., 2017b).
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important when a national EML is too extensive to be practical (Olson, 2012a) or when
it could result in the procurement of a variety of medicines which do not cater to the
needs of a population. According to Tema (2014), other common reasons for selecting
medicines outside an EML include:
 the EML does not address current health priorities;
 the EML is not regularly updated;
 prescriber do not accept EMLs and STGs; and
 products on the EML are not readily available on the market.
The development of EMLs is the backbone of medicine selection requires wide
agreement on its purpose and use (Iqbal et al., 2017b). For one thing, an EML’s
criteria must be credible and widely accepted by being defined and published (Olson,
2012a). As such, an EML can be improved through consultation with senior specialists
and experts which include professional organisations and academic institutions during
both its development and use phase (Olson, 2012a). Iqbal et al. (2017b) further add
that the selection process of essential medicines for EMLs should be an open and
transparent system which is regularly updated to maintain its authority and
acceptance.
Moreover, as EMLs form the basis for prescribing medicines and training healthcare
personnel they need to be closely related to the STGs used to diagnose and treat common
diseases at different levels of care in a healthcare system (Namaya, 2007). STGs are
disease-orientated guides which reflect a consensus on the first choice of treatment for a
range of health conditions (Olson, 2012b). STGs are systematically developed statements
that help health practitioners make decisions on the appropriate treatment for various
health conditions. The lack of adherence to STGs results in large stock-outs and the
frequent expiration of unused medicine (USAID, 2011). All this underscores the fact that
an STG should only include medicines on the EML, to ensure a health system procures
only the medicines required by the system (WHO, 2002).
The starting point for developing a STG is to identify common diseases, then define
a standard treatment for each diagnosis (Olson, 2012b) for the most efficient and cost-
effective treatment of diseases (USAID, 2011). There are three types of STGs; namely,
individual, selective and comprehensive. Table 5.1 describes these three types below.
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Table 5.1: Types of STGs (Olson, 2012b)
Type Description
Individual A standard treatment procedure is developed to define various
ways to treat one health problem or disease.
Selective A standard treatment procedure is developed to define various
ways to treat a few high priority common health problems or
diseases.
Comprehensive The STG is developed to define various ways to treat the
majority of health problems for a population group. The
guidelines ensures that practitioners are able to reference and
consult the manual, which promotes the standardization of
treatments and prescribing in a healthcare system.
Adherence to STGs has significant benefits to supply medicine management practices.
According to USAID (2011), if healthcare practitioners adhere to suggested treatment
protocols, a smaller range of products need to be available at each facility which makes
the management of the supply system easier to manage. If practitioners prescribe the
same products for the same conditions in a facility; product demand becomes more
stable and predicable which facilitates more accurate quantification outcomes (Iqbal
et al., 2017a). Table 5.2 below summarises the benefits of STGs for various stakeholders
in a healthcare system.
Table 5.2: Benefits of STGs for different stakeholders (Olson, 2012b)
Stakeholder Benefits
Health officials  Allows the identification of cost-effective treatments for
common health problems.
 Provides a basis for assessing and comparing quality care.
 Identifies most effective therapy in terms of quality and
combats antimicrobial resistance.
 Provides information for practitioners to give to patients
concerning the institution’s standards of care.
 Integrates special programmes at the point of the primary
health.
Supply management
staff
 Identifies which medicines should be available for the most
commonly treated problems.
 Facilitates pre-packing of course-of therapy quantities of
commonly prescribed items.
 Makes medicine demand more predictable, thereby making
quantification more reliable.
Continued on next page
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Table 5.2 – Continued from previous page
Stakeholder Benefit
Healthcare providers  Provides experts consensus the most effective, economical
treatment for specific setting.
 Gives providers the opportunity to concentrate on correct
diagnosis.
 Sets a quality of care standard.
 Provides a basis for monitoring and supervision.
Patients  Ensures most cost-effective treatments are provided.
 Improves availability of medicines.
 Improves treatment outcomes.
 Encourages adherence to treatment through consistency
among prescribers at all locations within the healthcare
system.
The key to success for a STG is establishing a monitoring and evaluation system
to guide updates and revisions to ensure the guideline remains relevant (Olson, 2012b).
This is facilitated by mechanisms to allow the users of STGs to report their experiences
using the guideline. According to Olson (2012b), monitoring programmes should focus
on improving issues of treatment and clinical failure by reporting on clinical failure
rates, healthcare worker’s compliance with STGs, patient compliance with prescriptions,
medicine quality, and antimicrobial resistance estimates. If clinical failure remains high
despite a high rate of compliance with STGs, then a review of the STG should be
conducted (Olson, 2012b).
At a national level, the essential medicine selection process should be the
responsibility of a procurement board which identifies the medicine needs of a
population. The level and breadth of expertise used in the selection process can range
from a single medical advisor to a multi-disciplinary team of pharmacists, nurses,
medical practitioners and other experts in the field of public health or health
economics (Pharasi & Miot, 2012).
At a facility level, a multi-disciplinary drug therapeutic committee is established
to guide the medicine selection process (Tema, 2014). The team should have clinical,
process and methodological knowledge to develop STGs and accompanying EMLs for
the selection of medicines in a healthcare system (Pharasi & Miot, 2012). According
to the WHO (1999), if such committee does not exist then an ad hoc committee must
be established for this purpose. The process of selection should be consultative and
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transparent, the selection of medicine should be based on explicitly defined selection
criteria and medicines selected must be linked to evidence-based STGs and EMLs (WHO,
2002). To ensure that an EML remains relevant, its review should correspond to changes
in the STG (Aitken, 2016). The review process should also make provision for input,
comments and also take into account drug resistance, adverse effects and treatment
failures (Olson, 2012a). In addition, revised EMLs and STGs should be distributed
throughout a healthcare system and should include background information, selection
criteria and listings under the therapeutic category and level of care.
5.2.2 Selection criteria
Patients deserve quality medicine (USAID, 2011). Counterfeit medicines make up an
estimated 25% of all medicines in developing countries (Conway et al., 2017) and
according to Iqbal et al. (2017b), approximately 70% of medicines registered in
developing countries can be considered duplicative or non-essential. Medicine selection
is largely influenced by marketing strategies which aim to manipulate scientific
evidence in favour of new, more expensive and on-patent medication (Shrestha et al.,
2018). According to Olson (2012a), these medicines often provide no therapeutic
advantage over existing medicines available on the market and personal observations or
popularity of a product in the market should not be used to justify the selection of
medicines.
The WHO’s Department of Essential Medicines and Pharmaceutical Policies is
responsible for promoting pharmaceutical quality through the development of quality
certification schemes and good manufacturing practice standards to ensure the safety
and efficacy of the medicines on the Model List (Dukes & Walkowiak, 2012).
Since patients do not have control over which medicines are available in a healthcare
facility, it is of central importance that selected medicines adhere to an established set
of criteria to ensure that patients have access to quality medicine at affordable price
points (Mackintosh et al., 2018). The quality, safety, and efficacy of medicines are
typically considered first before cost considerations (Meyer et al., 2017). Finding the
right balance between quality and cost is, however, a major challenge (Iannone et al.,
2011).
In most countries, pharmaceutical products require evaluation and approval from a
governing body (often called a drug regulatory authority) before the product can be
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used in the healthcare system (WHO, 2004). In this case, products registered should
have been proven to be efficacious, safe, and of adequate quality for the treatment
and prevention of diseases. Selecting medicine approved by a well-functioning national
regulatory authority of a country helps to ensure the quality of medicines (USAID, 2011).
The selection of high-cost medicine requires thorough evaluation which includes
clinical efficacy and effectiveness, cost-effectiveness and budget impact (Pharasi &
Miot, 2012). Determining the quality, safety and efficacy of pharmaceutical products
requires relevant, recent and unbiased information in the form of summaries of relevant
clinical guidelines, systematic literature reviews, important references, and quality
assurance standards (Olson, 2012a).
Relative cost-effectiveness is a major consideration when comparing medicines. As
advised by the WHO (2002) the total cost of treatment (not only the unit cost of
medicine) should be considered and compared to the efficacy of the medicine. For high-
volume, low-cost medicine, the selection is generally based on price (Pharasi & Miot,
2012). Quick et al. (2002) have also ascertained that medicine price information of
assured quality is indispensable for achieving optimum value for money. Akhlaghi (2012)
favours two basic ways to determine the purchase price of medicines. The first method
involves obtaining data on current medicine prices by referring to guides such as the
Management Sciences for Health International Drug Price Indicator, a guide which is
updated annually. The second method involves reviewing past purchase prices while
taking into account factors such as inflation (both nationally and internationally) and
reviewing fluctuations in currency.
Each drug has a chemical name and an International Non-proprietary Name (INN);
also known as a generic name. The generic name of a product is the official name of
a product regardless of which company or organisation that manufactures it (WHO,
2004). The generic names are used to categorise medicines which all share the same
active ingredient (Schellack & Meyer, 2010). Generic names are widely accepted as the
standard for describing medicine (WHO, 1999). Generic names are assigned by using
the WHO’s well-established procedure and provide a standard way of comparing similar
product prices and quality. Selecting medicine based on their generic names is often
cheaper and allows for the substitution of medicines which will serve the same purpose
(Olson, 2012a). In addition, generic name drug programmes are an economic strategy
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for drug supply because it increases competition among the producers and reduces prices
by up to 60% (Namaya, 2007).
The WHO Model List of Essential Medicines is meant to guide the development
of national and institutional EMLs (Namaya, 2007). According to the WHO Expert
Committee on the Selection and Use of Essential Medicines, essential medicine should
be selected based on the following eight criteria (WHO, 2002):
1. relevance to the pattern of prevalent diseases;
2. proven efficacy and safety;
3. adequate scientific data and evidence of performance in a variety of settings;
4. adequate quality;
5. favourable cost-benefit ratio;
6. desirable pharmacokinetic properties;
7. possibilities for local manufacture; and
8. availability as single compounds.
These WHO selection criteria are often adopted, modified and adapted to local
requirements. The WHO Model List of Essential Medicines is a useful reference for
selecting medicines and developing selection criteria for a facility as it includes
medicines that are widely considered to be safe, efficacious, cost-effective and of
acceptable quality (Olson, 2012a). The Model List is updated every two years through
a systematic approach guided by the WHO STGs for various diseases by an expert
committee made up of clinical pharmacologists and physicians. They evaluate the
latest clinical evidence and decide after several rounds of external reviews and
consultations on which medicines to add to the list (Aitken, 2016). Undoubtedly, such
continuous updates make the Model List a useful resources.
According to Hogerzeil (2004), as the selection criteria for essential medicine becomes
more systematic, only medicines listed on well-developed and evidenced-based STGs
should be selected. Thus the focus of the selection criteria should not be on the medicine
but should be based on its ability to treat patients effectively.
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Final selection criteria should be based on thorough discussions and acceptance by a
multidisciplinary committee of experts (Olson, 2012a). As the medicine selection process
evolves from an experience-based to an evidence-based approach (Laing et al., 2003), it
is important that the selection committee has access to information such as summaries of
the WHO clinical guidelines, systematic reviews, cost information, and quality assurance
standards to ensure that the selection criteria allows for the selection medicine that will
treat patients optimally (WHO, 2002).
5.3 Quantification
Quantification is technically the first step in the procurement process (Iqbal et al.,
2017b). Quantification is a process of estimating quantities and cost of medicines
required in a healthcare system and planning product delivery schedules to ensure the
uninterrupted supply of medicine (SIAPS, 2014c). The process is necessary to avoid
medicine wastage caused by over-stocking and treatment delays as a result of
under-stocking or stock-outs (WHO, 1999). According to USAID (2011), quantification
links information on services and commodities from a facility with policies and plans at
a national level to estimate the quantities and costs of the commodities required.
Quantification is important for informing supply management decisions on product
selection, financing, procurement and delivery (USAID, 2011). According to Akhlaghi
(2012), quantification may be summed up as being used to:
1. Calculate order quantities for procurement. The quantification process
needs to be conducted before each scheduled procurement. Accurate estimates of
medicine needs ensure that a system is able to avoid stock-outs, emergency
purchases and overstocking while maximising the financial resources available.
2. Estimate budget requirements. Medicine procurement budgets are often
determined by adding a fixed percentage to the previous year’s procurement
request to allow for contingencies such as financial cuts, population growth or
expansion of services. Quantification, however, provides a rational,
well-documented approach to ensure that the budgets developed enable the
system to acquire the needed medicines to treat and prevent prevalent diseases.
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Decentralised quantification at the facility level is known to improve the overall
accuracy and validity of the results for quantification at the national level (Akhlaghi,
2012). This is owing to the fact that consumption and service data from each facility are
used to inform high level decision-making on the procurement and financing of medicine
(USAID, 2008). In the healthcare sector, quantification incorporates both forecasting
and supply planning as seen in Figure 5.1 below (SIAPS, 2014c).
Figure 5.1: Quantification process (adapted from USAID (2008))
There are many factors that inhibit accurate forecasting and effective supply planning
in LMIC countries which often lack the necessary technical expertise to do so (SIAPS,
2014c). Lack of adequate training on medicine quantification also has a negative effective
on the availability of essential medicine (Tumwine et al., 2010). In addition, poor policy
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and misunderstood methodologies may further inhibit the implementation and success of
forecasting and supply planning if countries do not have the appropriate tools to address
gaps in their quantification capacity and knowledge (SIAPS, 2014c).
Quantification is a complex process and very susceptible to mistakes. Approximately
14% of medicine budgets are lost due to poor quantification (Iqbal et al., 2017a). Even
when quantification is done accurately there are various other factors that may further
influence the availability of medicines. For example, the quantification process ought to
incorporate contextual factors such as funds available, human resources capacity, storage
space capacity and capacity to deliver services (Akhlaghi, 2012; Iqbal et al., 2017b). It
also relies on access to good quality data, knowledgeable personnel and coordination of
key stakeholders to ensure that its outcome is adequate in estimating the medicine needs
of a system (SIAPS, 2014c).
In order to maximize effectiveness and usefulness quantification outcomes, it is
recommended that quantification be done for a period of two years (USAID, 2008).
According to USAID (2008), the two year period allows a facility to: identify gaps in
funding, mobilize the needed resources before stock-out occurs, adjust shipment
schedules to avoid overstocking and take changes in policies and plans into account.
According to USAID (2011), quantification is not a one-time exercise; rather a
continuous process that requires ongoing monitoring and routine updates. The output
of the quantification process should drive an iterative process of reviewing
quantification data and assumptions at least every six months to recalculate the actual
total medicine requirements and cost of the system (USAID, 2008).
As mentioned, as the quantification process is used to optimise the use of available
resources, then advocate for additional funding when needed, and so inform procurement
planning (USAID, 2008). It is, therefore, important that a multidisciplinary team of
administrative, planning, clinical and pharmacy staff are closely involved in the provision
and management of the quantification process (Iqbal et al., 2017a).
Subsections 5.3.1, 5.3.2 and 5.3.3 present the key focus areas for improving
quantification at facility level namely: data management, forecasting and supply
planning, respectively.
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5.3.1 Data management
Data management involves identifying, collecting, validating, storing, analysing and
applying information to make decisions and take action (SIAPS, 2014b). It is an
important part of managing ongoing operations, assessing performance over time, and
identifying problems and opportunities for improvement (SIAPS, 2014b).
One of the most critical elements in the quantification process is to assess the quality
of data (USAID, 2008). Unreliable data continues to hinder effective quantification in
most LMICs (Hedman, 2016). Data quality refers to the timeliness, completeness, and
accuracy of data (SIAPS, 2014b). A lack of reliable quantification data in a facility can
be attributed to poor consumption data reporting and limited monitoring and evaluation
of the quantification process (Tema, 2014). Table 5.3 below lists the quantification data
required for accurate forecasting (Iqbal et al., 2017a) and supply planning (USAID,
2008).
Table 5.3: Quantification data
Forecasting data Supply planning data
 EMLs  Funding and supplier information
 Average consumption  Procurement and supplier lead times
 Epidemiological information  Stock on hand
 Prescription patterns  Expiration date of products in stock1
 Minimum and maximum stock levels  Quantity on order 2
 Stock on hand  Minimum and maximum stock levels
 Frequency of stock-outs  Procurement and distribution information
 Length of the procurement cycle
Ensuring that only the right data is collected helps to reduce the amount of human
and financial resources needed to complete data management activities and improve
the accuracy and timeliness of the data collected (SIAPS, 2014b). Therefore, a needs
assessment should be conducted to determine which information and data is needed,
how it will be used, and what the process is to obtain it.
Another factor that arises is when, despite the availability of high-quality data,
systems often struggle to use data to inform decision-making due to a lack of
adequately trained personnel (SIAPS, 2014b). Training personnel can help improve the
1To assess whether they will be used before expiration
2Orders that have not yet been received
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capacity for data collection, however, the capacity for analyse and use data in
decision-making remains a problem (SIAPS, 2014b). Standard operating procedures,
therefore, need to be developed both to train staff on how to adhere to effective data
collection practices as well as on how to analyse and use results obtained (SIAPS,
2014b). According to USAID (2008), the reporting rate is a determinant of the quality
of data collected: a low reporting rate lessens the quality of data and cannot be used to
represent the actual medicine demand of a system. Data should be reported daily by
reviewing stock records, invoices from suppliers, and dispensing records (Akhlaghi,
2012).
It is important to identify the best-suited data collection method (whether paper-
based or sophisticated software) to ensure data collected is appropriate for its intended
use. For this, regular reviews of data collection practices ensure that data collected is
still in line with its objective (SIAPS, 2014b). All data used the quantification process
needs to be recent, as the older the data, the lower the quality (USAID, 2008). It is also
important to review whether historical data has been effective in estimating medicine
needs in past quantification periods as the outcome indicates the effectiveness of data
collection practices are in place (USAID, 2008).
Quantification committees need to formulate assumptions when data is missing or
its quality is questionable, unreliable, outdated or incomplete (Iqbal et al., 2017b).
Consumption data and service data, morbidity of data, demographic data, and
information on national programmes, policies, strategies, and plans should also be used
to inform assumptions for quantification (USAID, 2008). It is, however, important to
state clearly and specifically which assumptions are made and on which basis they were
made (USAID, 2008).
According to Akhlaghi (2012), conducting accurate quantification without
computerization is impossible. Computerised quantification has three main advantages:
speed, accuracy, and flexibility (USAID, 2008). The implementation of a health
management information systems (HMIS) and logistics management information
systems (LMIS) to capture all information required for quantification is essential to
improve the accuracy and usefulness of the outcome (Wagenaar et al., 2014). Tools
such as Quantimed (a data management software tool) can be used to ease the process
of quantification (Akhlaghi, 2012). Quantimed software helps to estimate the total cost
of medicines needed to provide healthcare services (USAID, 2011). However, while the
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appropriate use of tools is important in the quantification process, ultimately the
quality and accessibility data can only produce accurate forecasts and supply plan
outputs.
5.3.2 Forecasting
Forecasting is the process of estimating the expected consumption of medicine based
on historical consumption data, service statistics data, morbidity data, demographic
data and assumptions for a specific time frame (SIAPS, 2014c). It is the process of
projecting the future medicine needs of a healthcare system beyond the next purchase
order (Akhlaghi, 2012) by using statistical forecasting techniques (Meyer et al., 2017).
STGs and EMLs provide evidence-based guidance on which medicines to forecast for a
healthcare system (SIAPS, 2014c). Adherence to STGs and EMLs helps to reduce the
variability in medicine prescription and allows for better demand forecasting (Iannone
et al., 2011).
Owing to the nature of the healthcare sector, forecasting is inherently inaccurate due
to the many variables involved, therefore, human judgement is often required (Akhlaghi,
2012). Forecasting is a highly technical process and requires adequate training to conduct
accurate forecasts and supply plans (SIAPS, 2014c). The forecasting process is further
made complex by the simultaneity of production and consumption of medicines which can
lead to high unpredictability and unique demand that are difficult to forecast (Kanyoma
& Khomba, 2013). Forecasting methods, which predict the demand perfectly eliminate
lag times and also allow for efficient supply planning and resource allocation (Bam et al.,
2017).
Consumption data and service data are the most important elements in forecasting
medicine needs (WHO, 2017). Consumption data is the historical data on the actual
quantities of products that have been dispensed at service delivery points. Service data
includes the number of patient visits to a facility, the number of services provided, and
the number of people who have received treatment over a period of time (USAID,
2008). Consumption data needs to be adjusted to account for morbidity patterns,
seasonal factors, service level, prescribing patterns and patients attendance (WHO,
1999). The disadvantage of using consumption data is that records are often
incomplete and do not reflect the demands of the system (WHO, 1999). In such cases,
demographic and morbidity data are used to estimate the total unfulfilled need for a
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specific treatment. Morbidity data is the estimated incidences and prevalence of
specific diseases or health condition and demographic data is data on the proportion of
a specific population estimated to be affected by a specific health condition which
requires specific treatment (USAID, 2008). The type of forecasting method applied is
dependent on the information and resources available (Akhlaghi, 2012).
The consumption method is the preferred choice for medicine forecasting and is
considered the most reliable predictor of future consumption (Akhlaghi, 2012). This
method uses consumption data to estimate future demand of each product dispensed or
consumed during a specific quantification period (USAID, 2008). The method involves
analysing historical consumption trends and making assumptions about factors that
may influence the demand for medicine over a specified period of time (USAID, 2008).
The consumption method uses past consumption data and inventory levels of individual
medicines, makes adjustments for stock-outs and projected changes in medicine use to
determine the future need (Akhlaghi, 2012).
The accuracy of the consumption method is dependent on the quality of
consumption data, inventory records, recording of supplier lead times, projected
pharmaceutical costs, information on stock-out periods and anticipated changes in
demand (Akhlaghi, 2012). This method does not take into account the appropriateness
of past consumption, therefore, it does not always correspond to the population’s
priority needs; and risks perpetuating the irrational use of medicines (WHO, 1999).
The consumption method, therefore, cannot be applied in a system which experiences
widespread and long periods of stock-outs as it affects the accuracy of the estimated
demand (USAID, 2008). Stock-out information is particularly important in the
consumption method as it reflects consumption rates when medicines were not
available (Akhlaghi, 2012).
Trained pharmacists should analyse weekly, quarterly or annual forecasting data to
estimate the annual demand of a facility (Iqbal et al., 2017b). The major output of the
forecasting step is the monthly consumption demand of each product, this information
is a key input for the supply planning step (USAID, 2008).
5.3.3 Supply planning
Supply planning estimates the total commodity requirements and costs (USAID, 2011).
Supply planning initiates responses to medicines requirements outlined in the forecasting
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process (Meyer et al., 2017). Supply plans provide visibility of the supply system and
are the final output of the quantification process (Levenger et al., 2013). They detail the
actual quantities of each product to be procured as well as the delivery schedule based on
funding available and stock levels that account for procurement and supplier lead times
as well as safety stock (SIAPS, 2014c). Developing a supply plan entails coordinating the
timing of funding with supplier lead times and delivery schedules to ensure a continuous
supply of products and to maintain stock levels between an established maximum and
minimum levels (USAID, 2008).
A supply plan estimates the total commodities required for the quantification period
by calculating additional quantities of products needed to cover the procurement lead
time, supply lead time and safety stock and then subtracts the quantities of each product
on hand; any quantities that are ordered but not received; and any product that will
expire before they are used (USAID, 2008). Deliveries should be scheduled to arrive
when the stock reaches the established minimum stock level and the quantities ordered
should bring the stock level back up to established maximum stock level (USAID, 2008).
Supply planning software such as PipeLine Software is regarded as the best practice
to address the unique considerations of supply planning and monitoring public healthcare
programmes (USAID, 2011). PipeLine is a tool that helps to plan optimal procurement
and delivery schedules for any type of health commodity and monitor shipments (USAID,
2011).
Apart from the actual purchase price of medicine, other factors need to be taken into
account during the supply planning process, such as: hidden costs due to poor product
quality, poor supplier performance, short shelf life, and inventory holding costs (WHO,
1999). Good supply planning practices ensure that supplier selection, delivery schedules,
product availability, quality, and supplier performance are properly monitored (Ombaka,
2009).
It is also important to consider price, terms, delivery times, dependability, quality
of service, return policy and packaging when selecting a suppliers (Iqbal et al., 2017b).
Variability in a supply system can be reduced through supplier monitoring (Bam et al.,
2017). Long and fluctuating supplier lead times result in stock arriving too late to
satisfy demand (Bam et al., 2017). Bam et al. (2017) recommend selecting suppliers with
shorter and less variable lead times to improve the performance of the supply system as
it allows more flexibility when unexpected changes in demand occur. According to the
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WHO (1999), information systems in place also need to facilitate tracking and reporting
on the performance of suppliers, product defects, and other supply errors should be
recorded into the supplier monitoring system.
5.4 Procurement
Procurement is the defined the acquisition of goods and/or service at the best possible
cost of ownership, in the right quantity, of the right quality, at the right time, at the
right place, and from the right sources for the direct benefit or use of an organisation
(Muhia et al., 2017). Effective procurement has a significant impact on safeguarding
the availability of medicine (Kanyoma & Khomba, 2013). In a medicine supply system
procurement is defined as the process of acquiring good quality and cost-effective
medicine (Tema, 2014). According to Ombaka (2009), procurement encompasses a
complex range of operational, business, information technology, safety and risk
management, and legal systems - all designed to address a healthcare system’s needs.
Procurement involves all efforts to select appropriate procurement methods, qualify
suppliers and products, manage tenders, establish contract terms, assure medicines
quality, obtain best prices and ensure adherence to contract terms (WHO, 2017).
The procurement cycle, illustrated in Figure 5.2 below, represents the complex
functional steps in the procurement process (Tema, 2014). Given the long procurement
cycles, any delay in the functional steps of a procurement cycle creates a wave of
uncertainty in the system and results in system-wide stock-outs (Yadav, 2015).
According to Yadav (2015), delays are often a result of uncertain and highly variable
funding which hinders the start of the procurement cycle.
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Figure 5.2: Procurement Cycle (Barraclough & Clark, 2012).
According to Barraclough & Clark (2012), effective procurement is a result of the
collaboration between procurement units with adequately trained staff, an appropriate
management system and technical policy committees which make the final decision on
which medicine to purchase, in what quantities and from which suppliers. The
procurement method used in a healthcare system is dependent on national policies and
regulations. Tema (2014) outlines three main procurement methods in the public
healthcare sector, as:
1. The centralised model. In this model the main operational functions for
decision-making are tightly controlled and situated at a central level by a
national procurement unit.
2. The decentralised model. In this model the main operational functions are
diversely spread across different parts of the healthcare system. Procurement is
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conducted by sub-national entities including regional or provisional authorities and
healthcare facilities.
3. The mixed model. This model maintains some central functionality to promote
economies of scale, therefore, medicine requests for very large quantities are done
centrally as bulk purchasing to reduce costs.
Medicine procurement systems are traditionally centralised in many developing
countries with little management input from lower levels (Barraclough & Clark, 2012).
Procurement practices are often conducted at a national level due to the advantages
associated with centralised pooled procurement (Tema, 2014). According to Meyer
et al. (2017), the strategic use of market intelligence, improved competition, and
efficiencies associated with pooled volumes; lower prices can be achieved. Individual
hospitals are, therefore, pooled together at a central level, as centralised procurement
and decentralised distribution have been found to improve access to medicines at all
levels of a healthcare system (Iqbal et al., 2017b). In the centralised procurement
model, a central medical store is responsible for the procurement function in a
healthcare system. From a healthcare facility viewpoint, the central medical store can
be seen as the sole supplier of medicines. Hedman (2016) suggests that a supply
system should have at least three suppliers as sourcing for a single supplier increases
the exposure to risk and supply failure which can then paralyse the entire system
(Kanyoma & Khomba, 2013).
5.5 Storage
According to the WHO (2004), medicine should be stored in a secure area to:
 avoid contamination or deterioration;
 avoid disfiguration of labels;
 maintain the integrity of packaging and so guarantee quality and potency of
medicine during shelf-life;
 prevent or reduce pilferage, theft or losses; and
 prevent infestation of pests and vermin.
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Storage in medicine supply management, therefore, aims to ensure the physical
integrity and safety of products and their packaging in the storage facility until they
are dispensed to patients (USAID, 2011). In sum, storage facilities ensure the constant
availability and flow of essential medicines in appropriate quantities in a timely and
cost-effective manner throughout a healthcare system (SIAPS, 2014d). Poor product
traceability, insufficient human resources, poor physical infrastructure, and security
remain a big barrier to effective storage practises which may then lead to stock-outs,
overstocking and medicine wastage (SIAPS, 2014d).
Storage facilities need to practise appropriate inventory control and have adequate
storage capacity to ensure the quality, safety and efficacy of essential medicines during
the distribution process (Musonda et al., 2018). Subsections 5.5.1, 5.5.2 and 5.5.3 below
present an overview of the key focus areas for improving essential medicine storage:
namely, storeroom criteria, storeroom management and inventory control, respectively.
5.5.1 Storeroom requirements
An effective storage facility allows for the efficient flow of supplies (Iqbal et al., 2017b).
The dimensions and design of a storeroom need to be appropriate for the storage needs
of different types of medicines. According to the WHO (2017), a storeroom should have
the following designated areas for:
 receiving stock;
 main storage area;
 expired products;
 inflammable products;
 controlled substances; and
 cold chain products.
A clean and tidy storeroom is easier to manage. The storeroom should be organised and
medicines should be easily accessible on good quality shelving (Olson & Savelli, 2012).
Shelves should be kept neat and be labelled for each item on it. Keeping products off
the floor makes them less susceptible to pests, water and dirt damage (USAID, 2011).
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The storeroom should be cleaned and disinfected daily to prevent rodents and insects
from infesting the storeroom and damaging products (WHO, 2004). A storeroom should
never have waste in it; therefore, a schedule is recommended to establish designated staff
responsibilities to maintain a clean and tidy storeroom (Sallet et al., 2012).
In terms of temperatures for storage, most medical supplies can be kept at
uncontrolled room temperatures with the basic requirement of a dry, clean and
well-ventilated environment and temperatures ranging between 15 to 35 degrees
Celsius (Sallet et al., 2012) and out of direct sunlight (USAID, 2011). It is, however,
advisable that the manufacturer’s storage recommendations are followed since the
expiry date provided by the manufacturer assumes that products are stored under the
prescribed conditions (Sallet et al., 2012). Certain medicine storage requirements
ensure that the physio-chemical quality and shelf-life of the medical products are not
affected by environmental conditions (Snow et al., 2003). In such cases, the
environmental conditions such as temperature, light, humidity and ventilation then
need to be monitored and reported to ensure compliance with medicine storage
requirements for effective storage practices (Iqbal et al., 2017b). For less stable
medicines, a storeroom also needs to be equipped with an environmental control
system (such as an air conditioning system) to regulate and maintain the conditions of
the storeroom (USAID, 2011). According to USAID (2011), cold-chain products which
require cold storage can be irreparably damaged if the cold chain is broken and this is
often the case when electricity supply is unreliable. A storeroom should, therefore,
have alternative energy sources such as bottled gas or generator to power a
refrigeration system if needed.
In terms of security measures, the storeroom must be secured to prevent theft. A
secure storeroom should have double doors or double locks at the entrance and burglar
bars on the windows to deter this likelihood (Sallet et al., 2012). A storeroom should,
therefore, only be accessible to designated and authorised personnel (Iqbal et al., 2017b);
limiting access to the storeroom and tracking the movement of products improves the
security of medicine in the facility (USAID, 2011).
Stopping a fire before it spreads can save thousands of dollars in supplies and the
storage facility itself (USAID, 2011). The storage facility should be fitted with fire
fighting equipment which should be regularly inspected and storeroom personnel
should be trained on how to use equipment with regular fire drills (Sallet et al., 2012).
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Fire-prevention measures should include a strict no-smoking rule, careful disposal of
combustible waste material, and careful handling of flammables (USAID, 2011).
5.5.2 Storeroom management
Storeroom management is concerned with the receiving, inspecting and systematically
storing medicines in a storeroom. A well-managed storeroom enables easy identification
of medicine which saves time when picking medicines from shelves (WHO, 2004). It also
helps to prevent the stock from being lost (Olson & Savelli, 2012). According to Snow
et al. (2003), when receiving medicines, it is important to:
1. ensure that there is sufficient storage space;
2. prepare and clean the area used for receiving and storing stock; and
3. inspect the packages for damage or expired products.
A clear procedure for receiving stock should also be in place in a storage facility.
In an ideal world, all medicines are stored under ideal environmental conditions and
according to their specific storage requirements; however, in the real world, the quality
of storage practices may vary widely during the distribution of the medicine. It is,
therefore, important to inspect the quality of medicine received in storeroom (USAID,
2011). Inspecting for quality assurance includes: inspecting the packaging, integrity of
containers, completeness and legibility of labels, and expiry dates to ensure that the
medicines have an adequate remaining shelf life (Sallet et al., 2012).
After medicines from suppliers have been inspected on receipt, reporting of potential
problems of product quality should be reported (WHO, 1999). If stock is not verified
and inspected upon arrival, it increases both the opportunity for theft and poor quality
products entering the storeroom (Sallet et al., 2012), as well as the possibility that
the amount of product received is not the amount of product ordered. After inspection,
therefore, discrepancies must be noted and reported immediately to avoid disputes later.
Another way of avoiding wastage is to store items according to their expiry dates.
This is known as the first-expired, first-out (FEFO) rule whereby items which expire
earlier should be stored on the shelves in front of those that expire later. While the FEFO
prevents wastage it also ensures stock rotation (Snow et al., 2003). In a well-managed
storeroom expiry dates are monitored regularly and expired medication is removed from
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the storeroom, orders can then be placed regularly and stock is rotated, making wastage
due to expiry something that does not occur (Schellack & Meyer, 2010).
The WHO (2004) also recommend the arrangement of medicines in alphabetical
order of the generic names and in separate and distinct areas for each dosage form.
In addition to an alphabetical order, medicines should be stored according to their
frequency of usage (medicines that are fast moving stored close to the entrance of the
storeroom for easier access and faster product picking (USAID, 2011)). Furthermore,
to avoid spoilage, lightweight items should be stored higher up on shelves while heavy
fluids and fragile items should be stored on lower shelves (Snow et al., 2003).
Every product moved into or out of the storeroom should be recorded in a stock-
keeping record. Stock records should be available for each dosage form of a medicine in
the storeroom for accountability of stock movement (WHO, 2004). Stock records include
product name, product description, stock on hand, receipts, issues, losses, adjustments,
closing balances and transaction references. Other information that is valuable to have
on the stock records include special storage conditions, unit price, item codes and expiry
dates. Physical inventory count is the process of counting by hand the number of each
product in the storeroom at any given time. Physical inventory helps to ensure for the
stock keeping records correspond of the physical stock in the storeroom (USAID, 2011).
Recording the flow of products into and out of the storage is often paper-based,
time-consuming and subject to risks of error (SIAPS, 2014d). Without clear processes,
paper-based systems limit the visibility of stock in the facility. According to the WHO
(1999), even a well-functioning manual inventory control system should be converted to
a computerised one. A computerised record-keeping system like the use of a bar coding
system enables the efficient tracking of medicines in a facility for data collection (Meyer
et al., 2017). Tracking systems allow for an accurate record of inventory components
such as expiration dates and physical quantities of medicines. Overall, regular stock-
taking, inventory reconciliation, FEFO practices and traceability of medicine supplies
have been known to improve the availability of essential medicines (Sallet et al., 2012).
5.5.3 Inventory control
Poor inventory management is one of the biggest challenges facing healthcare facilities
(Jurado et al., 2016). Inventory management is a branch of business management
concerned with planning and controlling inventory (Iqbal et al., 2017b). Poor inventory
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management at a facility level is a major contributor to medicine shortages and
stock-outs (Shrestha et al., 2018). The complexity of the problem stems from the
stochastic nature of medicine demand which increases the probability of shortages and
stock-outs (Jurado et al., 2016). A good inventory management system, therefore, is
key to the success of a steady availability of medicines (Muhia et al., 2017).
Inventory control is a branch of inventory management which aims to maintain
specific levels of stock in a system (Iqbal et al., 2017b). According to Schellack &
Meyer (2010), inventory control in a healthcare facility is responsible for determining:
when to order medicine, how much to order and how to maintain appropriate stock
levels to avoid overstocking, under-stocking or stock-outs. The effectiveness of
inventory control in a facility, therefore, depends on reliable data and information to
inform decision-making and improve the availability of medicine (Iannone et al., 2011).
Undoubtedly, the regular monitoring and evaluation of stock levels ensures good
inventory control.
The challenge is that while increasing stock levels is a proven method of preventing
stock-outs; overstocking is not always possible due to budgetary and storage space
constraints (Jurado et al., 2016). Kanyoma & Khomba (2013) caution that while
stock-outs can lead to treatment delays which can have fatal consequences;
overstocking increases inventory holding costs. The failure to control costs, in turn, has
long-term negative effects on healthcare delivery as services become unaffordable and
unavailable (Kanyoma & Khomba, 2013). To find the balance to this dilemma, Sallet
et al. (2012) have suggested that the purpose of inventory control at a facility level is
to:
 prepare effective orders;
 maintain sufficient safety stock levels within budget limits;
 maintain records in accordance with requirements;
 adjust inventory levels to respond to new morbidity trends and changes in STGs;
 provide appropriate, safe and secure storage; and
 prevent expiry of medicines.
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? Some have acknowledged that traditional inventory control models are not always
applicable to the healthcare sector due to the nature of essential medicines and the
severe consequences of shortages and stock-outs (Uthayakumar & Priyan, 2013). The
standard minimum-maximum inventory control system is the most successful inventory
control system used for managing health commodities (USAID, 2011). According to
Dias et al. (2012), it is designed to ensure that stock levels fall within an established
desired range. The desired range refers to the maximum and minimum stock levels which
are expressed as the number of months of stock; to indicate how long supplies will last
(USAID, 2011). When setting the minimum and maximum stock level it important to
set the minimum level high enough to avoid stock-outs and the maximum low enough
not to increase the risk of expiration or holding costs (Dias et al., 2012). Factors such as
lead time and safety stock levels are required to determine the minimum and maximum
stock levels of a product. Safety stock refers to stock kept in reserve in the event of an
unexpected increase in demand, delayed deliveries or other unexpected events (Akhlaghi,
2012). Implementing safety stock policies helps to reduce stock-outs without excessively
high holding costs (Bam et al., 2017). As supplier lead times are variable, the safety
stock and minimum stock levels need to ensure that stock-outs do not occur.
A requisitioning system is often used to order medical supplies at facility level (Sallet
et al., 2012). It reviews all stock levels at the end of a review period and orders stock
quantities which bring the stock level up to the established maximum level for medicines
that are at, or have fallen below the allowable minimum stock level for the facility (Jurado
et al., 2016). According to Yadav et al. (2011), under normal conditions reaching a
minimum stock level is when actions to replenish inventory should occur. A review period
is the routine interval of time between assessments of stock levels that determines if
additional stock is needed (USAID, 2011). According to the WHO (2004), it is advisable
to order medicine on a regular basis to prevent shortages and stock-outs. The re-order
point is the stock level that indicates when a new order should be placed to last from the
period between placing the order and the delivery of the medicine (WHO, 2004). The
re-order quantity is based on the desired stock level of a facility for at least two to four
months. Adhering to the re-order point ensures that no shortage or stock-outs occur
before the arrival of the new order. This ensures that time-consuming and generally
expensive emergency orders are rarely placed (USAID, 2011).
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Effective inventory control, therefore, needs an efficient information and control
system that monitors inventory levels in a storeroom and provides up-to-date
information on quantities received and distributed, data on consumption and demand
of each product (Serafim et al., 2011).
5.6 Distribution
The medicine distribution process ensures the delivery of medicines from the highest level
of a supply system to various levels of need in a healthcare system (SIAPS, 2014a). The
key function of medicine distribution is to maintain a constant supply of pharmaceuticals
at all levels of a healthcare system (Iqbal et al., 2017b). Most primary healthcare facilities
do not have the capacity to properly store large quantities of medicines and have to rely
on obtaining periodic shipments through a multi-tiered distribution system (Buckley &
Gostin, 2013). The multi-tiered distribution system in developing countries typically
consists of international manufacturers and suppliers, national medical stores, regional
medical stores, district medical stores, hospitals, and health centres (Buckley & Gostin,
2013). According to the Scho¨pperle (2013), effective medicine distribution at a national
level in developing countries is dependent on reliable transport, storage capacity, timely
flow of information for planning and adequate human and financial resources.
Having an efficient and reliable distribution system to move medicines from a
central medical store to their point of need remains a critical challenge in many LMICs
(SIAPS, 2014a). A poorly designed distribution system is likely to cause stock-outs at
healthcare facilities despite the availability of stock at a central medical store (Yadav
et al., 2011). A balanced approach that considers the current technical capability,
administrative structures and resources available should guide the design and operation
of a distribution system (Yadav et al., 2011). According to Namaya (2007), effective
medicine distribution aims to keep medicines in good condition throughout the
distribution process to:
 minimize losses due to spoilage and expiry;
 maintain accurate records;
 reduce theft and fraud; and
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 provide information for forecasting future medicine needs.
Medicine distribution systems at a national level can be characterised as a push or
pull system. In the pull system, each healthcare facility requisitions the quantities of
medicines needed, based on past consumption and inventory levels (Kagaruki et al.,
2013). This system requires accurate quantification at facility level to ensure stock-outs
and shortages do not occur (SIAPS, 2014a). As discussed in section 5.3, quantification
practices at facility level are often inadequate; therefore the use of the pull system can
result in frequent essential medicine shortages and stock-outs.
In the push system, medicine is distributed on a predetermined delivery schedule
without an order from a central medical store to a healthcare facility (SIAPS, 2014a).
For this system, delivery trucks are loaded with predetermined quantities of medicine
based on the population’s needs or previous consumption information (Yadav, 2015).
The push system works well for a limited range of medicines with relatively steady
demand and for facilities which keep sufficient safety stock levels to meet demand between
deliveries. The push system is also often used when starting a new medicines programme,
where consumption data is not available or the quality of the data cannot be used
to produce accurate quantification outcomes (Yadav, 2015). According to the SIAPS
(2014a), this system results in fewer shortages and stock-outs and improved information
management as a result of the regular intervals of direct deliveries and standardization
of the distribution process.
A combination of both push and pull systems can also be used for medicine
distribution at national level. The mixed system approach is often used in countries
where regional or district medicine stores are subsidiary of a central medical store. The
push approach is used to distribute medicine to subsidiary medical stores and the pull
approach is used to distribute medicines to healthcare facilities. According to
Scho¨pperle (2013), the choice of system is dependent on a healthcare facility’s capacity
to conduct accurate quantification.
Sub-section 5.6.1 below presents the different types of distribution systems that can
be used for medicine distribution to inpatients in healthcare facilities, while sub-section
5.6.2 presents the recommended practices for effective essential medicine distribution at
facility level.
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5.6.1 Distribution systems 1
At facility level, drug distribution is primarily focused on dispensing medicine to patients
(WHO, 2004). According to Bigdeli et al. (2013), up to 50% of medicines are incorrectly
dispensed to patients in LMICs. The accurate and safe distribution of medicines to
patients is the main responsibility of a hospital’s pharmacy (Iqbal et al., 2017b); which
is expected to optimize the medicine distribution system and develop comprehensive
policies and procedures for the safe distribution of all medicines and related supplies
to inpatients (Alsultan et al., 2012). Embrey (2012) suggests that effective medicine
distribution requires, among others, the following practices:
 selecting the appropriate distribution system;
 keeping reliable records of medicine stocks and consumption;
 allocating medicines based on actual treatment needs; and
 reinforcing reporting and supervision arrangements.
Hospitals can distribute medicines to inpatients by operating a central pharmacy
or satellite pharmacies. It is important to consider the appropriateness of distribution
system in meeting a facility’s needs prior to implementation (Anacleto et al., 2006). A
safe, organised and efficient distribution system is vital for controlling costs and ensuring
medicines are available when needed in a facility (Anacleto et al., 2006). The choice of
distribution system implemented should, therefore, be based on the size of the facility and
resources available to guarantee an efficient, effective, economical and safe distribution
of medicine (Serafim et al., 2011). This can either be accomplished through pharmacy
and clinical personnel consultations to identify inefficiencies in the distribution system in
order to develop improved practices (Anacleto et al., 2006) or, according to the SIAPS
(2014a), facilities could experiment with successfully implemented best practices from
other sectors to address challenges and re-design systems in an innovative way.
Medicines can be distributed to patients by using either the ward stock system
(WSS), individual order system or unit-dose dispensing system (UDDS). These are
each described below:
1This literature review focuses only on medicine distribution to inpatients in a healthcare facility.
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 In the ward stock system (WSS) the hospital pharmacy functions as a
warehouse and dispenses bulk containers of medicines on requisition, without
review individual patient’s prescription for appropriateness of treatment (Olson
& Savelli, 2012). In this system, nursing personnel are responsible for effective
distribution practices (Cousein et al., 2014); the nursing personnel order bulk
supplies from the central pharmacy, the medication is stored in a medicine room
or medicine cabinet in the ward and nurses administer medicines for each patient
during their administration cycle (Murray & Shojania, 2001). The main
advantage of this system is the shorter turnaround time between prescribing and
administering medication. However, according to Anacleto et al. (2006), the
absence of a pharmacist in a clinical role results in higher rates of distribution
errors and poor inventory control. In addition, the WSS requires nursing
personnel to use approximately 25% of their time for transcribing prescriptions,
checking inventory, filling in requests, as well as transporting and separating
medicines for various wards (Anacleto et al., 2006) - all of which reduces patient
care time (Schellack & Meyer, 2010). Another disadvantage in the WSS is that
institutional costs are relatively high due to poor medicine storage practices in
the wards and, therefore, often result in high medicine wastage due to expiration
and spoilage (McNally et al., 2016).
According to Olson & Savelli (2012), the WSS is suitable for emergency
departments and operating rooms where medication is required immediately after
prescription. In life-threatening emergency situations, medications need to be
kept in patient care areas as a time-saving measure. This system is also ideal for
high-volume, low-cost medicines that do not require a high level of control for
preventing theft or medication error. The WSS is the oldest distribution system
implemented in hospitals and according to Anacleto et al. (2006), has now
become obsolete over the years.
 In the individual order system, medicines are distributed to patients according
to a medical prescription to various wards over a period of 24 hours (Olson &
Savelli, 2012). An advantage of the system is that pharmacists review medical
prescriptions which improves rational medicine use and reduces inventory levels
in hospital wards (Olson & Savelli, 2012). One disadvantage is that distribution
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errors remain high when using this system despite the active participation from
the pharmacist in the distribution process (Anacleto et al., 2006). As in the WSS,
nursing personnel spend a significant amount of time calculating and preparing
dosages which results in higher costs for human resource and material handling as
well as losses due to theft and inadequate distribution practices.
 The unit-dose dispensing system (UDDS) was developed in the 1960s to
support nurses with medicine administration (Murray & Shojania, 2001). The
system was designed to reduce distribution error rates, costs, losses and theft while
improving the productivity of clinical professionals and the quality of healthcare
delivered (Anacleto et al., 2006). In the UDDS, a 24-hour medicine supply is
distributed in individually packaged unit-doses to each patient (Kjos et al., 2016).
The unit-doses are distributed according to a patient’s prescription which then
limits the nurses’ role in the medicine distribution process in the wards (Anacleto
et al., 2006).
A commonly proposed solution to reducing distribution errors and improving
distribution efforts is to move from the WSS to the UDDS (Cousein et al., 2014).
The UDDS is considered the best distribution method from the patient’s
perspective (Olson & Savelli, 2012) as it is deemed safer than other hospital
distribution systems (Murray & Shojania, 2001). The biggest advantage of
UDDS, however, is that it brings a pharmacist into the medicine distribution
process which reduces the overall potential for errors (Murray & Shojania, 2001).
As a result, this distribution system is generally well accepted and has been
widely1 implemented in hospitals (Murray & Shojania, 2001). According to other
researchers (Kjos et al., 2016; McNally et al., 2016), the use of centralised UDDS
in hospitals also has further advantages, such as:
– a reduced total cost of medicine related activities;
– more efficient use of human resources;
– improved medicine control and monitoring;
– fewer medicines in the ward; and
– an easily adaptable system for computerisation and automation.
1The UDDS is used in 90% of hospitals in the United States (McNally et al., 2016).
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In principle, a medicine distribution system in a hospital should manage the flow of
medicine from the time it enters the pharmacy to when it is dispensed to patients.
An effective distribution process, therefore, requires considerable planning, organisation
and resources to ensure quality healthcare service delivery (Serafim et al., 2011). One
measure of the quality of any distribution system is the incidence of reported medication
errors and here the UDDS has been proven to reduce the chance of medication errors as
well as saving costs (Alsultan et al., 2012). It is, therefore, the UDDS that is considered
best practice for medicine distribution at facility level. The UDDS process will be
discussed in more detail in Subsection 5.6.2 that follows.
5.6.2 Distribution process
In the UDDS, doctors prescribe medication to inpatients and prescriptions are sent to
a central pharmacy. Local and international accreditation standards recommend that
pharmacists review prescriptions for accuracy and appropriateness before dispensing
(Alsultan et al., 2012). A pharmacist reviews the orders and instructs technicians to
prepare the medicine ordered and then places these orders in a unit-dose cart. Each
drawer in the cart is labelled with the patient’s name, ward, room and bed number,
and contains each patient’s medication (Cousein et al., 2014). Then before a cart is
sent back to the ward, a pharmacist double-checks each drawer for its prescription
accuracy (Murray & Shojania, 2001). It is important that the unit-doses prepared by
pharmacy technicians are checked by pharmacists to lower distribution errors and
avoid any adverse reactions to medicines by patients (Alsultan et al., 2012). These
carts containing patient-specific medicine dosages are transported to wards daily for
nursing personnel to administer to patients.
The UDDS is also known to reduce wastage of medicines because those medicines
not administered to patients are returned to the pharmacy and put back into storage
without concern for identity or contamination (Olson & Savelli, 2012). However, this
reduced cost consideration of the UDDS is mainly a trade-off between pharmacy and
clinical personnel (Murray & Shojania, 2001). The workload for pharmacy personnel is
increased in hospital pharmacies where bulk supplies of tablets and capsules are
purchased from manufacturers and repackaged into unit dose packages, however, most
medication is commercially available in unit-dose form therefore technicians do not
have to waste time re-packaging doses (Murray & Shojania, 2001). In the UDDS,
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nursing personnel spend less time on distribution practices, allowing them to attend to
other clinical activities. The variable costs in the UDDS include the cost of equipment
for hospitals that order supplies in bulk and then repackage the unit-doses themselves.
The use of unit-dose dispensing is common in general and surgical wards but is less
commonly used in intensive-care units, operating rooms, and emergency wards
(Murray & Shojania, 2001).
Human errors have become more prevalent in the distribution of medication due to
shortages of well-trained personnel (Alsultan et al., 2012). Hand-written prescription
orders are particularly prone to error as they require transcription and can be difficult
to read. Electronic prescriptions, however, can help to reduce medication errors by
eliminating or reducing such transcribing ambiguities (Alsultan et al., 2012). Not only do
electronic prescriptions reduce the workload, errors and costs of the pharmacy but they
also facilitate therapeutic conduct by permitting real-time access to basic information
regarding the patient and medicine (Serafim et al., 2011). The use of technology in the
distribution process improves the efficiency of medicine distribution, assists with cost
containment, and decreases the total number of medication-adverse events (Alsultan
et al., 2012).
The UDDS is closely linked to the increasing use of automated dispensing devices
(Murray & Shojania, 2001). As such, automated UDDSs electronically control and
track the distribution of unit-doses for each patient based on the patient’s medication
profiles (Olson & Savelli, 2012). Other interventions, such as the use of bar codes, have
proved to: reduce distribution errors by tracking the use of medicine in the hospital
(Cousein et al., 2014), reduce the risk of medication errors, and improve dispensing
accuracy (Alsultan et al., 2012). In addition, the implementation of new technology into
the medicine distribution processes has also decreased turn-around time for processing
medicine orders and increased the accuracy of medication administration to patients
(Alsultan et al., 2012).
5.7 Conclusion: Chapter 5
Chapter 5 presents a background overview of the WHO Medicine Management Cycle.
A literature review is conducted on the WHO Medicine Management Cycle’s functional
areas, namely, Selection, Quantification, Procurement, Storage and Distribution. The
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aim of the literature study is to identify key focus areas within the functional areas for
improving medicine management practices and access to essential medicines at facility
level. Chapter 6 presents the essential medicine management assessment framework
developed in this study. The chapter describes the framework development process and
presents the outcome of the subject matter expert consultations used to validate the
framework developed.
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Framework
Chapter 5 presented the best practices for effective medicine supply management
aimed at improving access to essential medicines at facility level. Chapter 6 presents
the essential medicine management assessment framework developed in this study. The
chapter describes the framework development process and presents the dimensions and
maturity levels included in the framework along, with the maturity assessment
instrument developed. This chapter also presents the outcome of the subject matter
expert consultations used to validate and refine the assessment framework developed
and concludes with a framework analysis and presentation of the final version of the
assessment framework.
Section objectives: §6.1: To present the dimensions and maturity levels used
in the maturity model and describe the maturity
assessment procedure;
§6.2: To present the outcome of the subject matter expert
consultations used to validate the assessment framework
developed; and
§6.3: To present the refined and validated essential medicine
management maturity model and maturity assessment
instrument.
78
Stellenbosch University https://scholar.sun.ac.za
6.1 Framework Development
6.1 Framework Development
This research study has developed an assessment framework which can be used to
benchmark essential medicine management practices at facility level. The assessment
framework developed aims to identify inefficiencies in medicine management practices,
to identify opportunities for improvement and help to prioritize improvement
interventions in order to improve access to essential medicines and the quality of
healthcare services delivered. The literature reviews in Chapter 4 and Chapter 5 form
the basis of the assessment framework developed in this study. The maturity model
was developed by integrating the essential medicine management dimensions into
maturity model architecture as outlined in Section 3.4.1. Sub-sections 6.1.1, 6.1.2 and
6.1.3 present the maturity model’s dimensions, maturity levels and assessment
instrument respectively.
6.1.1 Dimensions
Following the extensive literature review of essential medicines and medicine
management practices in Chapter 5, it was decided to use the WHO Medicine
Management Cycle’s functional areas as dimensions for the maturity model developed
in this study. As discussed in Section 2.2, the medicine management cycle represents
the key focus areas for efficient medicine supply. The WHO Medicine Management
Cycle is typically used to evaluate medicine supply management practices at national
level; however, the literature argues that efficient and robust medicine supply
management practices at healthcare facility level ensure that the right medicines, in
the right quantities, at reasonable prices and recognised quality are continuously
available without stock-outs or shortages to patients (Iqbal et al., 2017b).
This study’s assessment framework, therefore, is designed to monitor and evaluate
these essential medicine management practices at facility level. In terms of
procurement, however, Section 5.4 describes how it is more favourable to conduct
procurement practices at national instead of at a facility level. The maturity model
developed therefore, did not include the procurement functional area as a dimension;
as only functional areas applicable to healthcare facility level were included. Table 6.1
below defines the four essential medicine management maturity model dimensions;
namely, Selection, Quantification, Storage and Distribution.
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Table 6.1: Essential medicine management maturity model dimensions
Dimension Description
Selection Essential medicine selection at facility level is concerned with
identifying essential medicines required to effectively prevent or
treat prevalent diseases for a defined population group.
Quantification Essential medicine quantification at facility level is concerned with
estimating the quantities and cost of essential medicines required in
a healthcare facility and the planning of delivery schedules.
Storage Essential medicine storage at facility level is concerned with
ensuring the physical integrity and safety of products and their
packaging until they are dispensed to patients.
Distribution Essential medicine distribution for inpatient care, in a healthcare
facility, is the process of dispensing medicine from a central hospital
pharmacy to inpatients in various wards.
The above four dimensions selected were divided into sub-dimensions to allow for a
richer analysis of dimensions. The sub-dimensions highlight the key focus areas to be
monitored and evaluated (within the WHO Medicine Management Cycle’s functional
areas) to improve medicine management performance and access to essential medicines.
Table 6.2 defines these essential sub-dimensions of the medicine management maturity
model.
Table 6.2: Essential medicine management maturity model sub-dimensions
Dimension Sub-
dimension
Description
Selection
Selection
Process
The selection process for essential medicine selection
refers to the well-documented process of identifying
the medicines needed in a healthcare facility to prevent
and treat prevalent diseases.
Selection
Requirements
The selection criteria for essential medicine selection
refers to the attributes that medicines must adhere to;
in order to be deemed adequate to prevent and treat
prevalent diseases for a healthcare facility’s defined
population.
Quantification
Data
Management
Data management in the process of essential medicine
quantification in a healthcare facility is concerned with
identifying, collecting, validating, storing, analysing
and applying information needed for evidence-based
decision making.
Continued on next page
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Table 6.2 – Continued from previous page
Dimension Sub-
dimension
Description
Forecasting Forecasting, in the process of essential medicine
quantification, is the process of estimating the
expected consumption of essential medicines based
on historic data and assumptions for a specific
quantification period for a healthcare facility.
Supply
Planning
Supply planning, in the process of essential medicine
quantification, estimates the total essential medicine
requirements and cost for a healthcare facility. Supply
planning initiates responses to medicine requirements
outlined in the forecasting step.
Storage
Storeroom
Requirements
The storeroom requirements details the minimum
requirements of the storage facilities used to store
essential medicine in a healthcare facility.
Storeroom
Management
Storeroom management is concerned with the material
receiving, incoming inspections and systematic storage
of medicine in a healthcare facility’s storeroom.
Inventory
Control
Inventory control in a healthcare facility is responsible
for determining when to order medicine, how much to
order, and how to maintain appropriate stock levels to
avoid overstocking, under-stocking and stock-outs.
Distribution Distribution
Process
The distribution process at facility level is responsible
for accurate and safe distribution of medicine to
patients as prescribed by healthcare practitioners.
6.1.2 Maturity levels
The maturity model developed contains five CMM-like maturity levels. The maturity
levels represent the evolutionary scale and intermediate states through which essential
medicine management practices must transition to improve. The maturity level names
were adapted from the CMM 1 maturity level names, namely: Initial, Repeatable,
Defined, Managed and Optimising, however, the definition of the levels were changed.
Each maturity level provides a distinguishing descriptor which describes the intent,
1The CMM is a well established and widely applied maturity model that has led to the development
of various maturity models in a range of domains. The systematic literature study in Section 2.6.4
found that CMMs are commonly used to guide the design and development of maturity models in the
healthcare sector. This supported the researcher’s decision to develop CMM-like maturity levels for the
maturity model in this study.
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characteristics, typical behaviour or requirements of a dimension at a specific level of
maturity.
The literature review outlined in Chapter 5 studied the critical success factors and
best practices for effective medicine management at facility level to improve access to
essential medicines. The findings were used to determine the maturity levels of the
dimensions for this study’s maturity model. The maturity levels are sequential and
represent a hierarchical progression of maturity with Level 1: Initial (representing the
lowest level of maturity) and Level 5: Optimizing (representing the highest level of
maturity). Table 6.3 below presents the generalised maturity levels for the essential
medicine management maturity model. The detailed maturity levels are presented in
the refined maturity model on Page 100.
Table 6.3: Essential medicine management maturity model maturity level
Maturity level Description
Level 1: Initial The dimension is unmanaged.
Level 2: Repeatable The dimension is repeatable with the use of arbitrary
operational procedures.
Level 3: Defined The dimension is well-defined with standardised operational
procedure.
Level 4: Managed The dimension is well-managed, and outcomes of operational
procedures are predictable.
Level 5: Optimising The dimension’s operational procedures are continuously
improving.
6.1.3 Maturity assessment
A maturity assessment instrument was developed to provide an easy and simple
method of determining the maturity level of a facility’s medicine management
dimensions.1 The assessment instrument investigates strong, weak or missing points in
the definition and implementation of a dimension with respect to the maturity model.
The maturity assessment instrument provides a detailed account of the maturity level
requirements for a dimension at a specific level of maturity; unlike the maturity model
developed in this study which only provides a description of the typical behaviour and
characteristics of a dimension at a specific level of maturity. The maturity level
requirements were determined from the literature review in Chapter 5, which identified
1This refers to dimensions defined for this study in Section 6.1.1
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the critical success factors and best practices for effective essential medicine
management at facility level. The aim of the assessment instrument is to benchmark
the state of medicine management practices and guide the prioritization of
improvement interventions to increase access to essential medicines.
The maturity level requirements in the assessment instrument aim to provide a
sufficient level of abstraction to avoid dictating how a maturity level requirement
should be achieved and rather indicate what requirements should be met to improve
the facility’s medicine management practices and access to essential medicines. A
facility’s achievement of a maturity level’s requirement is dependent on the facility’s
capacity and resources1 available. It is important that each facility investigates the
best approach to achieve the maturity level requirement. An example to illustrate how
the maturity assessment instrument can be used is shown in Appendix C.
The assessment should be performed in an open, collaborative environment by
individuals or teams which are knowledgeable about the domain as well as the
fundamental concepts of the maturity models. The assessment process takes the form
of an interview with senior medicine supply management personnel. The assessment
also requires observations to verify if the answers provided in the interview, are
accurate. The assessor’s professional judgement and knowledge are used to decide
whether the facility’s practices satisfy the requirements of the maturity level. The
assessor is required to read the maturity level requirements from the maturity
assessment instrument (see Page 104) for the different dimensions to the interviewee,
and the interviewee is required to answer “yes” if the requirement is met and “no” if
not. The maturity model so developed is a staged maturity model in which all2
requirements of a maturity level need to be achieved before progression to higher
maturity levels. This transitioning procedure allows for long lasting and continuous
improvement. The outcome of the maturity assessment is used to benchmark the
facility’s essential medicine management practices on the maturity model (see Page
100). The maturity model provides the facility with a description of the dimension at a
specific level of maturity. A visual representation of maturity allows for fast and easy
interpretations and comparison of outcomes.
1Resources include: human resources, infrastructure and financing.
2This rule does not apply to Level 1 of the model. All, some or none of the requirements need to be
met to achieve this level. Level 1 represents an unmanaged state, therefore not achieving all requirements
of this level implies that the dimension is unmanaged.
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Each facility should aim to reach Level 5: Optimising. It is inadvisable to skip
maturity requirements as each maturity level requires the achievement of the previous
level’s requirements for continuous improvement. Therefore, although a facility might
meet some of the maturity requirements at a higher level of maturity, it must still
comply with all the preceding requirements to stabilise the foundation for continuous
improvement. The findings from the assessment should be used to derive opportunities
for improvement and recommendations for improvement. The structure of the
maturity model also provides an indication of which dimensions require the most
immediate improvement (i.e. sub-dimensions at Level 1 need to be prioritised for
improvement before sub-dimensions at Level 4). As discussed in Section 2.2, the
medicine management cycle’s functional areas are dependent on the the success of each
other; therefore it is important that progression through the maturity levels is even
across all the dimensions (i.e. the storage dimension should not reach Level 4 while the
selection dimension is at Level 1 because the success of the storage dimension relies on
the success of the selection dimension). The essential medicine management maturity
model and maturity assessment instrument developed are presented in Section 6.3.
6.2 Framework Validation
Validation in research ensures the integrity of the conclusions drawn and that the
research output addresses the research’s objectives. The aim of the validation was to
ensure the framework is able to adequately assess the performance of medicine
management practices in order to identify opportunities for improvement, which can
improve access to essential medicines at facility level. As discussed in Section 3.4.2,
implementation and case studies are not feasible validation methods for this study,
therefore validation using semi-structured interviews with subject matter experts was
identified as the most appropriate approach to evaluate the content validity of the
assessment framework developed.
Three subject matter experts were interviewed between 20 June 2019 and 31 July
2019. The interview was divided into five sections, namely: interviewee information,
research topic, framework, framework assessment and general. Table 6.4 summarises the
objectives of the different sections of the interview questions. The complete interview
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guide can be found in Appendix B. Each interview 1 was face-to-face interview and lasted
approximately an hour.
Table 6.4: Validation process
Interview
section
Objective Section
Interviewee
information
To determine whether the participants meet the
inclusion criteria stipulated in Section 3.4.2.1.
§6.2.1
Research topic To verify that essential medicine shortages and stock-
outs are a problem in public healthcare facilities.
§6.2.2
Framework To determine whether the dimensions and sub-
dimensions identified in literature and included
in the maturity model are adequate to assess
and benchmark essential medicine management
practices.
§6.2.3
Framework
assessment
To determine whether the maturity level
requirements included in the assessment framework
aimed at improving access to essential medicine
are adequate and that they can be realistically
implemented in healthcare facilities.
§6.2.4
General To determine if the framework developed is useful
and easy to understand.
§6.2.5
Sub-sections 6.2.1 to 6.2.5 present the outcome of the subject matter consultations
according to the different sections of the interview guide.
6.2.1 Interviewee information
All the participants met the inclusion criteria stipulated in Section 3.4.2.1. All the
participants have experience in medicine management in the public and private
healthcare sector which allowed them to provide information from both perspectives.
Table 6.52 presents the profiles of the three participants.
1Before an interview, the researcher provided a background on the research study and explained the
research’s aim and objectives, introduced the concept of maturity models and the usefulness of maturity
models as a assessment framework in the healthcare domain. The researcher also explained what would
be expected from the interviewee during the interview in terms of the types of questions that would be
asked and how they would be asked.
2Although all the participants are currently registered pharmacists in Namibia, they have practised
in other sub-Saharan African countries including: South Africa, Zimbabwe and Tanzania.
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Table 6.5: Participant summary.
Interviewee Qualification Years of Experience Country
Participant 1 Bachelor of Pharmacy 30 Namibia
Participant 2 Bachelor of Pharmacy 14 Namibia
Participant 3 Bachelor of Pharmacy 7 Namibia
6.2.2 Research topic
All participants agreed that essential medicine shortages and stock-outs are a major
problem in the public healthcare sector. In particular, Participant 1 and Participant 2
indicated that poor quantification is one of the major causes of essential medicine
shortages and stock-outs in the public sector. Participant 1 attributed the erratic
availability of essential medicines in public healthcare facilities to the shortages and
stock-out of essential medicine due to poor management of resources and a lack of
accountability all the way from the highest level of the healthcare system to the lowest
level. Participant 2 and Participant 3 both attributed the shortages and stock-outs to
poor medicine management practices at central medical store level from where public
healthcare facilities order essential medicine. Participant 3 added that central medical
stores fail to ensure the availability of medicines in the country which makes it
impossible for healthcare facilities to acquire the medicines ordered, which results in
shortages and stock-outs.
All participants noted an increase in the number of patients forced to buy essential
medicines from private healthcare facilities due to stock-outs of medicine in public
healthcare facilities. Participant 2 stated that the current1 supply system practices are
inadequate because they fail to ensure the availability of medicine hence the increased
frequency of medicine shortages and stock-outs in the public sector.
6.2.3 Framework
All participants agreed that the dimensions and sub-dimensions included in the
framework are the key focus areas for effective medicine supply management and are
sufficient to benchmark essential medicine management practices at facility level.
1The current system in place referred to by Participant 2 is the healthcare system in Namibia.
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6.2.4 Framework assessment
This section of the interview took the form of a questionnaire, in which the interviewer
read the maturity requirements identified from the literature and asked the participant
if the maturity requirement was useful and whether it would be realistic to implement or
achieve in practise. Participants were given the opportunity to provide comments on how
the maturity level requirements could be adjusted or changed to make the requirement
achievable based on their experience in the field. The outcome of this section of the
interview is presented in the following paragraphs according to the four dimensions of
the maturity model. Only maturity level requirements which needed to be changed or
adjusted are presented in the discussion of the outcome (i.e. maturity level requirements
which the participants agreed with are not discussed in this section, but rather presented
in the final assessment framework in Section 6.3.).
Selection
 Participant 2 and Participant 3 agreed with the maturity level requirement that
requires the selection process to be based on disease prevalence; however,
Participant 1 argued that determining the disease prevalence of a population is
difficult to do at facility level, as it requires a lot of resources to determine
accurately. Participant 1 suggested that facilities identify the most prominent
diseases for the population group it serves, by monitoring the “movement” of
specific medicines which would imply the most prominent diseases for the
population and help to determine which medicines are required in the facility.
 Participant 1 and Participant 2 did not think it feasible to procure only
medicines that appear on a facility’s EML as it would restrict the doctors’ ability
to prescribe what they consider to be the best treatment for a specific condition.
Both participants, therefore, think that a facility’s EML should be flexible and
adaptable to changes in disease prevalence. Participant 3, however, argued that
procurement from a well-constructed EML should be sufficient to cater to all the
medical conditions that a facility treats.
 All participants thought that considering cost as a selection criterion for essential
medicine selection in the assessment framework would increase the possibility of
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procuring poor quality medicine based on their low cost price. Participant 2 stated
that higher quality products are often more expensive, hence it is better to make
a selection based on the cost-effectiveness of the medicine.
 Participant 2 said that although the selection criteria of a facility should be closely
linked to the WHO’s essential medicine selection criteria, at facility level it is
not useful to consider desirable pharmacokinetic properties, possibility for local
manufacture and availability as a single compound. Participant 2 went on to state
that those criteria should be the responsibility of a National Drug Regulatory
Authority body as it requires specialised professional skills to determine whether
medicines meet those criteria.
Quantification
 o Participant 1 and Participant 2 believe it is essential to have an electronic data
management system for effective quantification as the margin for human error is
bigger for manual systems. Participant 3, however, stated that manual data
management systems are able to produce “accurate” quantification results,
although it requires commitment from the facility’s personnel to keep the records
up to date.
 Participant 1 stated that it is not feasible to validate the quality of data each
time data is collected. Instead, it was recommended that facilities select a data
management system that sends alerts or warnings when poor quality data is
submitted into the system to prevent the time-wasting exercise.
 Participant 1 stated that although forecasting using forecasting software is
important, personnel conducting the forecasting exercise need to be
knowledgeable and experienced in order to account for changes in demand and
disease prevalence accordingly and produce accurate forecasts.
 Participant 1 and Participant 2 did not think it is feasible to forecast the demand
for each and every medicine required in a healthcare facility, as such an exercise
becomes too exhaustive. Instead they recommended that forecasts should only be
prepared for fast moving and expensive medicines.
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Storage
 All the participants recommended the maturity level requirement which stipulate
that facilities should ensure that medicine is stored in a dry, clean and well
ventilated area with temperatures ranging from +15 to +25 degrees Celsius
should be changed or adjusted as the aforementioned environmental conditions
need to be adhered to by law. Participant 1 suggested that the maturity level
requirement require healthcare facilities to monitor the environmental conditions
in a storeroom regularly and keep records to ensure compliance on a consistent
basis. Participant 2 and Participant 3 said that regulating temperature in a
storeroom is important and recommended that a thermometer is placed in
various areas in the storage facility and monitored twice a day minimum as some
medicines are sensitive to extreme temperatures.
 Participant 1 said that stock cards in the storeroom are redundant if a facility has
an adequate information system in place to capture the movement of medicine in
and out of the facility and increases the administrative work for the personnel.
However, Participant 2 and Participant 3 believed that using stock cards to track
the movement of essential medicines is an important back-up system that helps
increase the accuracy of the stock data as the electronic tracking system can be
validated and reconciled with the stock-card records.
 All participants agreed that physical stock counts should be conducted to reconcile
stock records to ensure that the records correspond with the stock on hand and they
insisted that the framework should specify that stock counts should be conducted
at least every quarter.
 All the participants believed that an alternative energy source in a healthcare
facility is ideal; however, it is not so feasible to implement due to the high cost of
the alternative energy source infrastructure.
 Participant 1 recommended that the inventory control sub-dimension include a
maturity level requirement that requires healthcare facilities to have an information
system that notifies personnel when inventory levels have reached a reorder point.
According to Participant 1, this is an effective way to ensure that orders are placed
in time to avoid shortages and stock-outs.
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Distribution:
 All the participants agreed that the unit-dose system is the best system to
distribute medicines to inpatients in a healthcare facility. However, they stated
that the implementation of such a system requires significant changes to the
current systems in place in public healthcare facilities1. According to Participant
1 the implementation of the unit dose distribution system would require
significant capital investment and human resources to operate efficiently, both of
which are limited in the public sector.
 Participant 2 agreed with the maturity level requirement that stipulates that
medicine distribution should be initiated by the presentation of a prescription to
the pharmacy. However, the participant recommended that the prescriptions
should be accompanied by a patients’ files (health history) to ensure that the
medicines dispensed treat the medical condition most effectively.
6.2.5 General
 All participants indicated the assessment framework was easy to understand.
Participant 3 further stated that the maturity assessment instrument
compliments the maturity model well and made identifying the level of maturity
a lot easier than if the maturity model was presented on its own.
 Participant 1 stated that for the model to be effective in identifying the
shortcomings of medicine management practices, the assessment must be
conducted by honest individuals to ensure that the maturity level that is
identified is the actual maturity level of the facility. Participant 1 suggested an
evaluation by an external and knowledgeable person would ensure the objectivity
of the assessment results. According to Participant 1, in order to improve access
to essential medicines in public healthcare facilities the dimensions identified
need to be improved. However, such improvements would require the financial
resources available to be allocated properly.
1This response is based on the subject matter expert’s experience and does not imply that all public
healthcare facilities have the same inpatient distribution system in place.
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 Participant 2 thought that the assessment framework has the potential to be
useful if the healthcare facilities prioritize achieving the maturity level
requirements of the different dimensions. According to Participant 2, in order to
improve access to medicine, this assessment exercise should be conducted at all
levels of the healthcare system.
The subject matter consultation outcomes above were used to make changes to the
assessment framework developed, in order to address the identified shortcomings of the
model. The analysis of the subject matter expert consultation outcomes is presented in
Section 6.3.1.
6.3 Analysis and Results
A preliminary maturity model and maturity assessment instrument was developed, and
validated by subject matter experts in this chapter’s Section 6.1 and 6.2, respectively.
Subsections 6.3.1 and 6.3.2 present the analysis of the subject matter expert
consultations and the validated and refined assessment framework, respectively.
6.3.1 Subject Matter Expert Feedback and Analysis
The feedback from the subject matter expert consultations was analysed and
incorporated into the assessment framework developed, to address the shortcomings
identified. The feedback from the subject matter consultations in Section 6.2.4 was
compared to findings in the literature to determine maturity levels requirements should
be kept, removed or changed. Table1 6.6 presents the outcome of the analysis.
1This table presents a summarised version of the feedback provided by the subject matter experts.
The full feedback responses are presented in Section 6.2.4
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6.3 Analysis and Results
From the subject matter expert consultations, the researcher inferred that the
assessment framework developed has the potential to benchmark the state of medicine
management practices in healthcare facilities in order to identify opportunities for
improvement.
6.3.2 Essential Medicine Management Assessment Framework
The maturity model developed in this study is a staged, descriptive, fixed process-focused
maturity model, which can be used to benchmark essential medicine practices at facility
level in order to identify opportunities for improvement to improve access to essential
medicines. The validated and refined essential medicine management maturity model
and maturity assessment instrument is presented on Page 100 and 104 respectively. The
name of the framework stems from the fact that the dimensions of the model are based
on the functional areas of the WHO Medicine Management Cycle and are rooted in the
principles of improving access to essential medicine in the public healthcare sector.
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Dimension 
Selection  
Sub-dimension 
Selection process 
Maturity level requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for its own essential medicine selection.   
Level 1 
The facility has a defined process for the selection of essential medicines.   
The selection process is based on the observed disease prevalence of the 
population group the facility treats. 
  Level 2 
The facility has a comprehensive, evidence-based, standard treatment 
guideline (STG) for the most cost-effective treatment of diseases.  
  
Level 3 
The facility has an essential medicine list (EML) based on its comprehensive 
STG.  
  
The facility has a multidisciplinary team of healthcare professionals 
responsible for the development of STGs and EMLs and ultimately the essential 
medicine selection process. 
  
The multidisciplinary team considers patterns of prevalent diseases, the type 
of treatment facility, the training and experience of available personnel, 
financial resources, demographics and environmental factors in the selection 
of essential medicines.   
  
The facility’s STGs are adhered to by all practitioners.    
Level 4 
The procurement of medicine is based on and limited to the facility's EML.   
The facility assesses the performance of the selection process by reporting on 
its ability to select essential medicines that meet the needs of the facility. 
  
The selection process is formally documented in the form of a guideline or 
policy which is in line with the country's National Health Act. 
  
Level 5 
The facility’s EML and STGs are updated every two to three years.    
The multidisciplinary team of healthcare professionals continuously review the 
selection process to identify opportunities for improvement. 
  
The facility observes cost saving due to a limited list of medicines procured.    
Dimension 
Selection 
Sub-dimension 
Selection criteria 
Maturity level requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a selection criterion for essential medicines.   Level 1 
All essential medicines selected are approved by a national drug regulatory 
authority.  
  Level 2 
The facility selects essential medicines according to their International Non-
proprietary Name (INN) (generic names). 
 Level 3 
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The facility selects essential medicines based on their quality and cost-
effectives. 
  
The facility considers the total cost of treatment not only the unit cost of 
medicine. 
  
The facility’s selection criterion is based on relevant, recent and unbiased 
information. 
  
The facility’s selection criterion was developed by a multi-dispensary 
committee of healthcare professionals. 
  
The facility's selection criterion is closely linked to the WHO essential 
medicine selection criteria: relevance to the pattern of prevalent diseases, 
proven efficacy and safety, adequate scientific data and evidence of 
performance in a variety of settings, adequate quality and favourable cost-
benefit ratio.  
  Level 4 
The facility's essential medicines selection criterion is evidence based.   
Level 5 
All medicines in the facility adhere to the selection criteria.    
The facility's selection criteria are continuously reviewed to identify 
opportunities for improvement. 
  
Dimension 
Quantification 
Sub-dimension 
Data management  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a data management system in place.   Level 1 
The facility conducted a needs assessment to determine the type of 
information and data required for quantification.   
Level 2 
The facility has a standardised data collection process which is conducted 
according to formally defined standard operation procedures.   
The facility makes use of information technology to manage data.   
The data is collected in a timely manner.    
The facility has a system to analyse and validate the information and data 
required for quantification.   
The facility’s data management is the responsibility of trained personnel.   
The data is available in real-time and presented in a useful form.    
Level 3 The data meets established quality standards of timeliness, completeness 
and accuracy.    
The facility’s data management system enables reasonably accurate 
quantification outcomes on a consistent basis.   Level 4 
The facility’s data is used to inform supply management decision-making.   
The facility’s data management processes are continuously reviewed to 
identify opportunities for improvement.    
Level 5 
Dimension 
Quantification 
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Sub-dimension 
Forecasting 
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for forecasting its own essential medicines needs.    Level 1 
All medicines forecasted form part of the facility's essential medicines list.    
Level 2 
The facility’s forecasts are developed using forecasting software.    
Demand estimates are made for each essential medicine.   
The facility makes use of the consumption method to forecast essential 
medicines demand.   
Forecasting is conducted by well-trained personnel.    
The consumption data used for forecasting is adjusted to account for 
morbidity patterns, seasonality factors, service level, prescribing patterns and 
patient attendance.    
Level 3 
The assumptions made during the forecasting process are evidence based 
and informed by consumption data, service data, morbidity data, 
demographics data, policies, strategies and plans.    
The forecasting process is a collaborative effort by a multi-disciplinary team 
of administrative- and planning staff along with both clinical- and pharmacy 
staff.   
The forecasting outcomes are reviewed and updated every six months to 
incorporate changes in demand.   
Level 4 
The forecasting process predicts the facility’s medicine demands with 
marginal lag time.   
The multi-disciplinary team reviews the forecasting process continuously to 
identify opportunities for improvement.   
Level 5 
Dimension 
Quantification 
Sub-dimension 
Supply planning  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for developing its own supply plans.    Level 1 
The supply plans developed are based on the outcome of the forecasting 
process, inventory levels and funding available.   
Level 2 
The supply plans determine the quantities, cost and delivery schedules of 
essential medicines.   
The supply plans incorporate supplier lead times and performance.   
Supply planning is conducted by well-trained personnel.   
Supply plans consistently ensure that inventory levels remain between the 
facility’s established maximum and minim levels.   
Level 3 
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Supply planning is a collaborative effort by a multi-disciplinary team of 
administrative- and planning staff along with both clinical- and pharmacy 
staff.  
The data used for supply planning is adjusted to account for morbidity 
patterns, seasonal factors, services levels, prescribing patterns and patient 
attendance.    
The facility makes use of supply planning software to improve the accuracy of 
the supply planning process.  
The assumptions made during supply planning are evidence based and 
informed by consumption data, service data, morbidity data, demographics 
data, policies, strategies and plans.    
The facility monitors the performance of suppliers based on pricing, terms, 
delivery times, dependability, quality service, return policy and packaging.   
 Level 4 
Supply plans are reviewed every six months and adjustments are made to 
incorporate changes in the availability of financial resources and demand.  
Supply planning practices ensure orders are consistently delivered on time 
and in full.    
The multi-disciplinary team reviews the supply planning process to identify 
opportunities for improvement.  
Level 5 
Dimension 
Storage 
Sub-dimension 
Storeroom requirements  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a designated weatherproof room to store essential medicines.    Level 1 
The storeroom is dry, clean and well ventilated with temperatures between 
+15 and +25 degrees Celsius.    
Level 2 
The storeroom is fitted with equipment to control environmental conditions.   
The environmental conditions of the storeroom are monitored and reported.  
Narcotics and controlled products are kept in a locked area.   
The storeroom is fitted with fire-fighting equipment and personnel is trained 
on how to use this equipment.  
The storeroom is fitted with shelves.  
Each shelf contains stock cards and labels of the medicines on it.  
The storeroom is only accessible to authorised personnel.  
The storeroom has security measures to avoid theft.  
Essential medicines are not exposed to direct sunlight and never stored on 
the floor.    
The storeroom has designated areas for: receiving stock, a main storage area, 
expired products, controlled substance, and cold chain products.   
Level 3 
The storeroom is routinely monitored for compliance to storeroom 
requirements.  
Level 4 
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The facility has alternative energy sources in the event of power shortages.   
Level 5 All medicines are stored according to the conditions specified by their 
manufactures.    
Dimension 
Storage 
Sub-dimension 
Storeroom management  
Statement  
Answer 
(Yes/No) 
Level 
The facility's storeroom follows a defined procedure for receiving, inspecting 
and storing essential medicines.   
Level 1 
Stock is inspected for quality upon arrival in the storeroom.   
Level 2 
There is a clear procedure to report discrepancies of medicines received.    
Essential medicines are systematically arranged according to the FEFO rule.   
Level 3 
Stock records are kept and updated regularly.    
The stock records are reconciled with physical stock takes at least every 
quarter.    
Storeroom management is conducted by trained personnel.    
The facility has effective guidelines in which contain standard operation 
procedures for receiving stock, quality assurance inspections and systematic 
storage practices.    Level 4 
The facility has an information system in place to track movement of 
medicines in the storeroom.    
The facility does not experience excessive essential medicine losses due to 
expiry, poor quality products or theft.    
Level 5 
Essential medicines maintain their effectiveness and shelf life throughout the 
storage period.    
The facility’s storeroom management practices are continuously reviewed to 
identify opportunities for improvement.    
Dimension 
Storage 
Sub-dimension 
Inventory control  
Statement  
Answer 
(Yes/No) 
Level 
The facility has an inventory control system in place.    Level 1 
The facility has standard operating procedures for monitoring stock levels.   
Level 2 
The facility regularly monitors inventory levels.   
The facility's inventory records are complete, reliable and accurate and are 
used to inform inventory control decisions.    
Monitoring inventory levels is the responsibility of well-trained personnel.    
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The facility has a well-calculated minimum and maximum inventory level that 
consistently ensures few shortages and stock-outs.   
Level 3 
The safety stock and lead times are considered when determining minimum 
and maximum inventory levels.   
The facility’s reorder quantity is based on the desired inventory levels for two 
to four months of inventory.    
The facility has an information system in place which sends notifications 
when inventory levels reach the established reorder quantity.   
The medicine review period ensures medicines do not fall below established 
minimum stock levels.   
The inventory control system considers the facility’s storage capacity and 
financial resources available.    
Personnel responsible for inventory control have received adequate 
inventory management training.    
The facility’s safety stock policy is adequate to withstand increase in demand.   
Level 4 
The order quantities consistently last for the period between when orders are 
placed and when orders arrive.  
Inventory control system prevents the facility from being over-or-under-
stocked.   
Inventory control practices are continuously reviewed and updated through 
consultation with various stakeholders to identify opportunities for 
improvement.   
Level 5 
The system rarely places emergency orders.    
Dimension 
Distribution 
Sub-dimension 
Distribution process  
Statement  
Answer 
(Yes/No) 
Level 
The facility has defined process for distributing essential medicines to 
inpatients.    
Level 1 
The medicine distribution process is initiated by an order in the form of a 
prescription which is accompanied by each patient’s medical records.    
Level 2 
The facility distributes medicines in unit-doses from the facility’s central 
pharmacy.    
The facility makes use of the unit-dose dispensing system to distribute 
medicine to inpatients.    
Level 3 
The medicine distributed is only for a 24-hour period.   
The facility’s personnel are well-trained and efficient in preparing unit-dose 
carts.  
The facility has effective guidelines which contain standard operation 
procedures for distributing medicines.  
6.3 Analysis and Results
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The medicine is only distributed after the review of a prescription and patient 
records by pharmacists.    
Reliable records are kept to monitor the consumption of medicines.    
Distribution data is collected in a timely manner.    
The turnaround time between receiving an order and administering 
medication is short.   
Level 4 
The facility experiences fewer distribution errors and medicine losses due to 
spoilage.    
The distribution process is formally defined in a facility policy and consistently 
applied.   
Level 5 
Pharmacy and clinical personnel consultation help to identify inefficiencies in 
the distribution system and opportunities for continuous improvement.   
 
 
6.3 Analysis and Results
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6.4 Conclusion: Chapter 6
Chapter 6 presents the essential medicine management assessment framework. The
framework developed is validated by subject matter experts to ensure that the
dimensions and maturity levels included are adequate for benchmarking essential
medicine management practices at facility level. The aim is to identify opportunities
for improvement for better access to essential medicines. Changes to the model
according the recommendations by subject matter experts were included in the
assessment framework to ensure that the model’s shortcomings were addressed.
Chapter 7 provides a research overview and presents the objective attained by the
research study. The chapter also presents the research study limitations and
recommendations for future work.
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Chapter 7
Conclusion and Future Work
Chapter 6 presented the validated essential medicine management assessment framework
that can be used to benchmark essential medicine management practices at facility level.
This is to identify opportunities to improve access to essential medicines. Chapter 7 is
the final chapter of this research study and presents a summary of the research and
discusses how the objectives the research were attained. The chapter concludes with a
presentation of the research’s limitations and recommendations for future work.
Section objectives: §7.1: To present an overview of the research conducted;
§7.2: To discuss how the research’s objectives of this study
were achieved;
§7.3: To present the research study’s limitations; and
§7.4: Provide recommendations for future research.
7.1 Research Summary
The purpose of the research presented in this thesis is to develop an assessment
framework that can be used to assess essential medicine management performance in
public healthcare facilities in sub-Saharan Africa. The aim is to identify areas for
improvement and extend access to essential medicines.
Chapter 1 serves as an introduction for the research study and presented the rationale
for the research, the problem under study and the research aim and objectives. The
chapter also presented a brief discussion on the ethical implications of the study and the
document outline.
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Chapter 2 presents a literature review which provided an overview of challenges
facing medicine supply systems and introduces the concept of medicine management as
an approach to improving access to essential medicines. The chapter also presented a
review of existing methods of assessing access to medicine which provided evidence to
support the need for the development of an alternative assessment method for evaluating
essential medicine management performance at facility level. Finally, Chapter 2 also
highlighted the benefits of using a maturity model as a benchmarking assessment tool
for evaluating essential medicine management performance.
Chapter 3 presents the research methodology used in this research study. The chapter
defines the type of research conducted and identifies the research methods used for data
collection. Chapter 3 also presents the research approach applied for the development
of the essential medicine management assessment framework.
Chapter 4 introduces the to concept of maturity and provides a brief historical
overview of maturity models. The chapter also describes the types of maturity models
that can be developed and the type of entities that can be measured using maturity
models in practice. Finally, Chapter 4 reviews maturity model architecture literature
to gain an understanding of the architectural elements of a maturity model, that is
used to guide the development the essential medicine management assessment
framework in this study.
Chapter 5 presents a literature review of the functional areas of the WHO Medicine
Management Cycle namely, selection, quantification, procurement, storage, and
distribution. The literature review focuses on identifying recommended practices for
key elements within the WHO Medicine Management Cycle’s functional areas to
improve access to essential medicines and ensure effective medicine supply management
practices at facility level.
Chapter 6 presents the essential medicine management assessment framework
developed in this study. The chapter describes the framework development process and
presents the dimensions and maturity levels included in the maturity model. It also
describes how the maturity of essential medicine management practices can be
measured. Chapter 6 also presents the outcome of the subject matter consultations
used to validate the assessment framework developed and concludes with a framework
analysis and results which show the changes made to the model according to the
recommendations from subject matter experts to address the model’s shortcoming.
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Chapter 7, the final chapter of this research study, provides a research overview and
presents the objectives attained by the research study. The chapter also presents the
research study limitations and recommendations for future work.
7.2 Attainment of Research Objectives
The aim of this study, as outlined in Chapter 1, is to develop an assessment framework
that can benchmark essential medicine management performance in public healthcare
facilities in order to identify opportunities for improvement. To accomplish this aim,
five research objectives were identified. Table 7.1 summarises the research objective of
this study and each chapter in which they were addressed.
Table 7.1: Research objectives
No. Objectives Chapters
1. Identify factors which hinder effective medicine management. §1 & §2
2. Investigate an appropriate approach for
structuring/developing the proposed framework.
§2 & §4
3. Describe best practices for medicine management. §5
4. Develop a benchmarking assessment framework to evaluate
essential medicine management practices.
§6
5. Validate the developed assessment framework. §6
The following paragraphs describe how the research objectives were achieved:
1. Objective 1 is achieved in Chapters 1 and 2 by conducting literature reviews on
essential medicines and medicine supply management challenges to identify the key
factors at facility level that hinder effective medicine management practices and
thereby contribute to medicine shortages and stock-outs.
2. Objective 2 is achieved in Chapters 2 and 4 by conducting literature reviews on
the effectiveness of benchmarking to assess process performance and facilitate
continuous improvement. A review is conducted on benchmarking assessment
frameworks in the literature and the maturity model was chosen as the most
appropriate tool to do this assessment at facility level. A systematic literature
review is conducted to determine the appropriateness of using maturity models
for assessing processes in the healthcare domain. The literature on maturity
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model architecture is also reviewed to guide the development of the essential
medicine management assessment framework developed.
3. Objective 3 is achieved in Chapter 5 by conducting a literature review on the
key practices for effective medicine management and identifying the recommended
practices and focus areas that improve access to essential medicines.
4. Objective 4 is achieved in Chapter 6 by integrating the essential medicine
dimension identified in the literature into the maturity model architecture. The
essential medicine management assessment framework developed is designed to
enable healthcare facilities to assess the medicine management practices using an
easily understood framework that can identify areas for improvement to prioritise
improvement interventions and access to essential medicines.
5. Objective 5 was achieved in Chapter 6 through consultation with subject matter
experts to identify the shortcomings of the assessment framework developed and
ensure its ability to benchmark medicine management performance at facility level.
This framework provides a complimentary assessment method to traditional
quantitative methods in the healthcare sector which focus on collecting data on
performance outcomes. The assessment framework developed in this study focuses on
the various practices that drive essential medicine management performance. It can
potentially be used by policymakers to better understand the root causes of poor
performance which result in essential medicine shortages and stock-outs.
7.3 Research Limitations
The research has several limitations that need to be taken into account when reviewing
the results, namely:
 The majority of the literature available on medicine management focuses on
improving medicine management practices at a national level. The literature was
therefore adapted to a facility level context. The process of adapting literature
presents the potential of misrepresenting the medicine management dimensions
for facility level.
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 The maturity model developed in this study can only be used to assess medicine
management practices for a healthcare facility that operates using a central
pharmacy system and does not include the assessment of medicine distribution to
outpatients or emergency wards.
 The ethical clearance and institutional clearance required to validate the essential
medicine management framework through implementation or case studies could
not be obtained, instead the maturity model was validated by subject matter
experts. While this form of validation is used in practice; however, only three
subject matter experts took part in the study. This research, therefore, cannot be
regarded as a representative sample. Although the subject matter experts
confirmed the validity of the model it does not necessarily prove its general
usability in practice. Furthermore, all of the interviewed subject matter experts
have experience in the same developing Southern African country. Thus, the
results may not be generalisable to other sub-Saharan African countries.
7.4 Recommendation for Future Research
Various challenges regarding medicine management at facility level were identified in the
literature and became apparent during the subject matter expert consultations. The
recommendations for future research identifies research problems that aim to improve
access to essential medicine at facility level but lie outside the scope of this research
study.
1. There is a constant need for the development of assessment frameworks to
evaluate the performance of healthcare processes to improve the quality of
healthcare services in public healthcare facilities. As mentioned in Section 2.2,
effective medicine management relies on good management support systems
which include financing, information systems, human resources, and regulations
and policies. These support systems, however, happen to be some of the main
challenges for effective medicine supply systems. The researcher recommends
further research into the development of a benchmarking framework to assess the
performance of these support systems at facility level. This is required to identify
opportunities for improvement and ultimately improve access to essential
medicines.
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2. Research should also be conducted into the effects of contextual factors such as
the size of the healthcare facility, number of employees, and number of patients
treated on medicine management performance.
3. There is a need for continuity and comparability in performance measures at all
levels of the healthcare system. This would ensure that the effects of performance
improvement effort at a national level filters down to facility level. Having a
standard measure for reviewing medicine management for a whole health system
could potentially foster a culture of learning and continuous improvement.
Therefore, research could be conducted to develop an essential medicine
management assessment framework to assess medicine management performance
at a national level.
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Appendix A
Review of benchmarking
frameworks
Appendix A presents a brief overview of assessment frameworks considered for
benchmarking medicine management practices at a facility level. The review considers
three assessment frameworks, namely: gap analysis (section A.1), balanced scorecards
(section A.2) and maturity models (section A.3).
A.1 Gap analysis
The gap analysis is considered one of the first steps of an accurate and complete
benchmarking process (Marra et al., 2018). The gap analysis is a technique used for
identifying discrepancies in a system to achieving its set objectives (Amalfitano et al.,
2018). It is used to identify the difference between the current and proposed state of an
organization and its functionalities- this difference is called a “gap” (Marra et al.,
2018). The gap analysis was developed in the 1980s to study quality in the service
industry by analysing the difference between customer’s expectations and their
perceptions of a service (Amalfitano et al., 2018). According to Amalfitano et al.
(2018), a gap analysis is usually conducted to improve compliance to a set of
requirements or standards. The usefulness of the information retrieved from a gap
analysis is dependent on how an evaluation is conducted (Zuhaira et al., 2017). Since
its initial use in the service industry, the gap analysis has been applied in various
domains, including business process management and supply chain management
131
Stellenbosch University https://scholar.sun.ac.za
A.2 Balanced scorecards
(Marra et al., 2018). The gap analysis is widely used in management studies to
determine the potential for process improvement in a system.
According to (Zuhaira et al., 2017), comparing an organization’s current system to
a best-practices system to identify gaps is cumbersome, time-wasting and rarely
delivers accurate, precise or detailed results. The gap analysis identifies gaps by
analysing prominent problems in a system and comparing them to their optimized
solutions. This approach provides insight and understanding of a system’s problem
areas (Zuhaira et al., 2017). The gap analysis defines the “to-be” state of a system by
determining the best practices of a system in the domain understudy (Ahmed & Rafiq,
2002). Making comparisons against the best practices of a domain or stated aims of an
organization allows it to assess the nature of the leap needed to match or surpass its
work class competitors (Ahmed & Rafiq, 2002). According to Tontini & Søilen (2014),
the gap analysis helps organizations prioritise resource allocation for process
improvement interventions needed to enhance and mature their systems.
A.2 Balanced scorecards
The balanced scorecard is a well-known performance measurement tool that provides
organizations with the ability to measure their performance from different perspectives at
the same time (Salem et al., 2012). The balanced scorecard was developed by Kaplan and
Norton in 1992 to reflect on the inadequacy of traditional management systems, which
are highly dependent on financial measures (Salem et al., 2012). According to Pandey
(2005), financial measures alone are not sufficient to guide performance for creating value
and are highly dependent on non-financial measures. Salem et al. (2012) also noted that
traditional management systems that incorporated non-financial measures often did not
take into account an organization’s strategy.
The balanced scorecard focusses on executing an organization’s strategy by
evaluating the cause and effect relationship between its strategic objectives (Asan &
Tanyas¸, 2007). It combines both financial and non-financial performance measures into
a single scorecard that focuses on the linkage between organizational processes,
decisions and results (Pandey, 2005). According to Gomes & Liddle (2009), the
balanced scorecard aims to translate the vision and strategy of an organization into
objectives, measures, and targets from four perspectives, namely:
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1. Financial perspective: The financial perspective determines whether the
organization’s financial strategy contributes to achieving positive performance
results (Broccardo, 2015). The financial perspective provides a common language
for analysing and comparing organizations (Pandey, 2005).
2. Customer perspective: The customer perspective requires an organization to
know how it should create value for its customers if it is to succeed (Pandey, 2005).
3. Internal process perspective: The internal process perspective helps
organizations to determine their competencies and processes and identify where
it must excel to improve its performance (Bose & Thomas, 2007).
4. Learning and growth perspective: The learning and growth perspective
emphasizes employee training and building an organizational culture that
facilitates individual self-improvement, as well as, corporate development and
growth (Tontini & Søilen, 2014).
The process of translating strategy into action involves turning the organization’s
strategic vision into clear and understandable objectives for the four perspectives
discussed above (Bose & Thomas, 2007). Each of these perspectives provide relevant
feedback on how well the organization’s strategic plan is executed in order to make
adjustments where inefficiencies are identified (Salem et al., 2012). Each perspective of
the balanced scorecard includes (Pandey, 2005):
 Objectives: The organization specifies major objectives to be achieved under
each perspective.
 Measures: Measures are the indicators that determine progress towards reaching
an objective.
 Targets: Targets are the values for the measures.
 Initiatives: Initiatives are the actions that need to be performed to achieve the
organization’s objectives and targets.
Balanced scorecards are a strategic performance measurement frameworks that
help organizations translate their strategies into a set of goals and objectives, with
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implementation tracked through multiple performance measures (Bose & Thomas,
2007). Balanced scorecards provide a simple, systematic, and easy-to-understand
approach for performance measurement, review, and evaluation on a continuous basis
and provide quick feedback for control and evaluation Pandey (2005). According to
Pandey (2005), balanced scorecards also guide strategy formulation, implementation,
and communication.
A.3 Maturity model
Maturity models provide a structured approach for improving organizational
capabilities1 (Brookes et al., 2014). They are an established approach for assessing
organizational and operational capabilities in industries where there exists a strong
emphasis on evolution and levels of process formality (Srai et al., 2013). For more than
40 years, maturity models have been used as assessment frameworks to help improve
processes and ensure better process outcomes in the software engineering industry
(Hofmann et al., 2012). Since their initial application in the software engineering
industry, maturity models have gained popularity in other domains such as supply
chain management, innovation networks, knowledge management, and project
management (Lahti et al., 2009). They are widely used in different domains to
measure, plan, monitor and benchmark processes (Caralli et al., 2012). According to
Brookes et al. (2014), the value of a maturity model lies in its use as both an analysis
and benchmarking tool.
Maturity models are useful for organizations that aim to implement change or
improvement strategies in a well-structured way which will ensure tangible
transformation (Caralli et al., 2012). According to Van Dyk & Schutte (2012),
maturity models are a way of measuring the status quo and providing an improvement
approach that is specifically catered to an organization while prescribing the best
practices parameters of the industry in which it operates. Comparing the “as-is”
maturity of an organization to the “to-be” maturity helps to develop a staged plan
which prescribes which maturity levels need to be attained and in which sequence to
ensure sustained process improvement initiatives (Cleven et al., 2014). Using a
maturity model as a standard measurement approach helps organizations to determine
1Capabilities predict the most likely outcomes and results of a process (Paulk et al., 1993).
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where in the improvement journey they find themselves (Caralli et al., 2012). When
applied in a broader setting, maturity models also allow organizations to benchmark
their performance against other organizations in the same domain, which helps to drive
positive competition and encourages continuous improvement.
A maturity model describes the typical behaviour exhibited by an organization at
a specific level of maturity (Lahti et al., 2009). It consists of discrete maturity levels
for dimensions that represent the anticipated, desired or typical evolution path for an
organization’s practices (Schriek et al., 2016). According to Brookes et al. (2014), there
is vast evidence which supports the efficacy of maturity models, which is reflected in the
exponential growth in the development and application of these models.
135
Stellenbosch University https://scholar.sun.ac.za
Appendix B
Interview questions
136
Stellenbosch University https://scholar.sun.ac.za
Interviewee information  
1. What is your qualification? 
2. How many years of experience do you have in the field of pharmacy? 
Research topic 
1. Do you think essential medicine shortages and stock-outs are a problem in public 
healthcare facilities? 
2. What do you think is the main problem? 
Framework  
1. Do you think the dimensions and sub-dimensions included in the maturity model are 
sufficient to assess essential medicine supply management? 
Framework assessment 
Dimension: Selection 
Sub-dimension: Selection process   
 No.  Maturity level requirements  
Useful 
(Yes/No) 
Realistic 
(Yes/No) 
Comment  
1 
The facility is responsible for essential medicine 
selection. 
    
 
2 
The facility has a defined process for the selection of 
essential medicines.  
    
 
3 
The selection process is based on the observed 
disease prevalence of the population group in which 
the facility operates. 
    
 
4 
The facility has a comprehensive evidence-based 
standard treatment guideline (STG) for the most 
effective and cost-effective treatment and prevention 
of prevalent diseases.  
    
 
5 
The facility has an essential medicine list (EML) 
based on its comprehensive STG for the treatment 
and prevention of prevalent diseases.  
    
 
6 
The facility has a multidisciplinary team of healthcare 
professionals consisting of doctors, nurses, 
pharmacists, specialists and experts in public health 
or health economics which is responsibility the 
development of STGs and EMLs and ultimately the 
essential medicine selection process. 
    
 
7 
The multidisciplinary team considers patterns of 
prevalent diseases, the treatment facility, the 
training and experience of available personnel, 
financial resources, demographics and 
environmental factors in the selection of essential 
medicines.   
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8 STGs are adhered to by all practitioners.       
9 
Procurement of medicine is based on and limited to 
the facility's EML. 
    
 
10 
The facility has a monitoring and evaluation system 
to assess the performance of the selection process 
in selecting essential medicines that meets the 
needs of the facility. 
    
 
11 
The selection process is formally documented in the 
form of a guideline or policy which is in line with the 
country's National Health Policy. 
    
 
12 
EML and STGs are updated every two to three 
years.  
    
 
13 
The multidisciplinary team is continuously 
developing guidelines and policies to improve the 
selection process. 
    
 
14 
Cost-saving is observed due to a limited list of 
medicine procured and economies of scale.  
    
 
15 
The facility experiences fewer stock losses, 
medicine shortages and stockouts as a result of the 
consistently applied essential medicine selection 
process.  
    
 
Dimension: Selection 
Sub-dimension: Selection criteria:   
No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
1 
The facility has a selection criterion for essential 
medicines. 
    
 
2 
All essential medicines selected are evaluated and 
approved by a national drug regulatory authority.  
    
 
3 
Essential medicine is selected base their 
International Non-proprietary Name (INN) (generic 
names).  
    
 
4 
Essential medicine selection is based on the cost 
of the medicine. 
    
 
5 
The facility selects essential medicines based on 
their clinical efficacy and effectiveness, cost-
effectives, budget impact, quality, and safety. 
    
 
6 
The facility considers the total cost of treatment not 
only the unit cost of medicine. 
    
 
7 
Essential medicine criteria are based on relevant, 
recent and unbiased information. 
    
 
8 
The selection criterion is developed by a multi-
dispensary committee with access to relevant 
information on cost and quality assurance.  
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9 
The facility's selection criterion is closely linked to 
the WHO essential medicine selection criteria: 
relevance to the pattern of prevalent diseases, 
proven efficacy and safety, adequate scientific data 
and evidence of performance in a variety of 
settings, adequate quality, favourable cost-benefit 
ratio, desirable pharmacokinetic properties, 
possibilities for local manufacture and availability 
as a single compound.  
    
 
10 
The selection criterion is developed based 
accurate information regarding public health 
relevance, comparative cost-effectiveness, and 
pharmaceutical advances.  
    
 
11 
The facility's essential medicine selection criteria 
are evidence-based. 
    
 
12 
All medicines in the facility adhere to the selection 
criteria.  
    
 
13 
The facility's selection criteria are continuously 
reviewed to account changes in healthcare needs. 
     
Dimension: Quantification 
Sub-dimension: Data management 
 No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
1 The facility has a data management system.      
2 A needs assessment is conducted to determine 
which information and data are needed.     
 
3 
The facility has a standardised data collection 
process.      
 
4 The facility makes of use of information 
technology to collect and store data.     
 
5 Data is collected in a timely manner.       
6 
Data collection is the responsibility of trained 
personnel.     
 
7 Data is available and presented in a useful form.       
8 Data collected is sufficient for the quantification 
of essential medicine needs.      
 
9 The data meet established quality standards of 
timeliness, completeness, and accuracy.      
 
10 
The facility has an information system to analyse 
and validate the information and data required for 
quantification.      
 
11 Quantification data is available in real-time.       
12 
Data collection and analysis is guided by 
standard operating procedures.      
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13 
Data management process is monitored and 
evaluated to determine its ability to accurately 
estimate the medicine needs of the facility.     
 
14 
Data collected is analysed to inform the decision 
making of the supply system.     
 
15 Data collected is reliable and complete.       
16 
Data management process is continuously 
reviewed to determine if the practices in place 
are effective in producing accurate quantification 
outcomes.      
 
Dimension: Quantification 
Sub-dimension: Forecasting 
No.  
Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment  
1 The facility is responsible for forecasting the 
essential medicine needs of the system.  
     
2 Medicines forecasted form part of the facility's 
essential medicine list.  
     
3 Essential medicine forecasts are developed with 
the use of forecasting software.  
     
4 Quantity estimates are made for each type of 
essential medicine. 
     
5 Data used in the forecasting process is validated 
and is of high quality. 
     
6 The facility makes use of the consumption 
method to forecast essential medicine needs. 
     
7 Forecasting is conducted by well-trained 
personnel.  
     
8 Consumption data used for forecasting is 
adjusted to account for morbidity patterns, 
seasonal factors, services level, prescribing 
patterns, and patient attendance.  
     
9 Forecasting assumptions are informed by 
consumption data, service data, morbidity data, 
demographics data, policies, strategies, and 
plans.  
     
10 Assumptions are evidence-based and clearly 
stated. 
     
11 Forecasting is a collaborative effort by a multi-
disciplinary team of administrative and planning 
staff along with both clinical and pharmacy staff. 
     
12 Forecasting outcomes are used to inform supply 
plans. 
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13 Forecasting outcomes are reviewed and 
updated every six months to incorporate 
changes demand. 
     
14 The forecasting process is monitored and 
evaluated for accuracy in predicting the essential 
medicine needs of the facility.  
     
15 Forecasts are reviewed every six months and 
adjustments are made to meet the medicine 
demand. 
     
16 Forecasts are accurate in predicting the 
essential medicine needs of the facility. 
     
17 The facility experiences fewer shortages and 
stock-outs as a result of the accuracy of the 
forecasts. 
     
18 The multi-disciplinary team reviews the 
forecasting process to identify inefficacies. 
     
Dimension: Quantification 
Sub-dimension: Supply planning 
 No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
1 
The facility is responsible for developing supply 
plans.      
 
2 
Supply plans are based on the outcome of the 
forecasting process.     
 
3 
The facility determines the quantities and 
delivery schedules of essential medicines.     
 
4 
Supply plans incorporate variables such as 
supplier lead times and performance.     
 
5 
Supply planning is conducted by well-trained 
personnel.     
 
6 Supply plans are based on inventory levels.      
7 
The facility's supply plans are based on the 
financial resources available.     
 
8 
Suppliers chosen to provide adulate pricing, 
terms, delivery times, are dependable, quality 
service, return policy and packaging.     
 
9 
Supply plans consistently ensure that stock 
levels remain between the established maximum 
and minim stock levels of the facility.      
 
10 
Data used for supply planning is adjusted to 
account for morbidity patterns, seasonal factors, 
services level, prescribing patterns and patience 
attendance.      
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11 
Assumptions are informed by consumption data, 
service data, morbidity data, demographics data, 
policies, strategies and plans.      
 
12 
Assumptions are evidence-based and clearly 
stated.     
 
13 
Deliveries arrive before the stock reaches the 
established minimum level.      
 
14 
Stock ordered brings the stock level back to the 
maximum stock level.      
 
15 
Supplier selection, delivery schedules, product 
availability, quality and supplier performance are 
monitored.      
 
16 
The facility makes use of supply planning 
software to improve the accuracy of the supply 
planning process.      
 
17 
Orders are delivered on time and in full on a 
consistent basis.      
 
18 
Supply plans are reviewed every six months and 
adjustments are made to incorporate changes in 
the availability of financial resources and 
demand.     
 
19 
The multi-disciplinary team reviews the supply 
planning process to identify inefficacies.     
 
Dimension: Storage 
Sub-dimension: Storeroom requirements 
No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment  
1 
The facility has a separate or designated 
weatherproof storeroom to store essential 
medicines.      
 
2 
The storeroom is dry, clean and well ventilated 
with temperatures between +15 and +25 degrees 
Celsius.      
 
3 
Essential medicine is not exposed to direct 
sunlight.      
 
4 The storeroom is fitted with shelves.      
5 
The storeroom is fitted with infrastructure to 
control the climate.     
 
6 
Shelves are fitted with stock card and labels of 
essential medicines.      
 
7 
Narcotics and controlled products are kept in a 
locked area.      
 
8 
The storeroom is fitted with firefighting 
requirement and personnel is trained on how to 
use the equipment.      
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9 
The storeroom has security measures to avoid 
theft.      
 
10 
The storeroom is only accessible to authorised 
personnel     
 
11 
Storeroom has a designated area for receiving 
stock, main storage area, expired products, 
controlled substance, and cold chain products.      
 
12 
The facility has alternative energy sources in the 
event of power shortages.      
 
13 
Storeroom is routinely monitored and evaluated 
for compliance with storeroom requirements.     
 
14 
Essential medicines maintain their effectiveness 
throughout the storage period.      
 
15 
All medicines are stored according to the 
conditions specified by the manufactures.      
 
Dimension: Storage 
Sub-dimension: Storeroom management 
 No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
1 
The facility's storeroom follows a defined procedure 
for receiving, inspecting and storing essential 
medicines.     
 
2 
Stock is inspected for quality upon arrival in the 
storeroom.     
 
3 
There is a clear procedure to report discrepancies of 
medicines received.      
 
4 
Essential medicines are systematically arranged 
according to the FEFO rule.     
 
5 Each medicine is accompanied by a stock card.       
6 Stock records are kept and updated regularly.       
7 
Stock records are reconciled with physical stock 
takes.     
 
8 
Storage management is conducted by trained 
personnel.      
 
9 
The facility has effective guidelines which contain 
standard operation procedures for receiving stock, 
quality assurance inspections and systematic 
storage practices.      
 
10 
Information systems are in place to track products in 
the facility.      
 
11 
Storeroom management practices are monitored 
and evaluated based on their ability to maintain the 
integrity of essential medicines before distribution      
 
12 
The facility does not experience excessive essential 
medicine losses due to expiry, poor quality products 
or theft.      
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13 
The facility thoroughly investigates inefficiencies in 
storeroom management practices to identify new 
ways to improve the storage capacity of the facility.      
 
Dimension: Storage 
Sub-dimension: Inventory control 
 No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
1 
The facility has an inventory control system in 
place.      
 
2 
The facility regularly monitors and evaluates 
inventory levels.      
 
3 
The facility's inventory records are complete, 
reliable and accurate enough to be used to inform 
inventory control decisions.      
 
4 
Monitoring inventory levels is the responsibility of 
well-trained personnel.      
 
5 
The facility has a standard operating procedure for 
monitoring and evaluating stock levels.     
 
6 
The facility has a well-calculated minimum and 
maximum inventory level.     
 
7 
Reorder quantity is based on the desired stock 
levels for two to four months of stock.      
 
8 
Safety stock and lead-time are taken into account 
when determining the minimum and maximum 
inventory levels.     
 
9 
Medicine review period ensures medicine does not 
fall below-established minimum stock levels.     
 
10 
Inventory control takes into account the storage 
capacity of a healthcare facility.      
 
11 
Personnel responsible for inventory control have 
received adequate inventory management training.      
 
12 
Safety stock policy is adequate to withstand an 
increase in demand.     
 
13 
Order quantities consistently last for the period 
between when orders are placed and when orders 
arrive.     
 
14 
Inventory control system prevents the facility from 
being over-or-under-stocked.      
 
15 The system rarely places emergency orders.       
16 
Inventory control practices are reviewed and 
updated regularly through consultation with various 
stakeholders.     
 
Dimension: Distribution 
Sub-dimension: Distribution process 
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No. Maturity level requirements  
Answer 
(Yes/No) 
Realistic 
(Yes/No) 
Comment 
 
1 
The facility has defined a process for distributing 
essential medicines to inpatients.      
 
2 
Medicine distribution is initiated by an order in the 
form of a prescription.      
 
3 
Medicine is distributed in unit-doses from the 
hospital’s central pharmacy.      
 
4 The facility makes use the unit-dose dispensing to 
dispute medicine to inpatient.      
 
5 
The facility has effective guidelines which contain 
standard operation procedures for dispensing 
medicine.     
 
6 Medicine distribution is only for 24-hour supply.      
7 
Medicine is distributed after review of a 
prescription by pharmacists.      
 
8 
Reliable records are kept off to track consumption 
of medicines.      
 
9 Data is collected in a timely manner.       
10 
The turnaround time between a patient’s 
prescription and administer medication is short.     
 
11 The facility experiences fewer distribution errors.       
12 
The distribution process ensures minimum losses 
due to spoilage.     
 
13 
The distribution process formally defined and 
consistently applied.     
 
14 
Pharmacy and clinical personnel consultation are 
helping to identify inefficiencies in the distribution 
system.     
 
General: 
1. Is this assessment framework easy to understand? 
2. Do you think this assessment framework will be useful in improving access to essential 
medicines? 
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Appendix C
Framework use example
Appendix C presents a fictitious healthcare facility setting to illustrate how the
assessment framework developed should be used in practice. Sections C.1 and C.2
present the case description and assessment results, respectively.
C.1 Case Description
District Hospital is a public healthcare facility. The hospital has been experiencing
frequent medicine shortages and stock-outs since its budget for the 2018/2019 financial
year was not increased due to the economic state of the country. An annual performance
assessment found that the hospital had a 94% medicine availability rate. This figure is
relatively high when compared to other district hospitals in the province. However,
shortages and stock-outs still occur. The hospital’s management team does not know
the root cause of the problem and attribute the frequent shortages and stock-outs to
insufficient financing.
In recent months the hospital’s senior pharmacist and two pharmacist assistants
were dismissed after allegations of theft. The hospital currently relies on three junior
pharmacists to conduct all medicine management activities. The lack of managerial
experience coupled with limited personnel has left the pharmacists overwhelmed with
administrative work which has affected the efficiency of the hospital negatively.
The following paragraphs provide an overview of the District Hospital’s medicine
management practices.
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Selection process: District Hospital’s pharmacy department is solely responsible for
the selection of essential medicines. The selection process is based on the experience
of the personnel and it is not explicitly defined. The hospital uses a comprehensive,
evidence-based STG; which was developed when the hospital opened in 2003. The
national EML guides the selection and procurement of medicines in the facility. The
hospital often also procures medicines which are not on the national EML because each
doctor makes their own lists of the products they need to treat patients.
Selection criteria: The hospital does not have a medicine selection criteria. However,
all medicines in the facility are selected based on the latest national EML which was
last revised in 2013. All medicines in the hospital are approved by the National Drug
Regulatory Authority. Senior nurses have taken over some of the medicine management
responsibilities due to the personnel shortage in the pharmacy. The pharmacists do not
have the time or capacity to train the nurses on using Non-proprietary Names, therefore,
the hospital has been ordering brand name medicines which are more expensive than
generic medicines. This has increased the hospital’s medicines costs significantly.
Data management: The hospital recently received a donation of a healthcare
information system which is used for data management. Before the system was
implemented the hospital used a manual data management system. The conversion to
the new system has been challenging as the donor only provided training for one
personnel member. This makes it difficult to have up to date quantification data. The
facility has a standardised data collection process which is guided by standard
operating procedures. Trained personnel only collect the data required for
quantification purposes. Even though the data is not readily available the validation
system in place ensures that quality data is produced and used to make informed
quantification decisions.
Forecasting: The facility forecasts its own essential medicine needs using
sophisticated forecasting software and quality data. The consumption data used for
forecasting is adjusted to account for morbidity patterns, seasonal factors, services
level, prescribing patterns, and patient attendance. Due to the limited personnel
available in the pharmacy, forecasts are not prepared for all medicines. Some medicines
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are ordered in batches to save time. The forecasting outcomes are reviewed and
updated every six months to incorporate changes in demand.
Supply planning: The facility is responsible for developing its own supply plans. The
supply plans developed are based on the outcomes of the forecasting process, inventory
levels and funding available. The supply plans determine the quantities, cost and delivery
schedules of essential medicines. Supply planning is conducted by well-trained personnel.
The data used for supply planning is adjusted to account for morbidity patterns, seasonal
factors, services levels, prescribing patterns, and patient attendance. The facility makes
use of supply planning software for the supply planning process. Unfortunately, orders
are not consistently delivered on time and in full. Supply plans are reviewed every six
months and adjustments are made to incorporate changes in the availability of financial
resources and demand.
Storeroom requirements: The facility has weather proof storeroom which is fitted
with labelled shelves and each shelf contains stock cards for the medicines on it. All
medicines are stored according to the conditions specified by their manufactures. After
the dismissal of the pharmacy personnel, the hospital has upgraded its security
measures and the storeroom is now only accessible to authorised personnel. The
pharmacy personnel routinely monitor and evaluate the storeroom for compliance with
storeroom requirements. Due to the increase in electricity outages in the region, the
Department of Health installed generators in the hospital.
Storeroom management: The facility’s storeroom follows a defined procedure for
receiving, inspecting, and storing essential medicines. Storeroom management is
conducted by trained personnel who inspect stock for quality upon arrival in the
storeroom. The hospital has a clear procedure to report discrepancies of medicines
received. The facility conducts annual physical stock counts to reconcile inventory
data. The last stock count found that a lot of medicines in the facility were expired or
damaged.
Inventory control: The hospital has an inventory control system in place but the
facility finds it difficult to maintain desired stock levels. In recent months the facility has
placed numerous emergency orders which have been very expensive. Unfortunately, the
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facility does not have the capacity to conduct an investigation to determine the cause
of the problem and has opted to overstock the storeroom in an attempt to mitigate
shortages and stock-outs.
Distribution process: District Hospital has recently started distributing essential
medicines to inpatients using the unit-dose dispensing system. The process is defined
and is conducted using standard operating procedures. The distribution system works
well, but due to the limited personnel, medicines are sometimes distributed using the
ward stock system to save time. This practice results in distribution errors and medicine
wastage. The medicine distribution process is initiated by an order in the form of a
prescription which is accompanied by a patient’s medical records. The limited personnel
has also made it difficult to keep accurate consumption and distribution data records.
C.2 Results
The maturity instrument was used to assess the essential medicine management practices
at the District Hospital. Figure C.1 summarises the outcome of the assessment and the
actual assessment instrument outcomes can be seen on Page 149.
Figure C.1: Assessment results
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Dimension 
Selection  
Sub-dimension 
Selection process 
Maturity level requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for its own essential medicine selection. Yes 
Level 1 
The facility has a defined process for the selection of essential medicines.  No 
The selection process is based on the observed disease prevalence of the population 
group the facility treats. 
No Level 2 
The facility has a comprehensive, evidence-based, standard treatment guideline 
(STG) for the most cost-effective treatment of diseases.  
Yes 
Level 3 
The facility has an essential medicine list (EML) based on its comprehensive STG.  No 
The facility has a multidisciplinary team of healthcare professionals responsible for 
the development of STGs and EMLs and ultimately the essential medicine selection 
process. 
No 
The multidisciplinary team considers patterns of prevalent diseases, the type of 
treatment facility, the training and experience of available personnel, financial 
resources, demographics and environmental factors in the selection of essential 
medicines.   
No 
The facility’s STGs are adhered to by all practitioners.  No 
Level 4 
The procurement of medicine is based on and limited to the facility's EML. No 
The facility assesses the performance of the selection process by reporting on its 
ability to select essential medicines that meet the needs of the facility. 
No 
The selection process is formally documented in the form of a guideline or policy 
which is in line with the country's National Health Act. 
No 
Level 5 
The facility’s EML and STGs are updated every two to three years.  No 
The multidisciplinary team of healthcare professionals continuously review the 
selection process to identify opportunities for improvement. 
No 
The facility observes cost saving due to a limited list of medicines procured.  No 
Dimension 
Selection 
Sub-dimension 
Selection criteria 
Maturity level requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a selection criterion for essential medicines. No Level 1 
All essential medicines selected are approved by a national drug regulatory 
authority.  
Yes Level 2 
The facility selects essential medicines according to their International Non-
proprietary Name (INN) (generic names). 
No 
Level 3 
The facility selects essential medicines based on their quality and cost-effectives. No 
C.2 Results
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The facility considers the total cost of treatment not only the unit cost of medicine. No 
The facility’s selection criterion is based on relevant, recent and unbiased 
information. 
No 
The facility’s selection criterion was developed by a multi-dispensary committee of 
healthcare professionals. 
No 
The facility's selection criterion is closely linked to the WHO essential medicine 
selection criteria: relevance to the pattern of prevalent diseases, proven efficacy 
and safety, adequate scientific data and evidence of performance in a variety of 
settings, adequate quality and favourable cost-benefit ratio.  
No Level 4 
The facility's essential medicines selection criterion is evidence based. No 
Level 5 
All medicines in the facility adhere to the selection criteria.  No 
The facility's selection criteria are continuously reviewed to identify opportunities 
for improvement. 
No 
Dimension 
Quantification 
Sub-dimension 
Data management  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a data management system in place. Yes Level 1 
The facility conducted a needs assessment to determine the type of information 
and data required for quantification. 
Yes 
Level 2 
The facility has a standardised data collection process which is conducted according 
to formally defined standard operation procedures. 
Yes 
The facility makes use of information technology to manage data. Yes 
The data is collected in a timely manner.  No 
The facility has a system to analyse and validate the information and data required 
for quantification.  
Yes 
The facility’s data management is the responsibility of trained personnel. Yes 
The data is available in real-time and presented in a useful form.  No 
Level 3 The data meets established quality standards of timeliness, completeness and 
accuracy.  
No 
The facility’s data management system enables reasonably accurate quantification 
outcomes on a consistent basis. 
No 
Level 4 
The facility’s data is used to inform supply management decision-making. Yes 
The facility’s data management processes are continuously reviewed to identify 
opportunities for improvement.  
No Level 5 
Dimension 
Quantification 
Sub-dimension 
Forecasting 
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Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for forecasting its own essential medicines needs.  Yes Level 1 
All medicines forecasted form part of the facility's essential medicines list.  No 
Level 2 
The facility’s forecasts are developed using forecasting software.  Yes 
Demand estimates are made for each essential medicine. No 
The facility makes use of the consumption method to forecast essential medicines 
demand. 
Yes 
Forecasting is conducted by well-trained personnel.  Yes 
The consumption data used for forecasting is adjusted to account for morbidity 
patterns, seasonality factors, service level, prescribing patterns and patient 
attendance.  
Yes 
Level 3 
The assumptions made during the forecasting process are evidence based and 
informed by consumption data, service data, morbidity data, demographics data, 
policies, strategies and plans.  
No 
The forecasting process is a collaborative effort by a multi-disciplinary team of 
administrative- and planning staff along with both clinical- and pharmacy staff. 
No 
The forecasting outcomes are reviewed and updated every six months to 
incorporate changes in demand. 
Yes 
Level 4 
The forecasting process predicts the facility’s medicine demands with marginal lag 
time. 
No 
The multi-disciplinary team reviews the forecasting process continuously to identify 
opportunities for improvement. 
No Level 5 
Dimension 
Quantification 
Sub-dimension 
Supply planning  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility is responsible for developing its own supply plans.  Yes Level 1 
The supply plans developed are based on the outcome of the forecasting process, 
inventory levels and funding available. 
Yes 
Level 2 
The supply plans determine the quantities, cost and delivery schedules of essential 
medicines. 
Yes 
The supply plans incorporate supplier lead times and performance. No 
Supply planning is conducted by well-trained personnel. Yes 
Supply plans consistently ensure that inventory levels remain between the facility’s 
established maximum and minim levels. 
No 
Level 3 
Supply planning is a collaborative effort by a multi-disciplinary team of 
administrative- and planning staff along with both clinical- and pharmacy staff. 
No 
The data used for supply planning is adjusted to account for morbidity patterns, 
seasonal factors, services levels, prescribing patterns and patient attendance.  
Yes 
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The facility makes use of supply planning software to improve the accuracy of the 
supply planning process. 
Yes 
The assumptions made during supply planning are evidence based and informed by 
consumption data, service data, morbidity data, demographics data, policies, 
strategies and plans.  
No 
The facility monitors the performance of suppliers based on pricing, terms, delivery 
times, dependability, quality service, return policy and packaging. 
No 
 Level 4 
Supply plans are reviewed every six months and adjustments are made to 
incorporate changes in the availability of financial resources and demand. 
Yes 
Supply planning practices ensure orders are consistently delivered on time and in 
full.  
No 
The multi-disciplinary team reviews the supply planning process to identify 
opportunities for improvement. 
No Level 5 
Dimension 
Storage 
Sub-dimension 
Storeroom requirements  
Maturity requirement 
Answer 
(Yes/No) 
Maturity 
Level 
The facility has a designated weatherproof room to store essential medicines.  Yes Level 1 
The storeroom is dry, clean and well ventilated with temperatures between +15 
and +25 degrees Celsius.  
Yes 
Level 2 
The storeroom is fitted with equipment to control environmental conditions. Yes 
The environmental conditions of the storeroom are monitored and reported. No 
Narcotics and controlled products are kept in a locked area.  Yes 
The storeroom is fitted with firefighting equipment and personnel is trained on how 
to use equipment. 
Yes 
The storeroom is fitted with shelves. Yes 
Each shelf contains stock cards and labels of the medicines on it. Yes 
The storeroom is only accessible to authorised personnel Yes 
The storeroom has security measures to avoid theft. Yes 
Essential medicines are not exposed to direct sunlight and never stored on the 
floor.  
Yes 
The storeroom has designated areas for: receiving stock, a main storage area, 
expired products, controlled substance and cold chain products. 
No Level 3 
The storeroom is routinely monitored for compliance to storeroom requirements. No Level 4 
The facility has alternative energy sources in the event of power shortages. Yes 
Level 5 All medicines are stored according to the conditions specified by their 
manufactures.  
No 
Dimension 
Storage 
Sub-dimension 
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Storeroom management  
Statement  
Answer 
(Yes/No) 
Level 
The facility's storeroom follows a defined procedure for receiving, inspecting and 
storing essential medicines. 
Yes Level 1 
Stock is inspected for quality upon arrival in the storeroom. Yes 
Level 2 
There is a clear procedure to report discrepancies of medicines received.  Yes 
Essential medicines are systematically arranged according to the FEFO rule. No 
Level 3 
Stock records are kept and updated regularly.  No 
The stock records are reconciled with physical stock takes at least every quarter.  No 
Storeroom management is conducted by trained personnel.  Yes 
The facility has effective guidelines in which contain standard operation procedures 
for receiving stock, quality assurance inspections and systematic storage practices.  
No 
Level 4 
The facility has an information system in place to track movement of medicines in 
the storeroom.  
Yes 
The facility does not experience excessive essential medicine losses due to expiry, 
poor quality products or theft.  
No 
Level 5 
Essential medicines maintain their effectiveness and shelf life throughout the 
storage period.  
No 
The facility’s storeroom management practices are continuously reviewed to 
identify opportunities for improvement.  
No 
Dimension 
Storage 
Sub-dimension 
Inventory control  
Statement  
Answer 
(Yes/No) 
Level 
The facility has an inventory control system in place.  Yes Level 1 
The facility has standard operating procedures for monitoring stock levels. Yes 
Level 2 
The facility regularly monitors inventory levels.  No 
The facility's inventory records are complete, reliable and accurate and are used to 
inform inventory control decisions.  
No 
Monitoring inventory levels is the responsibility of well-trained personnel.  No 
The facility has a well-calculated minimum and maximum inventory level that 
consistently ensures few shortages and stock-outs. 
No 
Level 3 
The safety stock and lead times are considered when determining minimum and 
maximum inventory levels. 
No 
The facility’s reorder quantity is based on the desired inventory levels for two to 
four months of inventory.  
No 
The facility has an information system in place which sends notifications when 
inventory levels reach the established reorder quantity.  
No 
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The medicine review period ensures medicines do not fall below established 
minimum stock levels. 
No 
The inventory control system considers the facility’s storage capacity and financial 
resources available.  
Yes 
Personnel responsible for inventory control have received adequate inventory 
management training.  
No 
The facility’s safety stock policy is adequate to withstand increase in demand. No 
Level 4 
The order quantities consistently last for the period between when orders are 
placed and when orders arrive. 
No 
Inventory control system prevents the facility from being over-or-under-stocked. No 
Inventory control practices are continuously reviewed and updated through 
consultation with various stakeholders to identify opportunities for improvement. 
No 
Level 5 
The system rarely places emergency orders.  No 
Dimension 
Distribution 
Sub-dimension 
Distribution process  
Statement  
Answer 
(Yes/No) 
Level 
The facility has defined process for distributing essential medicines to inpatients.  Yes Level 1 
The medicine distribution process is initiated by an order in the form of a 
prescription which is accompanied by a patient’s medical records.  
No 
Level 2 
The facility distributes medicines in unit-doses from the facility’s central pharmacy.  No 
The facility makes use of the unit-dose dispensing system to distribute medicine to 
inpatients.  
Yes 
Level 3 
The medicine distributed is only for a 24-hour period. No 
The facility’s personnel are well-trained and efficient in preparing unit-dose carts. No 
The facility has effective guidelines which contain standard operation procedures 
for distributing medicines. 
Yes 
The medicine is only distributed after the review of a prescription and patient 
records by pharmacists.  
No 
Reliable records are kept to monitor the consumption of medicines.  No 
Distribution data is collected in a timely manner.  No 
The turnaround time between receiving an order and administering medication is 
short. 
No 
Level 4 
The facility experiences fewer distribution errors and medicine losses due to 
spoilage.  
No 
The distribution process is formally defined in a facility policy and consistently 
applied. 
No 
Level 5 
Pharmacy and clinical personnel consultation help to identify inefficiencies in the 
distribution system and opportunities for continuous improvement. 
No 
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Table C.1 presents a brief discussion of the results for two1 sub-dimensions, namely:
selection process and inventory control.
Table C.1: District Hospital maturity results
Sub-
dimension
Result Discussion
Dimension: Selection
Selection
process
Level 1: Initial.
The healthcare
facility does not
have an essential
medicine selection
process or the
process in place is
inadequate.
The District Hospital could be experiencing frequent
essential medicine stock-outs because the selection
process in place does not select the correct medicine
to prevent or treat prevalent diseases of the
population group the hospital serves. Since the
hospital has a 94% medicine availability rate it is
assumed that the hospital is performing optimally.
However, this figure could represent wrong medicines
that are made available in the facility which do not
help the hospital deliver quality healthcare. The
maturity assessment instrument provides a guide
and recommendations for improving the selection
process.
Dimension: Storage
Inventory
control
Level 1: Initial.
The healthcare
facility does not
have an inventory
control system
in place or the
system in place is
inadequate.
The District Hospital’s inventory control fails to
maintain the desired stock levels because practices
in place are reactionary and not standardized. The
healthcare facility does not monitor stock levels
regularly which means that the 94% medicine
availability could be significantly overstated. It
should be noted that to improve inventory control,
the quantification practices i.e. data management,
forecasting and supply planning need to be adequate.
This will ensure that the quantity of essential
medicine needed in a healthcare facility is known
which will allow the desired inventory levels to
be defined. It is impossible to maintain desired
inventory levels when the desired levels are not
established. The maturity assessment instrument
provides a guide and recommendations for improving
inventory control.
1Only two sub-dimensions were discussed to present the reader with an example of how results can
be analysed in practice.
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